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Abstract
Worldwide, an estimated 31% of people who die each year have a cardiovascular
disease (CVD), an all-encompassing group of diseases and conditions of the heart or
blood vasculature. Access to portable, user-friendly tools to test lipid levels accurately
and efficiently, without requiring large volume blood draws, will help improve access to
wellness management by reducing costs and facilitating early screening and monitoring
of CVD thus improving outcomes. Point of care micro or millifluidic chips to test
biofluids that are integrated into detection units are an attractive measurement tool
because of their potential for ease of use by patients at home or at satellite limited
function clinics.
This dissertation outlines four research efforts aligned with the larger goal of
CVD detection: 1) use laboratory equipment and microdevice measurements to compare
the lipid profile content of fasting plasma and blood samples to post-meal samples to
determine an optimal method to rapidly detect lipid levels, 2) compare the optimal
detection method, UV-Vis spectroscopy, against gold-standard medical laboratory tests,
3) examine the effects of tea consumption (Hibiscus sabdariffa tea or Camellia sinensis
(Oolong tea)) and a peach tea control on blood lipid profiles and cardiovascular
metabolic indicators, 4) design and test a millifluidic chip, miniaturizing the optimal
technology from Objective 1, to detect the lipemic state using a drop or two of blood
plasma.
The overarching hypothesis guiding this dissertation research was given that lowdensity lipoproteins of large and small lipid globules directly affect plasma turbidity,
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optical and electrical measurements can be simplified into a portable, point-of-care unit
to discern high- and low-density lipoproteins and triglyceride levels in human blood
samples for lipemia diagnosis or other CVD risk determinations. This dissertation
focused on detecting the transient lipemic state; however, this work could serve as a
foundation to eventually discern chronic cholesterol levels using a simpler approach than
current medical tests.
The new knowledge gained from this dissertation includes a simple dilutionbased, reagent-free method to discern lipemic status in donated blood samples. A
ratiometric analysis was conducted such that lipemic status could be discerned with a
99% confidence from a single unknown sample. These results are partially corroborated
with UV-Vis lipoprotein standards as well as a gold-standard medical tool, HPLC-MS.
Additional knowledge was gained regarding the time-dependent reduction in lipid
profiles of participants consuming Hibiscus and Oolong teas as compared to the peach tea
control. While the participant study was interrupted due to COVID-19 lab closures, the
data obtained provides preliminary suggestive evidence that these teas do influence lipid
profiles over time. A new device was also engineered to demonstrate portable lipid
testing.
Future work will involve measuring cholesterol levels in different human body
liquids such as tears, urine, skin, and saliva since research has been initiated into the
ability to use fluids other than blood (plasma or serum) for diagnostic testing. Using other
bio-fluids may make the test less invasive and less costly as well for the patient.
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1 Introduction

One in four deaths each year in the United States are attributed to heart disease 1.
Worldwide, an estimated 31% of people who die each year caused by cardiovascular
diseases (CVD) 2, an all-encompassing group of diseases and conditions of the heart or
blood vasculature 3. CVD prevalence varies with diet and lifestyle with regional and
cultural differences. For example, the rate of the CVD deaths in Saudi Arabia was
recently reported to be 42% 2, 4-8, significantly higher than the world average.
A majority of cardiovascular diseases involve lipid and lipoprotein metabolic processes
as factors of risk in disease cascades or progression 9. Lipids and lipoproteins comprise
8% of the body 10. One important lipid, cholesterol, is the most common steroid molecule
in the human body. Cholesterol and cholesterol derivatives serve critical biological
structures and signaling roles 11. Elevated free cholesterol levels in blood plasma have
been utilized as medical indicators of CVD for approximately 20 years, although
questions regarding the reliability of this indicator are surfacing. CVD diseases affect the
structures and function of the heart, and include: coronary heart disease (CHD) 1, 12,
known as coronary artery disease (CAD) 13. CHD is a type of disease that involves the
heart arteries and can be developed by lack of oxygen-rich blood being delivered to the
heart 13. In the National Cholesterol Education Program’s strategy, a proper blood
cholesterol level measurement is important to reduce morbidity and mortality that is
related to CHD 14. Cholesterol, and more broadly, lipids and lipoproteins present in the
cardiovascular system are indicators of CVD risk 9. A related condition, lipemia is a
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condition of high concentrations of circulating lipid globules in the cardiovascular
system. Furthermore, transient lipemia is the most frequent interference of blood
laboratory tests ranging from chronic CVD screening to pathogen and sepsis detection 10.
Lipemia is commonly measured via the visual cloudiness (turbidity) of human blood
serum/plasma, which is predominantly caused by high concentrations of low-density
lipoprotein particles 10, 15.
Until recently, low-density lipoprotein concentrations were used as the primary indicator
of CVD risks and the major focus of cure strategies. More recent clinical efforts have
determined two different lipid fraction ratios are useful risk indicators of cardiovascular
disease incidents and cardiovascular risk reduction: a) total cholesterol:high-density
lipoproteins and b) low-density lipoproteins:high-density lipoproteins 16. Tracking serum
lipid levels over the short-term (between 2 and 7 days apart) has a major influence on the
long-term (up to 3-year intervals) lipid profiles, based on research done on >40 healthy
Finnish 9-year-old boys between 1980-1989 17. Multiple studies illustrate that balanced
lipid profiles are important for cardiovascular health 9.
The overarching goal for this research dissertation is to accurately and robustly detect
lipid profiles for detection of lipemia status using a single drop of plasma in a portable
unit, which would enable simpler nutritional and CVD screenings for medical
interventions.

1.1 Research Objectives and Hypotheses
The motivation for my research is to engineer a point of care, and easy to use test to
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monitor lipids in human blood. The overarching goal for this project is to detect lipemia
states using a single drop of plasma, with the broader aim of enabling nutritional and
cardiovascular disease screenings for medical interventions. Therefore, the translation of
these tests to a lab on a chip platform means that lipid screenings can be performed at a
patient's bedside or can even be conducted by a patient at multiple points throughout the
day.

The work in this dissertation has maintained a focus on detecting the transient lipemic
state. However, the results could serve as a foundation to eventually detect chronic
cholesterol levels. We have split this research into four main objectives:
1. try to find the optimum analytical approach to differentiate lipid levels in the fasting
to the post-meal plasma and blood samples. Using this basic laboratory equipment
that would be feasible to scale down to a microdevice. Testing will occur using four
different methods of cholesterol detection; electrical characterizations,
dielectrophoresis, cell lysis, and ultraviolet-visible light spectroscopy (UV-Vis).
Given that low-density lipoproteins of large and small globules have previously been
shown to have the largest direct effect on turbidity, we hypothesize that a
combination of optical and electrical measurements (absorbance and electrical
characterizations) can discern high-density lipoproteins from low-density
lipoproteins, irrespective of size.
2. Compare the selected detection method, which was determined to be UV-Vis, against
the standard medical laboratory method of high-performance liquid chromatographymass spectroscopy (HPLC-MS). Calibrate the selected detection tool with the “gold3

standard” laboratory test. This objective explored detection of lipid profiles from
human blood samples and compare them to lipid standards using ultraviolet visible
spectroscopy (UV-Vis) as well as high performance liquid chromatography-mass
spectroscopy (HPLC-MS).
3. Examine a tea consumption intervention on lipid profiles, in coordination with other
cardiovascular measurements. Compare fasting and post-meal lipid profiles as well
as cardiovascular function for comparison across 3 participant tea groups over 9
weeks: a control group who drank peach tea, a group who drank Hibiscus sabdariffa
L. (HS) and a group who drank Oolong tea.
The third objective arose from collaborative discussions with Dr. John Durocher in
the Department of Biology. Our teams collaborated to examine and detect the effect
of tea consumption (Hibiscus, Oolong, and peach) on human health by reducing the
blood pressure and cardiovascular disease risks. Dr. Durocher’s group specializes in
arterial blood pressure and cardiovascular diseases indicators in response to stressors
or interventions. In a complimentary fashion, dynamic lipoprotein levels may
provide insights into transient indicators of patient health including cardiovascular
stressors. Combined together, these objectives provide a comprehensive exploration
of the detection and dependence of lipid profiles with short and mid-term diet
interventions.
4. Design and test a lab on a chip device for transient lipemia detection. Engineer a
device that miniaturizes the optimal technology from Objective 1 to detect the lipemic
state using a drop or two of plasma.
4

1.2 Background
1.2.1

Cardiovascular Diseases (CVD)

Cardiovascular disease (CVD) is the main cause of death, globally. CVD is a broad
classification of diseases that cover both blood-vessel and heart diseases. This type of
disease affects the structures and function of the heart, and includes: coronary heart
(artery) diseases (CHD), peripheral artery disease, heart attack, stroke, and heart failure 1,
18

. Cardiovascular diseases include all heart diseases but heart disease does not include all

types of cardiovascular diseases 1.

Many cardiovascular diseases (CVD) develop from atherosclerosis, which is plaque
buildup in the vasculature 19 that narrows the blood pathways to the tissues and organs.
Coronary heart diseases (CHD) are a subset of cardiovascular diseases, where
atherosclerosis causes the coronary arteries to narrow, and not allow enough blood and
oxygen are delivered to the heart, which can lead to a clot and heart muscle cell death 20.

There are many risk indicators of cardiovascular diseases such as: level of physical
inactivity, body composition, body fat distribution, diet, genetics, age, alcohol intake, and
tobacco use 21. For the past century, it has been reported that abnormal of lipid levels
such as lipids and lipoproteins in human blood are one of the most predominant risk
indicators of cardiovascular diseases 21. Some diseases, such as lipid disorders, diabetes
mellitus, and obesity, are risk indicators of cardiovascular diseases. Some measurements
have been shown to be positively correlate with increasing CVD risk such as; triglyceride
and low-density lipoprotein levels, blood pressure, and body-mass-index (BMI) 22, 23.
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1.2.2

Lipids and Lipoproteins

Lipoproteins are characterized by size (Figure 1-1), and there is an inverse relationship
between a lipoprotein’s size and its density. The lower density particles predominantly
contribute to the plasma sample’s turbidity. Turbidity is often greatest after having a high
fat and high carbohydrate meal and is due to the accumulation of large lipid particles in
human plasma, which scatters the light of lab instruments 24. Chylomicrons are the largest
lipoprotein in size and lowest in density which have the greatest impact on sample
turbidity 10.

Figure 1-1 Lipoprotein particle sizes 10. The smallest lipoprotein particles are the highdensity lipoproteins (HDL). As particle size increases, the density decreases to very-lowdensity lipoproteins (VLDL) (Recreated based on 10)

Human plasma contains six main categories of lipids: glycerophospholipids,
glycerolipids, fatty acyls (FA), sterols, sphingolipids, and pernols 25. Triglycerides (TG)
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contain a glycerol backbone that is ester-linked to three fatty acid molecules 26. There are
>200 triglyceride molecules detected in human plasma 25. Triglyceride is the most
common type of lipid in human blood stream. Mainly, introduced to the body by food,
especially oily and fatty food, also comes from the extra calories that are stored in fat
cells 27. Triglyceride is a risk indicator for heart and metabolic diseases because it is
associated with the insulin level increases and it is consider as the starter of the
cardiovascular diseases 25. Figure 1-2 below is the triglyceride general chemical structure.

Figure 1-2 Triglyceride Chemical Structure (Made using ChemDraw Software)

Cholesterol, a common lipid, is often attached to proteins as part of a combined molecule
called a lipoprotein. Additional lipids within blood and other biofluids also contribute to
cardiovascular function. Cholesterol has many useful functions in the body, and the
molecules are circulated within the blood to be delivered to different tissues. There are
7

two main types of cholesterol lipoproteins: high-density lipoprotein (HDL) (good for
health) and low-density lipoprotein (LDL) (bad for health). Excess circulating LDL may
intercalate with the walls of the blood vessels, building plaques that narrow the vessels.
In some later stages this may impede blood flow causing adverse cardiovascular events.
In contrast, HDL helps pick up excess free cholesterol in the blood plasma and transports
it to the liver to be broken down. Increasing HDL and reducing LDL may lower the risk
of heart diseases 28.

Low-density and high-density lipoproteins have almost the same components in their
cholesterol and cholesteryl ester layer - although the LDL has a higher concentration of
cholesterol and cholesterol ester layer - a similar monolayer of phospholipids and protein
(constant in both types), and apolipoprotein 29. Low-density lipoproteins (LDL), the more
“lethal” cholesterol, helps move cholesterol and triacylglycerol from the liver to tissues.
Also, LDL particles contain around three-fourths of the total cholesterol in human plasma
11

. High-density lipoproteins (HDL) move unused cholesterol from the tissues back to the

liver to be recycled into new compounds 29. HDL is termed healthy cholesterol.

1.2.3

Lipemia

A lipidomic plasma status was first defined in 2003 30. Lipidomic status is a condition of
lipids state in human liquids, that includes lipid types, behaviors, characteristics, and
complexes 30. A full human lipid profile screening yields what is known as the lipidome.
Lipids are located throughout human cell components which make the molecules
essential contributors to cell functions and disease mechanisms 30. Lipid disorders and
8

metabolic syndrome are a result of an increased low-density lipoproteins level and
reduced high-density lipoproteins level 9, such as the dyslipoproteinaemia which can be
characterized by hypertriglyceridemia 9, 16.
Lipemia is a condition of high concentrations of circulating lipid globules in the
cardiovascular system. Lipemia is a growing concern globally, with ~30% of the US
population displaying higher than normal levels. Normal levels are defined from
triglyceride (lipid) concentrations in either the plasma or serum 31, 32. The triglyceride
concentration in human blood have been used clinically as the starting point of many
diseases such as: heart diseases and metabolic diseases 25. Since lipids and lipoproteins
present in the cardiovascular system are indicators of CVD risk, being able to discern
transient from chronic lipids would be valuable. Furthermore, transient lipemia is the
most frequent source of interference in blood laboratory tests ranging from chronic CVD
screening to pathogen and sepsis detection 10. Lipemia (the lipemic state) is commonly
measured via the cloudiness (turbidity) of human blood serum/plasma, which is
predominantly caused by high concentrations of low-density lipoprotein particles 10, 15.
Collection of blood samples within 30 minutes – 3 hours after donors consume a fatty
meal, help to indicate the lipemic sate. Subsequent chemical analyses illustrate that
lipemic samples are the most common cause of analyte signal interference 10, 15 or
parenteral (without passing through the digestive system) inclusion of synthetic lipid
emulsions 10.

1.2.3.1 Lipemia Types
There are three main types of lipemia:
9

1. Postprandial lipemia: a dynamic, transient state, which is measured by the increase of
triglyceride lipoproteins after eating 33.
2. Familial hypercholesterolemia (FH): the most common monogenic cause of
hypercholesterolemia and premature atherosclerotic cardiovascular disease (ASCVD)
34

. This type of lipemia affects approximately 1:500 persons in the general

population11. It was the first genetic disease of lipid metabolism to be clinically and
molecularly characterized and is the most common and severe monogenic disorder 9.
3. Lipemia retinal: a rare condition that results in high levels of triglycerides and
chylomicrons present in the blood, with no symptom signs. So far, fewer than 100
cases of lipemia retinal have been reported in the US 35.
Serum lipid and cholesterol levels are affected by different factors such as biological,
behavioral, clinical, and sampling sources. Also, cholesterol and lipoprotein levels
change with the lifestyle characteristics such as diet, weight, smoking, exercise, clinical
conditions, various diseases, and medications 36. Sample variations can be reduced by
controlling factors such as fasting, time of day, consistent posture while drawing samples,
as well as sample handling and storage. Some other factors must be considered in
interpreting the results, such as concurrent diseases, medications, and life stressors 36.

Given this foundational information, the studies within this dissertation controlled for
fasting and post-meal sample donations as well as approximate timing with circadian
rhythms. Fasting donations were obtained in the morning a few hours after the donor
woke up. Post-meal donations were obtained the same day within two hours following a
high fat, high carb meal. Lifestyle characteristics were recorded for all donors. Further,
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standard reference samples were utilized for four of the classes of lipoproteins in Figure
1, ensuring the span of sizes and densities were accounted for in the standards.

1.2.4

Cholesterol

Free cholesterol concentrations in the blood depend on both the amount of cholesterol
produced by the liver for cells in the body and the concentration of the cholesterol
absorbed by the cells. It is typically considered a good sign to have relatively low levels
of free cholesterol present in the blood since higher concentrations can lead to health
problems 29. Cholesterol and triglycerides are insoluble in water, so these molecules are
transported by lipoprotein particles in the blood stream (plasma portion). Lipoproteins are
divided into five different main classes: high density (HDL), intermediate density (IDL),
low density (LDL), very low density (VLDL), and chylomicrons. Classification is based
on the particle’s hydrated density, electrophoretic mobility, size, and the proportional
content of cholesterol, triglycerides, and protein 11.
Cholesterol is a type of prevalent steroid molecule; cholesterol molecules and cholesterol
derivatives serve many important roles in the body encompassing biological structure and
signaling, including bile acids, bile salts, and steroid hormones. They serve as building
blocks for many important lipid membranes of cells and are a metabolic precursor of
several important chemicals in the body 29.
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Figure 1-3 (1&2) General Structure of Cholesterol 37 and (3) Cholesterol Molecules in
the Human Body 29 (Created using ChemDraw Professional Software)
1.2.4.1

Cholesterol structure, production, and transport

Cholesterol serves important roles throughout the body and thus needs to transport from
the liver after synthesis and to the liver for recycling. Transport of cholesterol is
accomplished by lipoprotein complexes of protein, phospholipids, cholesteryl ester, and
cholesterol. These chemical structures combine to produce globular/round shaped
structures that have another layer of proteins, phospholipid, and cholesterol. Inside the
lipoprotein complexes, triacylglycerols (triglycerides) and cholesteryl esters are held 29.
Many cholesterol molecules exist within the human body, but they all share a basic
chemical structure (Figure 1-3). Cholesterol molecules are steroid compounds, with a
complex of four non-planar rings (Cyclopentanoperhydrophenanthrene) serving as the
main rigid backbone. An attached hydroxyl (OH) group is important because it gives
cholesterol classification as a sterol and provides a weak amphiphilic character.
12

Cholesterol has a branched alkane chain at position C17, and two methyl groups at
positions C13 and C10. The OH-group in the structure aids transport through the
anhydrous hydrocarbon core of the bilayer. This group has a strong, positive charge,
which can form esters with the branched chain of other cholesterol molecules 29.
Producing cholesterol in the liver starts by converting the acetate to isoprene units. The
isoprene units concentrate to form cholesterol, the long-chain structure of four carbon
rings (Figure 1-3). When the LDL transports cholesterol from the liver to tissues, a
portion of the cholesterol circulates freely in the blood, which can cause a high
concentration of free cholesterol in the blood. The body’s immune system sends white
blood cells to stave off the strange bodies (the free cholesterol), inadvertently making the
white cells bigger in size. The macrophages (white cells) can then become larger than the
cross-sectional area of microcapillaries in tissues causing blockages. This inflammation
can also cause macrophages to attach with components on larger vessel walls such as
lipids and cholesteryl esters to produce plaque 29.

1.2.4.2

Cholesterol levels and medical problems related to cholesterol

Cholesterol levels have been utilized medically as a major indicator of cardiovascular
diseases (CVD) for the last 20 years. However, results of recent studies identify the highsensitivity C-reactive Protein (hs-CRP) as another important indicator of CVD risk 36.
The hs-CRP test costs between $12-16, and requires a small blood volume that can be
completed at the same time as cholesterol testing when sent to medical labs 38. Thus, it is
important to develop tools able to concurrently measure lipids and proteins. Standard
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practice has moved to use both cholesterol and lipoprotein levels to identify patients at
risk for adverse cardiovascular events 36. Both low and high-density lipoproteins are
traditionally measured to ensure effective insights into cholesterol transport and accurate
diagnoses of patients. Accurate measurements of cholesterol include determinations of
the levels of LDL, HDL, and triglycerides (TG). Total cholesterol levels, LDL, and HDL
levels are considered risk factors, not just diagnosis factors 29, 36.

Accumulation of cholesterol in the bloodstream can ultimately lead to severe health
problems such as cardiovascular disease (CVD), coronary heart diseases (CHD), and
brain stroke. Free cholesterol attaches to blood vessels causing inflammation such that
the white blood cells attack the free cholesterol chains then forming a larger structure
consisting of white blood cells, cholesterol, and lipids. This combined structure is called
plaque, a hard substance that leads to small openings in the blood vessel and highpressure blood. Accumulation of larger amounts of plaque can partially block vessels
(cardiovascular disease) or cause complete closure of vessels (heart attack/coronary heart
disease) or if mobilized into the brain can cause a stroke 29. When there is extra
cholesterol in the blood plasma, LDL keeps circulating and may build to plaque that
narrows the vessels. In contrast, HDL picks up the extra free cholesterol in the blood
plasma and transports it to the liver to be broken down. Increasing HDL and reducing
LDL may lower the risk of heart diseases 39.

Previous research completed by Pekkanen et. al.40, determined the associations of the
total, LDL, and HDL with mortality from coronary disease and cardiovascular disease. At
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baseline, 2541 white men were tested who age range between 40 to 69 years and kept
tracking them for an average of 10.1 years. They conclude that 17% of the examined
patients showed an effect of cardiovascular disease at baseline. After multivariate
adjustment on the group of men who had cardiovascular disease, they found that men
with high blood cholesterol levels were 3.45 times more likely to be at risk of death from
coronary heart disease than men with desirable blood cholesterol levels. Levels of highdensity, low-density, and total cholesterol levels foreshadow mortality in men of age
between 40-60 years old, especially those with undiagnosed and unmanaged
cardiovascular disease.

1.2.4.3 Cholesterol in different bio-fluids and skin
Additional studies have shown it is possible to use bio-fluids other than blood (plasma or
serum) to test for cholesterol and lipoproteins. Using other samples can make the test
less invasive for the patient. However, the use of alternative bio-fluids requires new
technology and protocols 36.
Examples of unconventional biofluids for testing cholesterol levels include using skin,
saliva, tears, and, to a lesser extent, urine 36. The cholesterol content indicates the
cholesterol level in the epidermis, which is noticeable in the patients with atherosclerosis
(a blood vessel disease that can be recognized by the precipitation of the fatty compounds
into the blood vessels inner walls). In saliva, cholesterol and lipoproteins can be
measured directly. The cholesterol level in saliva is 5% less than the level found in serum
36

. Free cholesterol level in human tears is between 9-21μg/g 41. Young and Hill 42
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measured cholesterol and cholesterol esters in human tears 43. According to Stuchell et
al.44 the main lipid component of human tears is cholesterol esters. Cholesterol ester
concentrations in human tears are higher than free cholesterol concentrations in serum41.
Urine usually does not contain cholesterol, but it contains mevalonic acid, which is a
regulatory enzyme in the biosynthesis of cholesterol. So, the concentration of mevalonic
acid in urine indicates the biosynthesis of cholesterol and is proportional to total levels in
the body 36.

1.2.4.4

Financial costs of cholesterol level measurements

According to research firm Washington G-2 Reports and a 2009 report by a unit
publisher BNA Inc., people spend about $20 million a year for cholesterol testing and the
sector has been growing at 15% to 20% annually 45.
There are many instruments/methods currently used for cholesterol testing. They include:
1. Cholesterol Reference Method Laboratory Network (CRMLN) 41
2. High-sensitivity C-reactive Protein (hs-CRP) 38
3. Capillary electrophoresis 46
4. Enzymatic cholesterol kits followed by using an analysis instrument such as a
fluorometric plate reader 41
5. High-Performance Liquid Chromatography (HPLC) 41
6. Gas Chromatography-Mass Spectrometry (GC-MS) or Immunoassay 41
7. Stable-Isotope Dilution Mass Spectrometry 41
8. High-performance liquid chromatography-mass spectrometry (HPLC-MS) 41
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9. Direct Insertion/Electron Ionization-Mass Spectrometry (DI/EI-MS) 41
There is significant demand for increasing the efficiency and speed of cholesterol level
tests36. In addition, there is an expressed need to test for time-dependent or time-averaged
cholesterol levels, which requires measuring cholesterol intercalated either into cell
membranes or via frequent testing before and after each meal. These new approaches
require strategically engineered instruments that are easy to use even by patients at home
and/or potentially can utilize alternative bio-fluids. Having instruments that can test
cholesterol levels accurately and efficiently without requiring additional reagents or a
large volume of blood to be drawn will help make these tests more accessible and easier
to conduct so that they can be performed easily in a physician’s office or even at home.
Therefore, this research has the potential to help improve public wellness by facilitating
screening for cardiovascular disease by simplifying sample handling and testing within a
well-engineered unit. In the short term, this research could potentially reduce costs for
traditional laboratory tests (using plasma or serum) and may also help facilitate the earlier
discovery of ailments or diseases, which can reduce medical costs by enabling timely
treatments.
The following sections review the instruments and methodologies available for use in this
research.

1.2.5

Ultraviolet-Visible Spectrophotometry (UV-Vis)

Ultraviolet-visible (UV–Vis) spectrophotometry is a fast, inexpensive, and easy to use
method that is available in a most analytical laboratories 47.
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UV-Vis spectrophotometry is an analytical quantitative technique, that measures the light
scattering of chemical species in the liquid or gas phases, in near-ultraviolet (180–390
nm) and visible (390–780 nm) wavelengths 48. Light absorption is dependent on the
solution analyte concentration, and this relationship is defined by Beer’s law 48, 𝐴 = 𝜀 ∗
𝐼 ∗ 𝑐, where: 𝜺 is the molar absorptivity, I is the path length, and c is the concentration of
the chemical species absorption 49.

Lipoproteins, cholesterol, and phospholipids have documented absorption maximum
(peaks) in the overlapping wavelength region of 205–212 nm 50. This is because the
lipoprotein spectrum reflects the absorption of their main components: cholesterol and
phospholipids 50. Low-density lipoprotein’s (LDL) natural auto-oxidation was recorded to
be absorbed in 234 nm 51, while the absorbance of LDL alone was 205 nm 50. LDL
density range was 1.006-1.063 g/mL and the concentration of lipoprotein was 200 μg of
protein/mL 51. High-density lipoproteins (HDL) fractions were recorded to be absorbed at
328 nm and 408.8 nm 50. Triglycerides, which are mainly fatty acids, absorbed UV light
at 232 nm 52. Albumin is a serum protein that is produced by liver at rate of 9-14 g/day,
its main components amino acids 53. Albumin has a strong peak at 204 nm and a weak
peak at 277 nm 53, albumin has been chosen based on its interference with the lipid and
lipoproteins analytic detection.

1.2.6

Liquid Chromatography-Mass Spectrometry (LC/MS)

Qualitative and quantitative lipid sample analysis requires a sensitive and precise
analytical method. There are many separation methods which include gas
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chromatography (GC) and liquid chromatography (LC), that can be paired with analytical
methods such as mass spectrometry (MS). MS is one of the most powerful analytical
methods with a high sensitivity and specificity, high throughput, and high accuracy30.
There are two lipid analysis approaches for mass spectroscopy: targeted and non-targeted.
Targeted lipid analyses focus on known lipids whereby researchers develop a tailored,
dedicated solvent/flow rate/injection method with high sensitivity to quantitatively
measure the known lipid. In contrast, non-targeted lipid analyses use generic
solvents/settings in order to help identify presence of all lipid species30. Targeted analysis
is highly quantitative, while non-targeted is treated as more qualitative.

1.2.6.1 Lipid Extraction
There are eight categories and 1.68 million species of lipids with highly complex
structures, making MS analysis a huge challenge30. Lipid sampling from biofluids is
another challenge. Biofluids, such as blood, are extremely complex, requiring selective
lipid extraction from the biological matrix for analysis30. Methods for lipid extraction and
analysis combined with bioinformatics technologies have greatly advanced lipidomics
(e.g. lipid analytical studies)30. In the 1950s, many human blood lipid extraction methods
were developed such as those described by Folch (1957) and Bligh & Dyer (1959)54.
There are many methods to extract lipids and proteins from human-based biofluids into
numbers and types of phases. Extraction types include liquid-liquid extraction (LLE),
solid-liquid extraction (SLE), one-phase extraction (OPE), and two-phase extraction
(TPE). Both Folch and Bligh & Dyer methods, which form the foundations of presentday optimized methods, are TPE methods that use methanol and chloroform as solvents54.
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In this research, two lipid extraction methods were tested: the Folch method55 and Bligh
& Dyer method56. The two methods both began with the extraction of blood serum from
whole blood, which required removal of both red and white blood cells as well as all
clotting factors, fibrinogen, and proteins54.
Prior to mass spec (MS), lipid extraction requires careful testing of both the extraction
efficiency as well as the extraction reproducibility. In general, to maximize lipid integrity
and operability, the whole process for lipid extraction should include as few steps as
possible and be kept as simple as possible30.
As mentioned, blood is a complex matrix within which lipids associate with proteins for
stability and to achieve active transport into the tissue. In 1934, serum albumin was
crystallized and was one of the first human plasma proteins that was extracted and
isolated for medical uses. In the 1940s, serum albumin was approved to be used in
clinical applications57
For simplicity, our efforts focused on albumin because this protein comprises the largest
fraction of proteins in human blood 58. We have measured the effect of the albumin
presence in the human plasma using the UV-Vis, to simplify the UV-Vis methodology
steps in measuring the plasma lipids profile. Thus, prior separation knowledge was
adopted in this work to separate protein from blood serum for separate lipid extraction for
MS.
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1.2.7

Tea benefits in human health

As mentioned previously, a number of previous studies have indicated that tea can reduce
the risk of cardiovascular disease 59-64. There are two main types of tea species: Camellia
Sinensis and Camellia Assamica. There are also numerous tisanes, or teas brewed from
non-camellia species. This study explores Oolong tea (camellia sinensis), Hibiscus
sabdariffa L. (HS, tisane) and peach tea (tisane). Polyphenols are the major active
compounds present in teas 65. Teas and other plants that are a rich resource of
antioxidants, such as flavonoids and other phenols, are thought to prevent and reduce
cardiovascular events 66. Other studies hypothesize that there is a correlation between the
reduction mechanisms of cardiovascular risks and reduction in low-density lipoprotein
(LDL) and triglycerides (TG) levels 67, 68. Similarly, health-approved drinks that are used
to reduce and minimize lipoprotein and triglyceride serum levels have as major
ingredients catechins and polyphenols 69. These ingredients have been found to help to
reduce both the low-density lipoprotein levels and general body fat, as well as to prevent
increases in post-meal triglyceride levels 69.

The degree of tea fermentation is used to categorize tea into four main types; nonfermented, semi-fermented (light, medium (Oolong tea), and heavy), fully fermented, and
post-fermented 70. Oolong falls between black and green tea in terms of fermentation
degree. The degree of tea fermentation also affects caffeine levels in the tea. Tea contents
and polyphenol levels are affected by the tea plant: types, leaves, climate, and season.
Oolong tea has antioxidants benefits, which can reduce blood pressure and reduce the
number of cardiovascular diseases incidents 62, 71. In Japan, consumption of >1 cup per
21

day of Oolong tea has been found to reduce cardiovascular risk 62, 71. In Taiwan, drinking
more than a half cup per day of Oolong tea post-adjusting, helps to minimize developing
a new hypertension risks

62, 72

. Other studies found no correlation relation between blood

pressure and tea consumption 62, 73-75. Drinking 1-6 cups per week and >1 cup per day of
Oolong tea helps reduce CVD risk 61.
Hibiscus sabdariffa L. (HS) is a medicinal flower that is used in herbal teas. The main
active ingredients include: polyphenolic acid, flavonoids, antioxidant activity, and
anthocyanins 76, 77. Several research studies have shown that HS and its components have
an impact on human health, and help to reduce the risk factors of different diseases,
especially cardiovascular diseases 76. There are two different colors of Hibiscus flower
calyxes; white (Alma Blanca) and red (Criolla). The calyx part of the Hibiscus red flower
is popular for its high nutraceutical value and anthocyanins that help reduce body fat and
prevent obesity risks and complications. Organic acids are one of the most important and
beneficial healthy component of the Hibiscus sabdariffa L. calyxes 77.
Hibiscus tea has been reported to have cardiovascular benefits of lowering blood pressure
(BP), and potentially improving plasma lipid profiles 68, 78-86. Studies have reported that
Hibiscus tea either improves plasma lipids 87, 88, or has no effect 89. Several very large
studies with 40,530 participants between 40-79 years have shown no relation between
blood pressure (another common indicator of CVD) and Hibiscus tea consumption 62, 7375

.
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No literature was identified regarding any health benefits from peach tea, but the peach
tea that we chose have Hibiscus tea in its main ingredients. This peach tea has
polyphenolics and antioxidant activities at lower percentage than the other teas. Thus, a
peach tea control was also tested because it was not expected to alter blood lipid levels
(e.g. no prior studies indicated health benefits from this).
Based on preliminary data that shows Hibiscus tea reduced blood pressure and
hypertension, which is one of the cardiovascular disses indicators, but there was not any
study indicate the benefits of Hibiscus tea in reduce blood lipids. This study hypothesized
that blood lipid profiles would become more favorable with Hibiscus tea or Oolong tea
consumption. Thus, this study examined both the metabolic syndrome indicators (lipid
profiles) and the atrial stiffness indicators (blood pressure) for tea drinkers.

1.3 Detailed Chapter Objectives
These foundations of knowledge are utilized in the following four objectives for this
dissertation, which broadly explores lipoprotein profiles in human blood.

Objective 1: This objective comprised the initial exploratory study for this research. The
hypothesis for this project was: Given that low-density lipoprotein of large and small
lipid globules have been shown to directly affect turbidity10, we hypothesize that a
combination of optical and electrical measurements (absorbance and electrical
characterizations) can discern high-density and low-density lipoprotein levels in human
blood samples for diagnosis of lipemia or other CVD indicators. This study is detailed in
Chapter 2.
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The first part of the objective 1 used basic laboratory equipment to measure and compare
fasting plasma and blood samples to post-meal samples, optimized protocols and selected
the most sensitive detection method. This work examined four tools to detect lipemia in
plasma and red blood cells; dielectrophoresis, cell lysis, electrical characterizations and
UV-Vis. Two tools, dielectrophoresis and cell lysis, tested RBCs, while the two
remaining tools, electrical characterizations and UV-Vis, tested plasma. Electrical
characterizations, dielectrophoresis, and cell lysis could not discern a lipemic state from a
healthy state. The UV-Vis tool successfully discerned lipemia in plasma.

Objective 2: Given this need to rapidly discern lipid profiles and states of lipemia, a study
was designed to compare fasting and post-meal samples. This experiment was conducted
with human blood plasma; controls were also completed. Based on prior results, we
designed our study to monitor lipid levels changes between fasting and post-meal state of
human plasma. To ascertain reproducibility, different-day plasma samples from the same
donor were analyzed with time differences between a few days, a few weeks, and a few
months. Ratiometric data analysis was conducted to ascertain relative features within a
single sample measurement. Also, to discern which lipoprotein standard most contributed
to the post-meal absorbance increases, purchased standards for HDL, LDL, TG, and BSA
were added to fasting plasma samples.
The reference samples for this study entailed creating plasma solutions with fixed
fractions of the purchased standards including LDL, HDL, TG, and bovine serum
albumin (BSA), as well as combinations in duo, trio, and quad mixtures. These reference
solutions were used to discern individualized spectra to ascertain which standard or
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combination of standards had the most impact on the post-meal plasma profile. These
UV-Vis quantified lipid profiles are reported in Chapter 3 and are also a draft manuscript
for submission.
HPLC-MS was also conducted to analyze fasting and post-meal serum samples.
However, these studies leveraged experimental matrices from Objective 3, so are
summarized after Objective 3.
Objective 3: Recent evidence suggests that tea consumption may impact cardiovascular
function and lipid profiles 59-64. Thus, a study structure was designed to compare fasting
and post-meal lipid profiles for inter-individual and intra-individual comparison across 3
participant groups over 9 weeks: a control group who drank peach tea, a group who drank
Hibiscus sabdariffa L. (HS) tea and a group who drank Oolong tea. There were a few
different comparisons between the plasma and serum of participants at the fasting and
post-meal state for the baseline and 6-week data: 1) Comparing the changes in the UVVis spectra of the fasting verses post-meal plasma UV-Vis spectra (primary shoulder,
secondary peak, secondary shoulder, and tertiary peak) for the baseline (0-week), 3-week,
6-week, and 9-week using PBS as the dilution/reference solution, 2) Comparing the
changes in the UV-Vis spectra of the fasting verses post-meal plasma for the baseline (0week) and 6-week using (tea-PBS) as the dilution/reference solution (future work), 3)
Comparing the changes in the UV-Vis spectra of the fasting plasma in PBS verses fasting
plasma in tea-PBS solution for the baseline and 6-week using PBS or tea-PBS buffer as
the dilution/reference solution (future work), and 4) Comparing the changes in the UV-
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Vis spectra of the Post-meal plasma at baseline verses post-meal plasma at 6-week using
(tea-PBS) as the dilution/reference solution (future work).

Those previous comparisons done by using the UV-Vis were the key to understand the
tea effects in plasma lipid levels. The second part of the study data collections was
measuring the tea effects on the arterial stiffness and blood pressure, which are indicators
of metabolic syndrome, through measuring and collecting the data at the baseline and
after 6 weeks of drinking the respective tea. The third part of the study and data
collection involved analyzing the chosen teas and human serum at the baseline and after 6
weeks of the study using HPLC/MS for more in-depth understanding of the chemical
active components in each tea. The goal was to ascertain tea consumption effects to
observe if they alter the lipid profile and/or the arterial stiffness profile.

Based upon preliminary data showing decreases in metabolic syndrome indicators
(Arterial stiffness and blood pressure) with human consumption of Hibiscus sabdariffa L.
and data quantifying hyperlipemic status in human plasma samples based on blood lipid
profiles, this portion of the work aimed to examine the chemical structure of Hibiscus
sabdariffa L. extract and to develop a protocol to quantify a lipemic profile (fasting and
post-meal). This study required standard profiles for low-density lipoprotein (LDL),
high-density lipoprotein (HDL), triglyceride (TG), and Hibiscus sabdariffa L. HPLCMS data was compared with existing UV-Vis data and later with microdevice UV-Vis
absorbance data. Combined, this data has the potential to reveal any benefit and extent of
benefit of Hibiscus sabdariffa L. on cardiovascular health. This information is detailed in
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Chapter 4 and also forms the foundation for a draft manuscript that will be submitted
once data acquisition is complete.

Development of extraction processes to analyze and test tea standards and plasma of the
tea study participants using two main methods: UV-Vis and LC/MS are detailed in
Chapter 5 (for the LC/MS part) and Chapter 4 (for the UV-Vis part) and is being
developed into a manuscript.
Triplicate HPLC-MS standards were planned to be run (pre-COVID interruptions) for
each fasting serum at t=0w and t=6w, post-meal serum at t=0w and t=6w, LDL, HDL,
triglyceride; and Hibiscus, oolong, and peach teas, for a total of 10 tests. Also, we ran
two fasting and two post-meal human plasma samples to compare the plasma profiles
before and after donor consumption of the Hibiscus tea for the baseline and after 6 weeks,
which is an additional four tests. In total, we planned to run a total of 54 sample runs
once the protocols were developed. This preliminary data will enable us to demonstrate
method development and capabilities to discern lipemic profiles for human blood
samples while examining the impacts of a Hibiscus tea intervention.
Mass spectrometry (MS) is a powerful instrument to analysis complicated chemical and
biological components duo to its high: sensitivity, efficiency, and precision 25, 30. Mass
spectrometry (MS) is one of the most important technology for lipid analysis. Recent
research approved that the MS development and enhancing its lipid profile analysis
usages, will help to discover more unique lipids using them in curing and understanding
the mechanisms of related disease, such as cardiovascular diseases 25, 30.
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The plasma and reference standards lipid signatures for HPLC-MS are reported in
Chapter 5. Once data collection is complete, this chapter will also be developed into a
manuscript for submission.

Objective 4: The prior studies have all utilized equipment in fully functional analytical
laboratories. However, with nearly 1/3rd of deaths due to cardiovascular disease,
ubiquitous tools to diagnose and monitor disease are needed. Historically, capillary
electrophoresis has been used to measure and quantify lipid profiles in blood plasma 46.
Microchips are an attractive alternative measurement tool because they can mimic
analytical separations and detection yet have the potential to be easy to use by patients at
home 90, 91. Access to portable, user-friendly tools to test lipid levels accurately and
efficiently without requiring large volume blood draws will help improve public wellness
by reducing costs and facilitating early screening and continuous monitoring of
cardiovascular disease.
Objective 4 focused upon the design and testing of a lab on a chip (LOC) device that
miniaturized the optimal UV-Vis technology from Objectives 1 and 2. The goal is to
detect and examine the design and use of a microfluidic chip device to measure human
plasma lipid levels to identify lipemic states using a drop or two of blood. The approach
was to create a microcontroller utilizing a photodiode to read photons given off by an
LED. With the sample placed in the light path, absorbance by the sample can be
calculated. This objective examines the design and use of a microfluidic chip device to
measure human plasma lipid levels after fasting and after a high-fat, high-carbohydrate
meal. The results of the microfluidic device were cross-correlated to our previous results
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of using a rapid UV-Vis spectroscopy screening of similar blood samples. Calibration
standards for high-density lipoproteins, low-density lipoproteins, triglycerides, and serum
albumin are in the process of being systematically measured individually and in
combinations to measure the contribution of blood plasma turbidity (cloudiness) and
lipemia (the high concentration of fat particles). Development and testing of a prototype
portable diagnostic device are detailed in Chapter 6 and are being developed into a
manuscript.
Future work will involve measuring cholesterol levels in different human body liquids
such as tears, urine, skin, and saliva since research has been initiated into the ability to
use fluids other than blood (plasma or serum) for diagnostic testing. Using other biofluids may make the test less invasive for the patient. Conclusions and future work are
included in Chapter 7.
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2 Preliminary Data: Comparison of Techniques and
Microchip Devices

Abstract
Lipemia is a condition of high lipid levels in the blood that adversely affects donated
blood quality. This project aims to simply and rapidly analyze lipid levels in different
bio-fluids using microchips. Four tests were completed: two focused on red blood cells
(RBC) (hemolysis and dielectrophoresis) and two focused on plasma (impedance and
UV-Vis absorbance). Hemolysis patterns were compared for the same healthy person
between fasting and post-meal donations. Cells lysed in 915 seconds with a slight
difference between the two cases. The lipid levels may slightly affect the hemolysis
percentage and the threshold time of post-meal RBC sample. Dielectrophoresis (DEP)
profiles were compared between the fasting and post-meal. Both profiles showed no
frequency shifts between positive and negative DEP behavior, reflecting there are no
significant differences in the dielectric properties of the outer RBC membrane. Plasma
impedance measurements did not vary significantly. However, UV-Vis absorbance
measurements revealed substantial spectral differences between the fasting and post-meal
samples suggesting plasma is impacted by meals. A ratiometric analysis was conducted
to ascertain lipemic state from a single test without relying upon a comparison between
fasting and post-meal absorbance profiles. This tool could be used to screen blood quality
prior to volunteer blood donations.
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2.1 Introduction
This work examined four different tools to determine which could detect lipemia in
plasma and red blood cells. Basic laboratory equipment was utilized to measure and
compare fasting plasma and blood samples to post-meal samples. Protocols were then
optimized to select the most sensitive detection method. The tools were dielectrophoresis
(DEP), cell lysis, electrical impedance characterizations, and ultraviolet-visible
microscopy (UV-Vis). The first two tools tested RBCs and later two tools tested the
blood plasma. Three of the tools could not discern a lipemic state from the healthy state.
The UV-Vis tool successfully discerned lipemia in plasma.

2.2

Materials and methods

2.2.1

Measuring free lipoprotein levels in human blood

In this experiment, we used different methods to measure the lipid and lipoprotein levels
in human blood (red blood cells (RBC) and plasma). These measurements were run using
three different microchip devices and a UV-Vis spectrophotometer as follows: (1) a
microdevice with four quadrupole gold electrodes 50 µm wide by >1 cm long by 95 nm
thick (blood typing) with 200 µm gap to measure the dielectrophoretic response of RBCs,
(2) a T-shape gold electrode microchip device with 100 µm gap to measure RBC lysis,
(3) a microdevice on a glass microscope slide with two parallel 30 µm wide by 3 cm long
by 95 nm thick gold electrodes with a 400 µm gap to measure the plasma electrical
impedance characterizations, and (4) a UV-Vis instrument to measure plasma absorbance
over wavelengths of 190nm – 1100nm. The experimental results represent a comparison
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of the free lipids in blood of a healthy, young donor for two cases: (a) fasting for 10-12
hours, and (b) post-meal occurring 2-3 hours after consuming a high fat, high
carbohydrate lunch.
A

B

C

D

Figure 2-1 Microchip devices utilized included: a) parallel electrodes for impedance, b)
quadrupole electrodes for dielectrophoresis, c) perpendicular for RBC lysis, and d) UVVis for plasma absorption.
2.2.1.1

Chemicals

Sodium chloride (NaCl, MW 58.44) solution with 0.9% NaCl solution, was prepared by
dissolving: 9 g of Sigma-Aldrich S7653 powder (BioXtra, 99.5%) in 700 mL distilled
water (dH2O), and then more water was added to bring the final volume to 1000 mL.
Phosphate buffered saline (PBS) buffer with a conductivity of 0.1 S/m was prepared
using: 24.935 mL of E-pure water (Millipore, MA), 1.233 g Sigma-Aldrich D9434

32

Dextrose powder (99% pure), and 65.386 L Sigma-Aldrich D9434 PBS salt stock
solution (99% pure).

2.2.1.2

Donor and sample donations

Donors (n=5) were between 18-50 years old, male and female, healthy, non-smoking and
omnivorous. Donors fasted for 12 hours. The first sample was collected in the morning
between 8 and 10 am while the second sample was collected two hours after the donor ate
a high-fat, high-carbohydrate meal.
One 4 mL vacutainer of blood was drawn by a trained phlebotomist at Portage Health
Clinic: SDC. Samples were transported following all safety protocols to a BL2
laboratory. Blood samples were centrifuged at 4000 rpm (relative centrifugal force or
RCF = 894 g) for 10 minutes; the plasma was isolated and stored in the freezer until used.
The remaining RBCs were resuspended and centrifuged twice at 3500 rpm (RCF = 684 g)
for 10 minutes to wash RBCs by using 3 mL (3000 μL) of 0.9% NaCl solution each time.

2.2.2

RBCs dielectrophoresis measurements and microchip setting

Samples were prepared by diluting 4.5 μl of packed RBCs with 1300 μl of (PBS stock
solution + dextrose stock solution (0.09 S/m)) to make RBC stock solution with final
dilution of 0.3 vol %. By using the quadrupole electrodes (blood typing) microchip
device, shown in Figure 2-1b, we measured positive and negative dielectrophoresis of the
RBC from both fasting and post-meal samples. Negative DEP occurred when the RBCs
centered in the middle of the electrode quadrupole (lowest electric field density region),
and positive DEP occurred when the RBCs gathered around the electrodes (highest
33

electric field density region). In this experiment, we measured dielectrophoretic responses
in the beta dispersion frequency region (0.1 to 0.9 MHz), which invokes a cellular
response due to polarization at the cell’s outer interface. This interface would be between
the outer membrane of the RBCs and any free lipoprotein molecules from the plasma. If
changes to the RBC dielectric properties occurred because of higher lipoprotein
concentrations, this experiment hypothesized that it might be noticeable as a different
dielectric signature between the fasting and post-meal samples.

2.2.3

RBCs lysis measurements and microchip settings

The hemolytic index (cell lysis) has been reported to increase with increasing lipemic
index 15, 92 that are a consequence of increased erythrocyte membrane fragility induced by
alteration in membrane lipid content 92. However, it is unclear if transient changes to the
lipemic index yield comparable results to chronic changes to the lipemic index.
RBC samples were separated from plasma by centrifugation at 1400 rpm (RCF = 109 g)
for 5 minutes. The RBCs were washed twice with 9% w/v% sodium chloride solution at
1400 rpm (RCF = 109 g) for 5 minutes. The RBCs were then mixed with PBS buffer to
prepare a 10 vol% RBC sample. By using the T-shape gold electrode microchip device
shown in Figure 2-1, we measured the hemolytic lifetime of the RBCs for fasting and
post-meal samples.
RBC lysis data was analyzed using two different steps. First, using the maximum
normalized intensity (INmax) and the minimum normalized intensity (INmin), the
normalized mean value of intensity (INMV) was obtained as equal to the mean data point
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divided by the maximum value of the mean data (Imax), following Equation 2-1. After
that, we can calculate the hemolysis percentage (H%), following Equation 2-2, which can
be found via the following equations 93:
𝐼𝑁𝑚𝑎𝑥 −𝐼𝑁𝑚𝑖𝑛

𝐼𝑁𝑀𝑉 = (

) × 100

Equation 2-1

𝐻% = (1 − 𝐼 𝑁 𝑚𝑖𝑛 ) × 100

Equation 2-2

𝐼𝑚𝑎𝑥

𝐼

𝑁 𝑚𝑎𝑥

Second, the normalized main value of intensity (INMV) versus the time (seconds) was
plotted. The following parameters: the maximum normalized intensity (INmax), the
minimum normalized intensity (INmin), the maximum value of the mean data (Imax), and
the normalized mean value of intensity (INMV) are a function of time, while the hemolysis
percentage (H%) was the overall amount of the red cells lysing that was achieved in 900
seconds. Each experiment was completed and analyzed in triplicate. The hemolytic
threshold time was noted. A feature termed threshold time occurred when the normalized
mean value of intensity decreases at a faster rate of cell lysis.

2.2.4

Plasma electrical impedance measurements

Impedance was measured via two parallel gold electrodes with 400 µm gap in a dedicated
microdevice. Plasma solution samples were utilized directly without any dilution with
other chemicals or E-pure water. First, E-pure water (18 MOhms, Millipore) was utilized
to wash the microdevice. Then, the microdevice was loaded with Phosphate Buffer Saline
(PBS) solution (0.09 S/m) to calibrate the impedance scope. Four different
characterizations were measured at different ranges: conductance (μS), resistance (kΩ),
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parallel capacitance (pF), and inductance (H), for both plasma samples: fasting and postmeal. The microdevice was washed with PBS between each run. Each donation sample
measurement was run in triplicate. In addition, three independent samples were obtained
from the same donor. Thus, a total of 9 runs were completed.

2.2.5

Plasma UV-Vis absorbance measurements and instrument settings

This experiment was conducted with the plasma portion of the human blood. As we
designed this experiment, we decided to run each donor blood five times at different
dates to discern experiment reliability. There were three different donors, D, with the
donor number designated as a subscript. R is the run with the subscript number that
indicates new donations. As a consequence of technical lab mistakes, the measurement
for the first donor (D1) sample was repeated six times instead of five.
For the UV-Vis experiments, plasma samples were initially used directly without any
dilution. Samples were placed in plastic disposable cuvettes and the absorbance of human
plasma samples were measured by the UV-Vis instrument for a range of 190 nm to 1100
nm. Absorbance measurements were focused into three different wavelengths and two
wavelength ranges: 1) the primary peak at 295 or 298 nm (since the primary peak had
some effect from the cuvette plastic (Figure B-1), it was excluded from our
measurements), 2) the secondary peak at 412 nm, 3) the tertiary peak at 571 nm, 4) the
primary shoulder at 322-373 nm, and 5) the secondary shoulder at 442-562 nm.
Subsequent experiments required dilution of the plasma samples.
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Ratiometric data analysis was conducted to ascertain relative features within a single
sample measurement. Ratios that differed greatly between the fasting and post-meal
plasma spectra provide the greatest potential to discern healthy from lipemic states. This
data analysis focused on different features of the spectra: primary peak height (298 nm),
primary shoulder median height (373 nm), secondary peak height (412 nm), secondary
shoulder median height (473 nm), and tertiary peak height (571 nm). Ratio percentages
were calculated between different features including primary peak/ primary shoulder,
secondary peak/ primary shoulder, and primary peak/ primary shoulder. This approach
extends this work to be able to screen unknown samples and determine lipemic state
without requiring a prior baseline.
Using the following equation, ratiometric analysis was calculated using the difference
percentage equation:

𝐷= [

𝑉1−𝑉2
(

𝑉1+𝑉2
)
2

] ∗ 100

Equation 2-3

Where V1 and V2 are spectra features, with an absorbance unit (a. u.).

2.3 Results and Discussions
Fasting and post-meal samples were acquired and tested for RBC changes via
dielectrophoretic polarization and hemolysis kinetics, and for plasma changes via
electrical impedance and UV-Vis adsorption.
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Fasting
Plasma

Post-meal
Plasma

Figure 2-2 Human plasma samples; left was the fasting and right was 2-3 hours postmeal. A visual color and turbidity difference were noticeable between the two plasma
samples, with the post-meal being more opaque or cloudy.

As seen in Figure 2-2, there is a visual difference between the fasting and post-meal
plasma samples. Post-meal plasma samples were cloudy while the fasting plasma samples
were translucent. The visual deference is due to the higher level of lipoprotein globules
and free cholesterol in the donor blood.
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2.3.1

Dielectrophoresis measurements
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Figure 2-3 RBCs dielectrophoresis data of (a) fasting (blue), (b) post-meal (red), and (c)
fasting and post-meal samples overlaid for comparison. Data are plotted to show the
average response (dark points) with an overlaid distribution of responses (shadow) at
each frequency. Since the distributions of responses overlay, there are little observable
differences in the DEP responses between the fasting and post-meal samples.

Figure 2-3 shows the relationship between the time (sec) and the dielectrophoretic
response (DEP) of both red blood cell (RBC) samples, fasting and post-meal. The applied
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frequency was swept from low to high and then back from high to low. Positive DEP is
represented by a response between 0.0 and 1.0, and negative DEP is represented by
response between 0.0 and -1.0. The 1st negative DEP zone was between 0-200 seconds
(100-580 kHz), the 1st transition DEP zone was between 200-300 seconds (580-820 kHz),
the positive DEP zone was between 300-580 seconds (820-508 kHz), the 2nd transition
DEP zone was between 580-680 seconds (508-268 kHz), and the 2nd negative DEP zone
was between 680-750 seconds (268-100 kHz). The difference at the end of the DEP was
because the number of cells in the microfluidic chamber differed slightly, which affected
the intensity signal used to calculate the relative DEP behavior. Overall, both samples
had similar dielectrophoretic results, which leads to the conclusion that there was
insignificant effect from the transient lipoprotein globules and free-lipid molecules on the
red blood cells membrane or dielectric properties.
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2.3.2

RBC lysis measurements
Post-meal RBCs
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Figure 2-4 Normalized Mean Intensity value versus RBC life time (hemolysis) of both
(a) fasting (blue) and (b) post-meal (red) RBCs samples using microdevice at 10 Vpp.
Vertical dotted line in a and b indicate the predicted threshold time. The dark points
indicate the average while the error bars indicate the distribution of intensity values for
each point in time. Plot (c) overlays the average values indicating only slight differences
between the fasting and post-meal samples.
Figure 2-4 shows cell lysis triplicated experimental runs of both fasting and post-meal
red blood cells by using a T-shaped microdevice at a fixed 1 kHz frequency and a 0.1
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Vpp /micron applied electric field to measure hemolysis. The RBCs lysing progressed
between 15 and 915 seconds. The hemolysis percentage for the fasting sample was
39.15%, while the post-meal sample achieved 33.60%, which indicates a slight difference
between the total fasting and the post-meal RBCs lysis. The threshold time of the fasting
RBCs occur around 465 seconds while the post-meal threshold time occur around 540
seconds, which suggests slight effects of from differing lipids level in the post-meal
samples. There was a slight difference between the RBCs lysis data of fasting and postmeal samples. The lipid levels may slightly affect the hemolysis percentage and the
threshold time of post-meal RBC sample.

2.3.3

Electrical characterizations measurements

Table 2-1 shows a slight difference in the conductivity, resistivity, inductivity, and
capacitance of fasting versus post-meal plasma samples. However, sampling distributions
reveal statistically insignificant Electrical characterization measurement results of
different samples.
Table 2-1 RBCs Electrical characterization measurement results of different samples
Electrical Characterizations Mode
Sample Type
Conductance Resistance Parallel
Inductance
(Average ±
(G) (μS)
(R) (kΩ)
Capacitance (L) (H)
STD)
(C) (pF)
Fasting Plasma 2040.6 ±
17639 ±
1907.4 ±
-12942 ±
Sample
302.7
6280.5
364.9
2086.7
Post-meal
2021.1 ±
16867 ±
1865.8 ±
-12932 ±
Plasma Sample 408.3
6177.7
267.3
1560.4
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We conclude from Table 2-1 that since electrical characterization measurements are
predominantly dependent upon plasma charge availability and distribution within the
solution, that lipids do not substantially alter the charge equilibrium in the plasma. This
suggests short-term shifts in lipids and lipoprotein concentrations in the plasma do not
substantially impact electrical properties of the plasma. These results indict that
impedance related measurements cannot be reliably employed to measure lipemia in
human plasma.

2.3.4

UV-Vis measurements

Systematic studies were conducted to determine the optimal dilution ratio for plasma to
not saturate the UV-Vis detector. Comparisons were then made between fasting and postmeal samples. A ratiometric analysis was also conducted to determine if features could be
extracted from a single sample’s absorbance spectra to ascertain a lipemic from a normal
state.
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Figure 2-5 Fasting (left) and post-meal (right) plasma dilutions. Data is shown from
concentrations of 50% to the most diluted sample of 5%. The optimum dilution for both
fasting and post-meal samples was determined to be 20% because the peak and shoulder
features were retained, and the maximum adsorption did not exceed 1.

Figure 2-5 shows UV-Vis absorbance at a range of wavelengths from 188 to 700 nm
illustrating peaks with red shifting shoulders for both fasting and post-meal samples.
Absorbance measurements displayed features at three different wavelengths and two
wavelength ranges: 1) the primary peak at 295 or 298 nm, 2) the secondary peak at 412
nm, 3) the tertiary peak at 571 nm, 4) the primary shoulder from 322-373 nm, and 5) the
secondary shoulder from 442-562 nm. We conclude from Error! Reference source not
found., the optimum dilution that was measured was 20% of human plasma with 70% of
PBS solution because absorbance features were retained, but the primary peak did not
saturate the detector. As the dilution decreased, the secondary and the tertiary peaks were
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affected. The area under the peaks decreased with decreasing concentration of the plasma
sample solution.
To determine the difference between the fasting spectra and the post-meal spectra a
contrast peak to peak of the lipid profile was analyzed.

Figure 2-6 Comparisons between the fasting and post-meal plasma UV-Vis of healthy
donor at the optimum dilution (20%). Post-meal plasma absorbance was higher than
fasting plasma absorbance with changes on peak characteristic. The wavelength of the
secondary peak is 412 nm, the primary shoulder is 373 nm, the tertiary peak is 571 nm,
and the secondary shoulder is 470 nm.

Figure 2-6 shows the results of fasting and post-meal samples for run donor 1, repeat 3
(D1, F&PR3), which is representative of all experiments. The primary peak from fasting
plasma samples was consistently narrower with a distinct shape. The fasting secondary
peak was observed as shorter and wider compared to the first peak. Meanwhile, the
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primary peak of post-meal samples displayed distinctive red-shift shoulders. The
secondary peak was much wider compared to the primary peak and was small in height
above the background shoulder. We conclude from Figure 2-6 that peaks of the post-meal
sample were wider with unequal shoulders because of the presence of lipoprotein
globules and free lipid molecules.
Recognizing that a patient will donate a single sample from which a single absorbance
profile can be obtained, ratiometric analysis within a single absorbance spectrum was
completed. Ratiometric analysis are in Table 2-2 below.
Table 2-2 Ratiometric Analysis of fasting and post-meal human plasma samples of a
patient on a single day
Fasting
Post-meal
Percent
UV-Vis Spectral Absorbance
Plasma
Plasma
Difference
Absorbance Absorbance
(%)
Primary peak (average height)
2.91
3.24
Secondary peak (average height)
1.22
1.96
Primary Shoulder (average height)
0.61
1.71
RATIO: Primary peak / Primary shoulder 4.77
1.89
86
RATIO: Primary peak / Secondary peak
2.38
1.65
36
RATIO: Secondary peak / Primary
2.00
1.15
54
shoulder

Data of the ratiometric analysis in Table 2-2, first illustrate the ratio calculated from the
absorbances. A second calculation was completed to determine the percent difference
between the fasting and post-meal lipid profile. The highest ratio was the primary
peak/primary shoulder for both fasting and post-meal. The comparison between these
ratios also illustrated the largest percent difference in ratios. The lowest ratio percent
difference was the primary peak/secondary peak. Because the primary peak exceeded
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the absorbance saturation limit (i.e. it was >1), the secondary peak/primary shoulder was
utilized instead. The percent difference between the fasting ratio of 2.00 and the postmeal ratio of 1.15 yields a 54% difference such that lipemic state is discernable. This
approach extends this work to be able to screen unknown samples and determine lipemic
state without requiring a prior baseline.

2.4 Conclusions
Four tools were explored for the detection of lipemia, UV-Vis was successful in detecting
and measuring the lipemic profile in human plasma, while three of which were
unsuccessful. The first tool, DEP characterizations (Figure 2-3) of both fasting and postmeal samples, showed that, overall, both samples had similar dielectrophoretic spectra.
The fasting sample responses transitioned from positive to negative DEP slightly slower
than the post-meal samples. This effect was fairly minor, demonstrating minimal effects
from transient changes in lipid level on the DEP response.
The second tool, RBC lysis (Figure 2-4), examined RBC membrane integrity via
hemolysis progression over time and identification of a threshold time. RBC hemolysis
was measured between 15 and 915 seconds with only slight differences between fasting
and post-meal samples and final hemolysis percent.
The third tool, electrical characterizations measurements (Table 2-1) could not
successfully discern transient changes in lipid levels because electrical impedance
characterizations are most sensitive to red blood cell changes, and transient lipemia
effects the plasma more than the red blood cells.
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The fourth tool, UV-Vis showed discernable differences in the fasting and post-meal
samples, and thus was chosen for more in depth study, which is discussed in detail in
Chapter 3.
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3 Lipemia Analysis in Human Blood: Comparisons Between
Fasting, Post-meal and Lipoprotein Standards

Abstract
Lipemia is a transient status of lipid levels in the blood that adversely affect
cardiovascular health and donated blood quality. Lipemic status was examined with an
unaltered UV-Vis spectroscopy for human serum after fasting for 12 hours and after a
high carbohydrate, high fat meal. Lipemic patterns were compared inter and intra-donor
between fasting and post-meal blood donations. To ascertain absorbance features, three
different lipid standards were analyzed: low-density lipoprotein (LDL), high density
lipoprotein (HDL), and triglycerides (TG). UV-Vis absorbance results revealed spectral
differences between fasting and post-meal spectra and similarities between the post-meal
plasma sample and fasting plasma plus LDL plus TG standards. The overarching
implications of this work is the ability to identify lipemia states using a drop or two of
blood.

3.1 Introduction
Worldwide, cardiovascular diseases (CVDs) comprise >30% of all deaths making them
the most prevalent disease class 3. Heart disease, a subset of CVDs, comprise 25% of
deaths in the United States every year 1 with 14% classified as coronary heart diseases
(CHD) 12, 94. For comparison, the prevalence of coronary heart diseases (CHD) in Saudi
Arabia was reported to be 5.5% 95. A commonly scrutinized indicator of CHD has been
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cholesterol, but recent evidence suggests a more complex dynamic with lipoproteins in
the blood 96.

Low-density lipoproteins (LDL) are associated with an elevated coronary heart disease
(CHD) risk; apolipoproteins are of the greatest interest because they are the main
lipoprotein components that play a critical role in atherosclerosis (plaque) creation and
formation 97. The apolipoprotein profile is one of the most valuable and an important risk
indicator for cardiovascular disease events. Clinical staff have been using the
apolipoprotein profile to cure or provide the best treatments/medications for individual
cardiovascular patients 97. In clinical studies, the apo B baseline level is a better indicator
than LDL level in predicting cardiovascular risk; further, elevated apolipoprotein apo B is
an indicator of increasing risk of a pending cardiovascular event 97. Other work has
shown that triglyceride and apolipoprotein total percentages are sufficient indicators able
to evaluate cardiac risk, or to moderate and assess efficacy of lipid‐lowering medicine 16,
97, 98

.

Thus, there is significant demand for increasing the efficiency, speed, and reliability of
blood lipid tests 36 to enable monitoring of the lipid profile over time. Lipid levels are
affected by biological, behavioral, and clinical factors 36, 94; further they can change with
lifestyle indicators including diet, body mass index (BMI), smoking, and exercise 36, 94, 99.
These indicators collapse into a condition termed metabolic syndrome known to increase
cardiovascular morbidity and mortality risk 99 by increasing the buildup of arterial plaque
that increases arterial stiffness and decreases cross sectional area of blood vessels 100. In
addition, reduced high-density lipoprotein levels and elevated triglyceride levels are also
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associated indicators of metabolic syndrome 100. Serum lipid levels can also be affected
by factors like sampling inconsistencies 36, 94. Sample variations can be reduced by
controlling fasting status, time of day, consistent routine, sample handling and storage.
Other confounding factors impacting lipid profiles include synchronous diseases,
medications, and life stressors 36.
What has emerged from the confounding factors is that transient lipemia, a condition of
high concentrations of circulating lipid globules, can also impact blood test reliability and
health. Lipemia is the most frequent interference of blood laboratory tests ranging from
CVD to pathogen and sepsis detection 10, 15. Lipemia is commonly identified and assessed
via the cloudiness of human blood serum/plasma. This turbidity is influenced
predominantly by high concentrations of low-density lipoprotein globules 10, 15. Lipemia
is a growing concern globally with ~30% of the US population displaying higher than
normal levels. Thus, expanding point-of-care monitoring beyond cholesterol into broader
lipid profiles may enable more reliable monitoring and mitigation of metabolic syndrome
and CVD risk as well as blood test reliability. Thus, this work builds upon the need for
time-dependent lipid level monitoring from blood, which could capture metabolic
timescales of variations before and after high-fat, high carbohydrate meals. Real time
monitoring may also eventually enable monitoring of metabolic processes such as
cholesterol production by the liver as well as lipid intercalation into cell membranes 101.
Lipoproteins are divided into five different main classes: high density lipoproteins
(HDL), intermediate density lipoproteins (IDL), low density lipoproteins (LDL), very
low-density lipoproteins (VLDL), and chylomicrons. Classification is based on the
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lipoprotein’s hydrated density, electrophoretic mobility, size, and the proportional content
of lipids, triglycerides (TG), and protein 11. There is an inverse relationship between the
lipoprotein size and its density. Since lipoproteins differ in size, the lower density
particles contribute more to the sample’s turbidity 10. Previous studies showed that nonfasting lipid levels (total cholesterol, HDL, LDL, TG, and albumin) do not change
significantly from fasting lipid profiles, although changes were recorded during the first
3-5 hours post-meal 102. Based on prior results, we designed our study to monitor the
post-meal samples in the first two hours after the meal was consumed. The use of nonfasting instead of fasting lipid profiles to screen for cardiovascular risks would simplify
clinical care 102, but would require greater knowledge of time-dependent variations of
separate lipoproteins.
HDL, LDL, and TG, which contribute to total cholesterol, are traditionally measured to
provide insights into cholesterol transport; elevated levels are considered risk factors, but
not diagnoses factors. Relatively low levels of LDL are considered good; higher
concentrations can lead to health problems 29. Lipids and triglycerides are insoluble in
water and are thus transported by lipoprotein particles in blood plasma 11.
Albumin is a serum protein that is produced at a rate of 9-14 g/day in healthy individual
livers, with a 13-19 day half-life in the bloodstream 53. Albumin controls 70-80% of the
colloidal pressure of normal plasma, which stabilizes blood volume circulation, and
assists with transport of hormones, enzymes, medicine and toxins 53. Albumin helps to
transport and deposition proteins in vivo (human and animal fluids and organism). Also,
it helps to store and transfer the endogenous (internal) and exogenous (external) plasma
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molecules such as amino acids, steroid hormones, fatty acids, metal ions, and drugs 103.
Low-levels of albumin in combination with cardiotoxin and uremic toxins are also
predictive factors for some cardiovascular diseases 104.
Determination of lipid levels in blood has been achieved in clinical applications 105.
Methods currently used for lipid and cholesterol testing include the Cholesterol
Reference Method Laboratory Network (CRMLN) standard 106 and high performance
liquid chromatography mass spectrometry (HPLC-MS) 41. Commercial tests for
cholesterol include Cholestech 13-454 LDX Analyzer Cholesterol Test 107 and Cholestrak
108

as well as home devices CardioChek, Steps Biometer Cholesterol Biometer Glucose

Monitoring System and Q 109. Prices per test vary between $15 to >$1000. Portable
instruments that can test lipoprotein levels accurately and efficiently without requiring a
large volume of blood would help make these tests more accessible and easier to conduct
so that they can be performed quickly in a physician’s office or even at home.
Enzymatic colorimetric method used in the clinical chemical process to quantify blood
components along with the usage of the ultra-violet – visible (UV-Vis) spectroscopy
instrument 110. In the medical and clinical laboratories, the most common human liquid
that been used to measure a specific component are blood (plasma/serum) and urine. By
using this method, not only we can detect the presence of a chemical component in
human liquids, but we can also quantify that chemical component.
Using the enzymatic method to analysis the triglycerides (TG) in human plasma or
serum; there are two main chemical process steps: the hydrolyzation step and the
oxidization step. As we mentioned previously, triglycerides consist of three fatty acids
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bound to a glycerol backbone. In the first step, the triglyceride is hydrolyzed to generate
glycerol. Then, the glycerol is oxidized using hydrogen peroxide (H2O2) and glycerol-3phosphate oxidase. The 4-(p-benzoquinone-monoimino)- phenazone absorbance
measured at 500 nm 111.
Also, using the enzymatic method we can quantify and measure the absorbance of the
high-density lipoproteins (HDL) in human serum. Lipoproteins are formed by the
chemical bond between the proteins that was created by apolipoproteins. High-density
lipoproteins are created by apolipoproteins B (Apo B). Using sulfated alpha-cyclodextrin
and magnesium ion (Mg+2), which can produce a new chemical complex with the apoB
containing lipoproteins and polyethylene glycol-coupled cholesteryl esterase and
cholesterol oxidase. Then, the qunoneimine dye absorbance was measured at 600 nm 111.
In this chapter we have not used the enzymatic method. We are planning to run our
standards: HDL and TG using this method on the near future. Using this method will help
us to quantify and identify the concentration of unknown samples.
This chapter examines the use of a rapid ultra-violet–visible (UV-Vis)
spectrophotometric screening of human blood plasma after fasting as well as post-meal
post high-carbohydrate and high-fat meal. Calibration standards for high density
lipoproteins, low density lipoproteins, triglycerides, and albumin were systematically
measured with both UV-Vis as well as HPLC-MS to demonstrate individual and
combined contributions to plasma turbidity and lipemia.
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Experiments were conducted with human blood plasma; controls with plasma were also
completed. Based on prior results, we designed our study to monitor changes in lipid
levels between fasting and post-meal state of human plasma. To ascertain
reproducibility, different-day plasma samples from the same donor were analyzed with
time differences between a few days, a few weeks, and a few months. Ratiometric data
analysis was conducted to ascertain relative features within a single sample measurement.
Also, to discern which lipoprotein standard most contributed to the post-meal absorbance
increases, purchased standards for HDL, LDL, TG, and BSA were added to fasting
plasma samples.

3.2 Materials and methods
Figure 3-1 illustrates the process that was employed to collect samples and conduct the
research.

Figure 3-1 Schematic diagram of the blood samples analysis process (Original drawing
made using Microsoft Visio).
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3.2.1

Donor and sample information

Donor recruitment (n=5), sample acquisition, and data handling all followed IRB
approved procedures per Michigan Tech M0540 [318164-13]. Donors (all genders) were
recruited between the ages of 21-35, were healthy, smoking and non-smoking, and
omnivorous. Donors fasted overnight for 12 hours. A trained phlebotomist collected a
fasting blood sample around 8 am and a second sample was collected two hours after the
donor ate a high-fat, high carbohydrate meal of their choice.
Blood samples in 3.0 mL BD vacutainers (Becton Drive, Franklin Lakes, NJ 07417 USA)
were transported to the lab following all transportation safety protocols then centrifuged
(Fisher Scientific LR56495) for 10 minutes, at RCF = 894 g. The plasma was isolated
and stored in the freezer until tested.

3.2.2

Chemical preparation

Phosphate buffered saline (PBS) with a conductivity of 0.1 S/m was prepared using:
24.935 mL of E-pure water (Millipore, MA), 1.233 g Sigma-Aldrich D9434 Dextrose
powder (99% pure), and 65.386 L Sigma-Aldrich D9434 PBS salt stock solution (99%
pure).
High-density lipoprotein (HDL) solutions were prepared using 0.154 mL Sigma-Aldrich
L8039 high density lipoprotein from human plasma (95% pure)112 combined with 0.846
mL PBS to achieve a total volume of 1 mL at 200 mg/dL HDL.
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Low-density lipoprotein (LDL) solutions were prepared using 0.1667 mL Sigma-Aldrich
L7914 low density lipoprotein from human plasma (95% pure)113 combined with 0.8333
mL of PBS to achieve a total volume of 1 mL of 100 mg/dL LDL.
Triglyceride (TG) solution was prepared using 1 µL Sigma-Aldrich 17810 triglyceride
mix (C2-C10)114, combined with 200 µL of human plasma, and 0.799 mL of PBS to
achieve a volume 1 mL of 100 mg/dL triglyceride. In this specified solution, plasma was
necessary to include because the triglyceride concentrated solution was hydrophobic and
did not sufficiently dissolve in pure PBS. The human plasma sample utilized was the
same for all standard solutions.
Bovine serum albumin (BSA) solution was prepared using 0.05 g/mL of Sigma-Aldrich
A7906 Albumin from bovine serum (98% pure), by dissolving BSA powder into 1 mL
of PBS solution to achieve a 50 mg/dL BSA.

3.2.3

Plasma UV-Vis absorbance measurements

To measure absorbance of human plasma, UV-Vis spectroscopy (Thermo Spectronic,
Genesys 10-S) measurements were conducted. Disposable plastic cuvettes with two clear
sides for absorbance (Fisher Scientific, 3mL, Polystyrene, absorbed light in the
wavelengths < 270nm) were consistently utilized for all tests. Absorbance was recorded
over a range of 190 nm to 1100 nm, but we focused on the wavelength between 290 nm
and 700 nm due to cuvette limitations and spectral features.
Both fasting and post-meal sample concentrations were optimized from a serial dilution
study to arrive at a fixed dilution protocol for all future tests. Plasma samples were
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diluted via 20% plasma and 80% PBS to remain within the absorption detection limits of
the UV-Vis spectrophotometer. Absorbance features included: 1) the primary peak at
295 or 298 nm (since the primary peak had some effect from the cuvette plastic (Figure
B-1), it was excluded from our measurements), 2) the secondary peak at 412 nm, 3) the
tertiary peak at 571 nm, 4) the shoulder from the primary peak from 322-373 nm
(specifically the absorbance height at 373 nm), and 5) the shoulder from the secondary
peak from 442-562 nm (specifically the absorbance height at 472 nm). For subsequent
analysis, the primary peak was near or at instrument saturation, so was neglected from
secondary analysis in this chapter.
To ascertain reproducibility, different-day plasma samples from the same donor were
analyzed with time differences between a few days, a few weeks, and a few months. For
trend analysis, five unique donors provided fasting and post-meal blood samples. All
samples were prepared 1:4 v/v% plasma: PBS, measured over 270 nm to 700 nm, with
four spectral areas of interest.
Secondary analysis included tabulating the primary shoulder median height, secondary
peak height, secondary shoulder median height, and tertiary peak height. Averages and
standard deviations were computed for the following independent variables: fasting and
post-meal samples with comparisons for the five different plasma samples of the same
donor as well as comparisons across five unique donors.
Ratiometric data analysis was conducted to ascertain relative features within a single
sample measurement. Ratios were identified that differed greatly between the fasting and
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post-meal plasma spectra because they provide the greatest potential to discern healthy
from lipemic states. This data analysis focused on three different features of the spectra:
primary shoulder median height, secondary peak height, and tertiary peak height. Ratio
percentages were calculated between different features including primary
shoulder/secondary peak (412 nm), primary shoulder/secondary shoulder, and primary
shoulder/tertiary peak (571 nm). This approach extends these results to be able to screen
unknown samples and determine lipemic state without requiring a prior baseline.
To ascertain spectral contributions from the lipid components in blood, commercially
obtained, purified lipids were spiked into human fasting plasma. UV-Vis absorbance with
and without the standard lipids HDL, LDL, and TG were measured. Lipids were spiked
individually as well as in binary combinations to examine spectral impacts. Secondary as
well as ratiometric analyses were also performed on these data sets.
Table 3-1 NIH NHLBI Lipid Level Classifications in Adult Blood
Total
HDL
LDL
Triglycerides
cholesterol cholesterol cholesterol (mg/dL)
(mg/dL)
(mg/dL)
(mg/dL)
Good
<200
<100
<149
40
Borderline 200-239
n/a
130-159
150-199
High
n/a
240
160
200
Low
n/a
<40
n/a
n/a
Table 3-1, compiled from the NIH National Heart, Lung, and Blood Institute115, lists the
acceptable, borderline, high, and low values for cholesterol and triglyceride
measurements for the average adult. All values are in mg/dL (milligrams per deciliter)
116

. Thus, lipid concentrations were selected to fall within acceptable ranges and were

spiked to HDL 200 mg/dL, LDL 100 mg/dL, TG 100 mg/dL, and for BSA 35 mg/dL.
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3.3 Results and discussions
Lipoproteins, cholesterol, and phospholipids have the absorption maximum at the same
wavelength region of 205–212 nm 50. Lipoproteins spectra reflects the absorption of their
main components: cholesterol and phospholipids 50. High-density lipoproteins (HDL)
fractions were recorded to be absorbed at 328 nm and 408.8 nm 50. Low-density
lipoproteins (LDL) natural autoxidation was recorded to be absorbed at 234 nm 51, while
the absorbance of LDL alone was at 205 nm 50. Triglycerides, which are mainly
comprised of fatty acids absorbs UV light at 232 nm 52. Albumin is a serum protein that
the liver produces at rate of 9-14 g/day with amino acids as the main products 53.
Albumin has a strong peak at 204 nm and a weak peak at 277 nm 53.

Table 3-2 Lipids and Lipoproteins UV-Vis Absorption Wavelengths
Lipids and Lipoproteins
Wavelength (nm)
Lipoproteins, cholesterol, and
The maximum absorption 205–212 nm 50
phospholipids
High-density Lipoproteins
328 nm, 408.8 nm 50
Low-density Lipoproteins
234 nm 51, 205 nm 50
Triglycerides
232 nm 52
Albumin
Strong peak at 204 nm 53
Weak peak at 277 nm 53
Initial tests were conducted to ascertain optimal dilution of the plasma portion of donated
human blood. Figure 2-5 below shows UV-Vis absorbance for a broad range of
wavelengths to illustrate the absorbance area peaks and shoulders. A comparison is made
between a representative fasting and post-meal plasma sample.

We concluded from the data in Figure 2-5 that the optimum dilution was 20% human
plasma with 80% PBS solution. Dilutions above 20% exceeded the absorbance ceiling.
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Dilution decreases below 20% affected the secondary and tertiary peak resolvability and
height. The area underneath each peak decreased with decreasing concentration of the
plasma sample solution.

3.3.1

Comparison of fasting and post-meal

Figure 2-6 shows fasting and post-meal UV-Vis absorbance spectra for the same donor
on the same donation 298
day.nm
Absorbance feature measurements were tracked and tabulated
from three different wavelengths and two wavelength ranges: 1) the secondary peak at
412 nm, 2) the tertiary peak at 571 nm, 3) the primary shoulder at 322-373 nm, and 4) the
secondary shoulder at 442-562
373nm.
nmFor the fasting plasma sample, the secondary peak at
412 nm

412 nm was shorter and wider than the first peak. Meanwhile for the post-meal sample,
the secondary peak was again significantly smaller than the fasting due to the prominent
571 nm

shoulder and increase in the baseline. It is apparent that the post-meal absorbance is
consistently higher at all wavelengths. However, this kind of difference cannot be
ascertained if one only has access to a single sample.
Thus, within a single run, a ratiometric analysis was conducted as described in the
materials and methods. For the fasting sample, the ratio between the primary shoulder
(373 nm) to the secondary peak (412 nm) was 1.231. The primary shoulder to the
secondary shoulder (472nm) was 0.614, and the primary shoulder to tertiary peak (571
nm) was 3.022. The ratios for the post-meal spectra were significantly different. The
primary shoulder to the secondary peak was 1.526; the primary shoulder to the secondary
shoulder was 0.759; and the primary shoulder to tertiary peak was 3.34. Thus, the most
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reproducible and biggest discernable difference (21%) between the fasting and plasma
ratios was the primary shoulder to the secondary peak at 1.231 and 1.526.
We conclude from Figure 2-6 that, in addition to the difference in peak and shoulder
heights, that the peaks of the post-meal sample were wider with a baseline shift causing
prominent peak shoulders likely due to lipid molecules and lipoprotein globules absorbed
from the meal.

3.3.2

Reproducibility

To discern experiment reliability, each donor’s blood was run five times for a single
sample and also was collected on different dates and tested.
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B) Post-meal Reproducibilty

Min range
Max range

Min range
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Absorbance (a.u.)

Absorbance (a.u.)

A) Fasting Reproducibilty

Wavelength (nm)

Wavelength (nm)

Figure 3-2 Reproducibility (n=5) of both the fasting (a) and post-meal (b) absorbance
values from different days of plasma blood donations from the same healthy male donor
at the optimum dilution of 20%. Absorbance is represented as a modified whisker plot
where yellow and grey represents the full range of spectra obtained above and below the
average black line, respectively. For the fasting trace, the deviation at 313 nm of the
primary shoulder was 0.044, the secondary peak deviation was 0.260, and the tertiary
peak was 0.033. For the post-meal trace, all deviations were substantially greater at
0.121, 0.321, and 0.171, respectively.

Figure 3-2 shows the reproducibility data for fasting and post-meal conditions of five
independent sample donation days for the same donor over a 5-month period. Fasting
sample peaks were highly reproducible with similar peak location, width, shape and area.
The five repeats are represented in Figure 3-2 as a modified continuous whisker plot
where yellow and grey represents the full range of absorbance readings above and below
the average black line. The greatest fasting deviation between runs was the height of the
secondary peak with a max to min range of 0.260 while absorbance variations elsewhere
were much smaller; the primary shoulder and tertiary peak ranges were only 0.044 and
0.033 respectfully. The post-meal spectra exhibited peaks at the same wavelengths, but
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post-meal sample peaks had greater variability, especially with heights of the primary and
secondary shoulders, the secondary peak, and ternary peak. These three features had the
greatest range between runs with 0.321 at the secondary peak, 0.121 and 0.171 at the
primary shoulder and tertiary peak, respectfully.
We conclude from these UV-VIS measurements that fasting spectra are highly
reproducible and post-meal spectra are sufficiently reproducible as well as
distinguishable to discern a lipemic state. To discern which lipoprotein standard most
contributed to the post-meal absorbance increases, purchased standards for HDL, LDL,
TG, and BSA were added to fasting plasma samples.
Figure 3-3 below shows comparisons between 20% fasting and post-meal plasma spectra
and the 20% fasting plus standard samples. Concentrations of the standards were fixed:
HDL at the concentration of 200 mg/dl, LDL at the concentration of 100 mg/dl, TG at the
concentration of 100 mg/dl, and BSA at the concentration of 35 mg/dl. These
concentrations are consistent with Table 3-1116.
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Figure 3-3 Purchased standards added to 20% fasting plasma compared to 20% postmeal plasma. Comparisons between fasting (yellow shaded) and post-meal (brown
shaded) plasma and a mixture (dashed line) of fasting plasma at 20% concentration plus a
purchased standard: A) High-density lipoproteins at 200 mg/dl in fasting plasma, B)
Low-density lipoproteins at 100 mg/dl, C) Triglycerides at 100 mg/dl, D) Bovine serum
albumin protein at 35 mg/dl. All plasma samples were obtained from the same healthy
donor at the optimum dilution of 20%.
HDL existence in fasting plasma spectra shown in (Figure 3-3, A) revealed that HDL has
the lowest effect on the spectra. Actually, HDL served to reduce the spectra heights; the
only part of the fasting plasma spectra that was elevated by the HDL is the first part of
the primary shoulder.
LDL addition to the fasting plasma spectra shown in (Figure 3-3, B) showed that LDL
has the greatest effect on the fasting spectra, nearly recreating the post-meal plasma
spectra. However, LDL did not affect the tertiary peak. LDL elevated the spectra,
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especially the secondary shoulder height which was much higher than the post-meal
plasma spectra secondary shoulder.
The addition of TG to the fasting plasma shown in (Figure 3-3, C) was clearly a slight
shift up of the fasting plasma spectra including the primary shoulder, secondary peak,
secondary shoulder, and tertiary peak.
The effects of adding BSA to the fasting plasma spectra shown in (Figure 3-3, D)
appeared mostly from the top part of the secondary shoulder all the way to the top of the
primary shoulder. BSA’s highest impacts were to increase the primary shoulder even
higher than the post-meal plasma primary shoulder. Comparing LDL effects and BSA
effects on the fasting plasma spectra, it is clear that LDL and BSA have more impact on
the spectra than the other two standards. The LDL had a more noticeable effect on the
secondary shoulder whereas the BSA had more effects on shifting up the primary
shoulder.

We conclude from Figure 3-3 above, that the standards that contributed to reproducing
the post-meal spectra were, in order of highest to lowest impact: LDL > BSA > TG >
HDL. Figure 3-4 below shows the combinations of the two standards together (six
different possibilities) to show the duplex of standards that can most accurately recreate
the post-meal plasma spectra.
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Figure 3-4 Combinations of duo standards added to 20% fasting plasma compared to
20% post-meal plasma. Fasting plasma is shown in yellow, the post-meal absorbance is
in brown, while the fasting plus two standards is the dashed line. Concentrations were
kept constant as follows: TG = 100 mg/dl, HDL = 200 mg/dl, LDL = 100 mg/dl, BSA =
35 mg/dl.
A comparison spectrum shown in (Figure 3-4, A) between the duo standards, HDL and
LDL, in fasting plasma and post-meal plasma spectra. HDL and LDL together shift up
only two parts of the spectra: primary and secondary shoulder.
A comparison spectrum shown in (Figure 3-4, B) between the post-meal plasma and the
mixture of the duo standards LDL and TG in fasting plasma. LDL and TG have the
greatest increase in absorption at all wavelengths compared to all other combinations.
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LDL with TG effects the whole spectra, maintaining a comparable shape to the post-meal
plasma spectra but also doubling the area under the curve.
Spectra shown in (Figure 3-4, C) revealed that the duo standards for HDL and TG have
the lowest effect compared to all other combinations. These two lipids together have a
minor effect shifting up the top part of the primary shoulder.
Comparison spectrum shown in (Figure 3-4, D) between the duo standards LDL and
BSA in fasting plasma to post-meal plasma spectra. LDL and BSA mixture shift up and
increasing the area under the spectrum from the beginning of the secondary shoulder all
the way to the top of primary shoulder.
A comparison spectrum shown in (Figure 3-4, E) between the addition of the duo
standards HDL and BSA in fasting plasma to post-meal plasma spectra. HDL and BSA
mixture have a minimal effect in shifting up and increasing the area under the spectra of
the secondary peak and the primary shoulder.
A comparison spectrum shown in (Figure 3-4, F) between the post-meal plasma and the
duo standards TG and BSA in fasting plasma. TG and BSA mixture have an effect on
translating up the whole fasting spectra. It is the duo standard combination that best
recreated the post-meal plasma spectra.

We can conclude from (Figure 3-4, B & F) spectra that the presence of TG changes the
area under the tertiary peak when combined with LDL or BSA. Meanwhile, in (Figure
3-4, C) there was no change found from the TG complex with HDL. (Figure 3-4, D &
E), the addition of LDL to BSA had more effect shifting up the spectra of the fasting
plasma. The duos with the highest impact in human post-meal plasma in order from
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greatest to least were: B) LDL and TG, F) TG and BSA, D) LDL and BSA, A) HSL and
LDL, and E) HDL and BSA. The presences of TG instead of BSA in combination with
LDL affected the whole fasting spectra. The post-meal plasma lipid profile can be
reproduced with only the addition of LDL and TG to the fasting plasma.
Figure 3-5 below shows four different standard trio combinations: A) HDL, LDL, and
TG, B) HDL, LDL, and BSA, C) HDL, TG, and BSA, D) LDL, TG, and BSA.

Figure 3-5 Trio of standards in 20% fasting plasma. Concentrations were kept constant
as follows: TG = 100 mg/dl, HDL = 200 mg/dl, LDL = 100 mg/dl, BSA = 35 mg/dl.

The trio mixture that was most effective at recreating the post-meal plasma spectra was in
(Figure 3-5, C) including HDL, TG, and BSA. The remaining trio combinations appear
to have affected the entire spectra from 270 to 700 nm. We conclude from Figure 3-5
that the presence of LDL in the plasma always elevates the secondary shoulder, while the
presence of the triglyceride elevates the tertiary peak. Last but not least, the albumin
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presence elevated the spectra by shifting up the top part of the primary shoulder which
had the effect of increasing the area under the shoulder.
It was clear that when HDL is in the presence of LDL, that the HDL works to reduce the
effect of LDL lipoproteins. Overall, the different trio standard mixtures effect four
different parts of the fasting plasma spectra: a) increases the area under the primary
shoulder by shifting up the primary shoulder, b) similar for the secondary shoulder, c) the
area under the secondary peak was bigger than the post-meal one because the secondary
shoulder was shifted up and c) the height of the tertiary peak.
Figure 3-6 below shows the last combination with four standards (HDL, LDL, TG, and
BSA) all together.

Figure 3-6 Quad standard mixture with HDL 200 mg/dl, LDL 100 mg/dl, TG 100 mg/dl,
and BSA 35 mg/dl in 20% fasting plasma.
The effects from combining all standards in fasting plasma at the normal range
concentration was to create a new spectrum whose absorbance is much higher than the
post-meal plasma spectra. This is true across all different areas of the spectra: primary
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shoulder, secondary peak, secondary shoulder, and tertiary peak. We conclude that this
quad standards mixture needs to be rerun with all standards at half of their original
concentrations to best see the features in this spectrum.

3.4 Conclusions
UV-Vis measurements were able to discern lipemia from the absorbance results of the
blood plasma. We found there are differences between fasting and post-meal samples
likely because the lipids, lipoproteins, and proteins predominantly exist in the plasma of
the human blood. Further, the UV-Vis proved to be a robust and reproducible tool as
illustrated by repeats of the same donor on five different days with little variation.
A systematic exploration of individual lipoprotein and protein standards revealed that the
lipids that contributed most in reproducing the post-meal spectra, in order from highest to
lowest impact, were LDL, BSA, TG, and the last one is HDL.
Exploration of duplexes of lipoprotein and protein standards revealed that the presence of
TG predominantly changes the area under the tertiary peak when combined with LDL or
BSA. There was no change observed from the TG duo with HDL. The addition of LDL to
BSA had more effect in the shifting up the spectra of the fasting plasma. The duo of
lipoproteins having the highest impact reproducing human post-meal plasma, in order of
best to worst match, were: B) LDL and TG, F) TG and BSA, D) LDL and BSA, A) HSL
and LDL, and E) HDL and BSA. The presence of TG instead of BSA in combination
with LDL affected the whole fasting spectra. This duo analysis revealed that the most
efficient way to reproduce the post-meal plasma lipid profile was via the addition of only
LDL and TG to the fasting plasma.
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It was clear that when both LDL and HDL are present that the HDL works to reduce the
effect of LDL lipoproteins on absorbance (and by inference turbidity). As we will see in
Chapter 4 (Figure 4-9, of the D#7 at week 0), there was not a big difference between the
fasting and post-meal plasma UV-Vis spectra, it might be due to the higher concentration
of the HDL present in the blood stream in the post meal plasma. Overall, using UV-Vis to
measure the absorbance of the lipid profile of the human plasma cannot analyze the
concentration of the individual lipids and lipoproteins. For this reason, using the
enzymatic method to prepare the plasma samples, before measuring each lipid and
lipoprotein separately, at the medical laboratories still more effective than using the PBS
buffer.
Overall, the different trio standard mixtures effected four different parts of the fasting
plasma spectra: a) increased the area under the primary shoulder by shifting up the
primary shoulder, b) similar for the secondary shoulder, c) the area under the secondary
peak was bigger than the post-meal one, and d) the height of the tertiary peak.
Overall, this work demonstrated the contributions of each lipoprotein in shifting the
fasting spectra up to the post-meal spectra. Triglycerides and low-density lipoproteins
make the greatest contributions to the lipemic state of human blood.
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4 The Effects of Hibiscus sabdariffa L., and Camellia
sinensis (Oolong) Tea on Blood Lipids Levels in Humans

This chapter was a collaboration project with Associate Professor John Durocher and his
master’s student Basirat Tolulope Shittu from Biological Sciences Department. Dr.
Durocher and Basirat were measuring the arterial stiffness measurements and we were
collecting participants fasting and post-meal blood to conduct the lipid profile
measurements, using the UV-Vis, LC/MS, and our designed portable device.

Abstract
Lipid profiles can provide insights into short-term food consumption as well as long-term
dietary choices. Lipids can be discerned from human serum and plasma via UV-Vis
spectrophotometry, standard analytical laboratory tests 76, and point of care microfluidic
devices. Lipids profiled included triglyceride (TG), low-density lipoprotein (LDL), and
high-density lipoprotein (HDL). Prior exploratory studies have examined tea
consumption with positive impacts on various dimensions of cardiovascular functionality.
The main hypothesis of this study, based upon compelling data from a small-scale pilot
study, is that blood pressure and blood lipid levels will be reduced by either HS tea or
Oolong tea consumption. A peach tea control will also be tested that, based upon no
evidence found in the literature, is not expected to alter blood lipid levels. This work
explores whether ingestion of tea impacts cardiovascular function and lipid profiles. Male
and female participants were divided randomly into three groups: 1) Hibiscus tea, 2)
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Oolong tea, 3) peach tea. In this work, lipid profile comparisons were made between
commercial UV-Vis instrument results of tea study participants. Participants donated
fasting and post-meal plasma prior to and after consuming tea daily for six weeks, while
abstaining from the use of any other teas other than the assigned tea. Preliminary results
are reported to compare fasting and post-meal lipid profiles for inter-individual and intraindividual comparison across 3 participant groups over 9 weeks: a control group who
drank peach tisane, a group who drank Hibiscus sabdariffa L. (HS) and a group who
drank Oolong tea. Comparisons are complimented with statistical analysis for each
grouping. Not all participants completed the 9-week trial due to COVID-19 research
interruptions. The implications are that it is necessary to recruit more participants to
increase the accuracy and resolvability of results and conclusions.
Key words: Lipidemic level, Lipoproteins, Triglycerides, Lipids, low-density
lipoproteins, high-density lipoproteins, UV-Vis, TG, HDL, LDL, TG, Lipid profiling,
Hibiscus tea, Oolong tea

4.1 Introduction
Throughout human history, teas and tisanes have been a significant part of culture and
medicine. In the modern era, tea is one of the most common beverages around the world
64, 65

. The medicinal and health benefits of herbals and camellia leaves continue to be

actively researched. As mentioned in previous chapters, a number of studies have
indicated that tea can reduce risk of cardiovascular disease 59-64.
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There are several beverages have been approved to be healthy drinks included, Oolong
and other teas as well as Hibiscus sabdariffa L. (HS), fruit and other tisanes. Health
approved drinks have been promoted and used to reduce fat and triglyceride serum levels.
The major ingredients of those approved drinks are catechins and polyphenols 69. These
ingredients have been found to help to reduce both low-density lipoprotein levels and
general body fat, and they also impede increases in post-meal triglyceride levels 69. Teas
and other plants that are a rich resource of antioxidants, such as flavonoids and other
phenols have been found to prevent and reduce cardiovascular events 66, although the
exact metabolic mechanisms are not yet fully understood.
In general, cardiovascular diseases (CVD) include any diseases impacting the heart and
blood vessels. In addition, CVD are the main cause of death globally with coronary heart
diseases (CHD), heart attack, and stroke leading CVD deaths 1.
Lipids and lipoproteins comprise 8% of the body 10. There is a reverse relationship
between a lipoprotein’s size and its density. Lipoproteins differ in size and the lower
density particles predominantly contribute to the sample’s turbidity 24. There are two
well-known types; high-density lipoprotein (HDL) cholesterol (good for health) and lowdensity lipoprotein (LDL) cholesterol (bad for health)28. Lipid profiles traditionally
include triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein
(HDL). Lipid profiles can provide insights into short-term food consumption as well as
long-term dietary choices. Based on the findings from some studies, the lipoprotein
values in post-meal samples changed significantly from levels measured using fasting
samples 117, 118. While the triglyceride concentration significantly increased 117, the high75

density and low-density lipoprotein concentrations decreased 118. Thus, using fasting
plasma (for at least 12-hours 119) is more reliable and accurate, especially for those at risk
of coronary heart diseases 120, hyperlipidemia 121, 122, and cardiovascular risk 117. Based
on other studies' findings, there are advantages for using post-meal samples, such as
making the lipid measurements more convenient, and there were no significant
differences between the fasting and non-fasting lipid profile values for those who have
normal lipid levels 117, 121, 122. Also, non-fasting samples help to assist decision-making
regarding prevention of coronary heart diseases 118. The use of non-fasting rather than
fasting lipid profiles to screen for cardiovascular risks would simplify clinical care 102 but
would require greater knowledge of time-dependent variations. Also, some studies
advanced an argumentative opinion that using the fasting samples over non-fasting
samples would measure metabolic responses to nutrient intake 123.
Cardiovascular health benefits of teas are an area of active research. There are two
primary types of tea species: Camellia sinensis and Camellia assamica. Tisanes are all
other types of steeped herbal drinks, often made from flowers or herbs. Hibiscus
sabdariffa L. (HS) is one of the most common. The degree of fermentation of Camellia
leaves enables division of teas into four main types: black, oolong, green, and white tea.
The degree of tea fermentation also affects the caffeine level in the tea; as the
fermentation degree goes up the caffeine level goes up. Black is fully fermented (higher
caffeine level); Oolong is partially fermented fitting in the middle between black and
green tea with the degree of fermentation. White tea is unfermented (the lowest level of
caffeine ~ almost decaffeinated) 65. The degree of tea fermentation affects the caffeine
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level in the tea; as the fermentation degree goes up the caffeine level goes up. The
chemical contents of the tea leaves are also affected by the growth of the tea plant
including types, leaves, climate, and season65. Across all tea growth and fermentation
conditions, polyphenols have been determined to be the major active health compound
present in teas 65.
Hibiscus sabdariffa L. (HS) has many different names in different parts of the world and
in different languages. In Arabic, it is called Karkade, while in British English it is called
Roselle 76. Hibiscus sabdariffa L. (HS) is a medicinal flower from a branch of the
malvaceae family and as such, it is considered an herbal tea. The Hibiscus flower’s main
active ingredients include polyphenolic acids and flavonoids, such as anthocyanins76, all
of which have antioxidant activity.
Based on several research studies examining Hibiscus tea and its components, evidence
suggests that HS has a positive impact on human health including helping to treat
different diseases, especially cardiovascular diseases 76. There are two different colors of
Hibiscus flower calyxes: white (Alma Blanca) and red (Criolla). The calyx part of the
Hibiscus flower is popular for its high nutraceutical value and its anthocyanin benefits
that help reduce body fat as well as prevent obesity risks and complications 77.
A wide variety of studies have explored beverage consumption and lipid and/or
cardiovascular effects66. Other studies hypothesize that there is a correlation between the
reduction mechanisms of cardiovascular risks and low-density lipoprotein (LDL) and
triglycerides (TG) levels67, 68. Based on findings 22, there are some diseases such as lipid
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disorders, diabetes mellitus, and obesity that are risk indicators of cardiovascular
diseases. According to Welsh et al.22, there are some life style behavioral acts such as
excessive sugar consumption that increase the risk of CVD. Also, some measurements
have been shown to positively correlate with increasing CVD risk, such as: triglyceride
and low-density lipoprotein levels, blood pressure, and body-mass-index (BMI) 22.
Hibiscus sabdariffa L. (HS) results vary in the literature. HS tisane was reported to have
cardiovascular benefits of lowering blood pressure (BP), and potentially improving
plasma lipid profiles68, 78-85. Studies have reported that Hibiscus sabdariffa L. (HS) tisane
either improves plasma lipids87, 88, or has no effect89. Several very large studies with
40,530 participants between 40-79 years have shown no relation between HS tea
consumption and blood pressure, another common indicator of CVD62, 73-75. Meanwhile,
the main outcome of another study 76 indicated there were benefits, but not any greater
benefits for HS tisane over black tea76.
Oolong tea (partially fermented Camellia sinensis leaves) catechins have been reported in
a several studies to help prevent increased levels of post-meal serum triglycerides, and
decrease levels of both body fat and low-density lipoprotein69. In Japan, consumption of
>1 cup per day of Oolong tea was found to reduce cardiovascular risk 62, 71. In Taiwan,
drinking more than a half cup per day of Oolong tea was found to help minimize new
hypertension risks 62, 72. Drinking 1-6 cups per week and >1 cup per day of Oolong tea
was found to help reduce CVD risks (hypertension risks) 61. Oolong tea has been
identified to have antioxidant benefits, which can improve blood pressure and reduce
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cardiovascular disease incidents 62, 71. However, other studies found no correlation
between blood pressure and tea consumption 62, 73-75.
Since this tea study design is an active control randomized clinical trial (RCT) and
double-blind study, we had to use a control beverage that has not a distinct color and taste
from the hibiscus tea. For that we have choose peach tisane as our study control. A peach
tisane control was also tested because it was not expected to alter blood lipid levels (e.g.
no evidence of prior studies was found in the literature regarding health benefits
including altered lipid or cardiovascular function). Based on preliminary data that shows
HS tisane reduced blood pressure and especially hypertension, which are cardiovascular
disease indicators, this study hypothesized that blood lipid profiles would become more
favorable with HS tisane or Oolong tea consumption. Thus, this research examined both
lipid profiles and atrial stiffness indicators (blood pressure) for tea/tisane drinkers.
Given the compelling, yet conflicting evidence that tea consumption may impact
cardiovascular function and lipid profiles 59-64. As well as compelling preliminary HSblood pressure data presented by the Durocher group [“The Effects of Hibiscus
sabdariffa Tea on Cardiovascular Health” by Nelson, E., Wakeham, T., and Durocher,
J.]86. Also, data from the Minerick group quantifying hyperlipemic status in human
plasma samples [Chapter 3]. This work examines whether short-term consumption of HS,
oolong, or peach (control) tea/tisanes impact lipid and/or cardiovascular profiles. Human
lipid levels for low-density lipoproteins (LDL), high-density lipoproteins (HDL), and
triglycerides (TG) were measured from plasma of donors in a fasting state and after
consuming a high-fat, high-carbohydrate meal. The study structure was designed to
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compare fasting and post-meal lipid profiles for inter-individual and intra-individual
comparison across 3 participant groups over 9 weeks: a control group who drank peach
tisane, a group who drank Hibiscus sabdariffa L. (HS) and a group who drank Oolong
tea. The study was structured with an initial cardiovascular and lipid profile baseline,
followed by tea/tisane consumption for 3 weeks (lipid profile data collection), an
additional 3 weeks of daily tea/tisane consumption (lipid and cardiovascular profiles data
collection), and 3 weeks of no tea/tisane (final lipid data collection). Fasting and postmeal blood plasma samples were measured by UV-Vis to ascertain lipids levels.
Comparisons were made between the plasma and serum of the participant at the fasting
and post-meal state for the baseline and 6-week data:
1) Comparing the changes in the UV-Vis spectra of the fasting verses post-meal
plasma UV-Vis spectra (primary shoulder, secondary peak, secondary shoulder,
and tertiary peak) for the baseline (0-week), 3-week, 6-week, and 9-week using
PBS as the dilution/reference solution
2) Comparing the changes in the UV-Vis spectra of the fasting verses post-meal
plasma for the baseline (0-week) and 6-week using (tea-PBS) as the
dilution/reference solution (future work).
3) Comparing the changes in the UV-Vis spectra of the fasting plasma in PBS verses
fasting plasma in tea-PBS solution for the baseline and 6-week using PBS or teaPBS buffer as the dilution/reference solution (future work)
4) Comparing the changes in the UV-Vis spectra of the Post-meal plasma at baseline
verses post-meal plasma at 6-week using (tea-PBS) as the dilution/reference
solution (future work).
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Previous comparisons completed using the UV-Vis were key calibration data from which
understandings of any tea effects in plasma lipid levels could be ascertained. This was
useful since plasma lipid levels are one type of indicator of metabolic syndrome. The
second portion of the study involved collecting data to determine any tea effects on
arterial stiffness and blood pressure. This was done by our collaborators by measuring
and collecting data at the baseline and after 6 weeks of drinking the tea. Cardiovascular
measurements included: brachial blood pressure, aortic blood pressure, pulse wave
analysis, and pulse wave velocity.

Thus, a study structure was designed to study if the ingestion of tea impacted
cardiovascular function and lipid profiles. To attempt to discern metabolic impacts of the
teas in human plasma, we tested a total of three teas: HS, Oolong and peach. Male and
female participants were divided randomly into three groups: 1) Hibiscus tea, 2) Oolong
tea, or 3) peach tea. In this work, lipid profile comparisons were made with a commercial
UV-Vis instrument to document results of tea study participants fasting and post-meal
plasma pre- and post- consuming tea for six weeks, while pausing any other teas other
than the assigned tea, but participants were not requested to pause coffee and wine, even
though coffee and wine have high polyphenol contents and could obscure our study
results. Participants who routinely drink tea prior to our tea study, we had must require
them to paused tea for at least 3 weeks prior their start of the tea trial because this could
impact their baseline measurements. Also, comparisons were made between fasting and
post-meal lipid profiles for inter-individual and intra-individual comparison across 3
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participant groups over 9 weeks: a control group who drank peach tea, a group who drank
Hibiscus sabdariffa L. (HS) tea and a group who drank Oolong tea.

4.2 Materials and methods
4.2.1

Chemicals and Standards Preparation

Phosphate buffered saline (PBS) with a conductivity of 0.1 S/m was prepared using:
24.935 mL of E-pure water (Millipore, MA), 1.233 g Sigma-Aldrich D9434 Dextrose
powder (99% pure), and 65.386 L Sigma-Aldrich D9434 PBS salt stock solution (99%
pure). Phosphate buffered saline (PBS) with a conductivity of 0.1 S/m spiked with tea
was prepared using the previous recipe except using water infused with the respective
tea/tisane; HS, Oolong, and peach. Each tea/tisane was prepared according to steeping
instructions: Hibiscus sabdariffa L. tisane: 2 g tea bag steeped in 8 oz. of boiling water
over tea bag provided, cover and steep 3-5 minutes; organic Oolong tea: 2 g tea bag
steeped in 8 oz. of under boiling water over tea bag provided, cover and steep 3-5
minutes; and peach tisane: 2 g tea bag steeped in 8 oz. of hot water cover and steep 4-6
minutes.

4.2.2

Participant Testing and Blood Sample Collection

Participant recruitment, sample acquisition, and data handling all followed IRB approved
procedures per Michigan Tech M1889 [1452743-1]. A total of 50 participants were
recruited from Michigan Tech and the surrounding community. 17 Individuals were
comprised of both men and women (ages 18-50), had a BMI in the range 18.5-35 kg/m2,
and had a blood pressure of 110 mmHg. Participants were excluded if they smoked or
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used vaporized nicotine, had diabetes, asthma, a history of fainting, stroke, or heart
attack, were pregnant, had a pacemaker, or were on any blood pressure medication.
Informed consent was obtained, and participants completed a uniquely coded - yet
disaggregated from identifiable information - health information sheet covering diet and
daily routines prior to officially enrolling in the study. The unique code was utilized to
match participant data longitudinally across the study from Week 0 (baseline), Weeks 3
and 6 (tea consumption twice daily), and Week 9 (final status). Figure 4-1 is a map that
shows the tea study trial processes.

4.2.3

Study Structure and Sample Collection

This study was comprised of five participant/researcher interactions: orientation,
baseline, week 3, week 6, and week 9. During orientation, participants had blood
pressure and BMI (height and weight) checked to determine if they were qualified to
participate in the study. For the baseline at week 0, participants had their cardiovascular
measurements (blood pressure and arterial stiffness) tested at the MTU sleep research lab
at the Student Development Complex followed by their blood lipid profile via a single
blood draw via phlebotomist at UP Health- Portage University Center. During week 3 and
week 9 sessions, participants only had the lipid profile checked. The week 6 session
followed exactly the same procedures as the week 0 baseline in which participants had
both cardiovascular measurements (arterial stiffness and blood lipid profile) acquired.
Prior to each collection, participants were asked to complete a questionnaire on their
daily routine for the prior 3 weeks. Participants were randomized into one of three
groups: two treatment groups (Hibiscus sabdariffa L. tisane, Frontier Co-op, Norway, IA)
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or (Oolong tea, Anthony’s Organic, Sparks, NV) as well as a control group (peach tisane,
Celestial Seasonings, Boulder, CO). Participants were asked to consume the tea/tisane
twice daily (i.e. once in the morning and once in the late afternoon / early evening) for 6
weeks. Instructions were provided for preparing the beverages as specified earlier.
For the lipid profile tests in all groups, the following protocols were performed at 0, 3, 6,
and 9 weeks. Participants fasted for 12 hours (overnight) and then met at the clinic to
have two (2) fasting samples collected into purple top (no anticoagulant) tubes. After
participants consumed a high carbohydrate, high fat meal, a post-meal sample was then
collected 2-3 hours after eating into one 6 mL red top (no anticoagulant) tube.
Participants were then provided tea/tisane samples and instructed to drink 2 cups tea/day
for three weeks. The following analyses and comparisons were conducted:
1. Fasting and post-meal lipid profile comparison of same participant at week 0,
week 3, week 6, and week 9
2. Fasting and post-meal lipid profile comparison of different participants of the
same tea group at week 0, week 3, week 6, and week 9
3. Fasting and post-meal plasma of participants from different tea group at week 0
and week 6
4. Fasting and post-meal lipid profile reproducibility at week 0, week 3, week 6, and
week 9
5. Fasting and post-meal average of the lipid profile at week 0 and week 6
6. Fasting and post-meal whisker plot of the lipid profile at week 0, week 3, week 6,
and week 9
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4.2.4

Participant Arterial Stiffness Measurements

This section was rephrased from Basirat Shittu’s master’s thesis to be defended August
2020. Brachial blood pressure was measured into two different positions: relaxed seated
and supine position. After a 15-minute rest, participants were instructed to remain quiet,
breath normally, and keep uncrossed arms and legs uncrossed. Using an automated
sphygmomanometer on the participants left arm (Omron HEM-907XL, Omron Health
Care, Kyoto, Japan), triplicate blood pressure measurements were taken for the relaxed
seated and supine positions, and then an average blood pressure reading was calculated.
While participants were in the supine position, an average supine blood pressure was
calculated and used to calibrate the SphygmoCor (SphygmoCor; AtCor Medical, Sydney,
Australia). Measurements of the participant’s torso were taken to decide the radial artery
locations to measure the aortic blood pressure. Radial applanation tonometry was
performed non-invasively on each of the participants, which involved placing a tonometer
probe on the radial artery and pressing the probe lightly against a carpal bone at the wrist.
By holding the tonometer probe still and pressing against a couple radial artery spots for
few seconds, ten strong radial pulses were captured. Duplicate measurements were
estimated for the aortic blood pressure. In the complimentary software, an operator index
greater than 80 was considered satisfactory throughout the testing period.
The SphygmoCor software analyzed the estimated radial pulse wave into several pressure
readings/values: the aortic systolic blood pressure (SAP), the aortic diastolic blood pressure
(DAP), the mean aortic pressure (MAP), the pulse pressure (PP), and the aortic
augmentation index (AIX). In this study, any participants with an aortic pulse pressure >50
85

mmHg were excluded, because for those conditions, participants would be more
susceptible to plaques that could potentially become dislodged with pressure.
The non-invasive applanation tonometry had a two-lead electrocardiogram (ECG) that
contained three different electrodes, which were connected to the participant’s torso, and
used to measure the pulse wave velocity. Two of the electrodes were attached to the left
and the right top front portion of the chest, and the third electrode was attached to the
left-side of the rib cage.
Two distances were measured to conducted central arterial stiffness (carotid-femoral): 1)
the distance (mm) between the pulse site in the carotid artery and suprasternal notch, 2) the
distance between the femoral pulse located in the femoral artery and the suprasternal notch.
Central arterial stiffness (carotid-femoral) was measured by placing the tonometer on the
pulse site first on the carotid artery and subsequently on the femoral artery. Carotid-femoral
pulse wave velocity (cfPWV) was calculated by the SphygmoCor software, which compile
the measured distance and the time delay from the appearance of the incident wave in the
heart and the arrival of the reflected wave back at the pulse site, duplicate measurements
was collected and analyzed with ≤ 10% standard deviation, to standardized the procedure.
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Figure 4-1 Tea Study Trial Process (made by using Lucidchart)
4.2.5

Blood Sample Handling

Blood was drawn by Portage Health Clinic phlebotomists according to approved
procedures. Blood samples were transported to the lab, then centrifuged at 4000 rpm
(relative centrifugal force, RCF = 894 g) for 10 minutes to isolate the plasma/serum,
which was then stored in the freezer until analysis.
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The measurements of the lipid levels profile using the UV-Vis methodology are detailed
along with experiments and comparisons to ascertain any tea/tisane consumption benefits
on blood lipid levels and/or arterial stiffness profiles.

4.2.6

Fasting and post-meal plasma sample dilutions

Serial dilutions of the fasting and post-meal plasma samples were run to ascertain an
optimum dilution within the meaningful adsorption range (0.0 to 1.0 whereby 99.9% of
light adsorbed at 1.0)124 for the UV-Vis instrument (Thermo Spectronic, Genesys 10-S).
The optimal dilution was determined to be 20% plasma (or serum) and 80% isotonic
phosphate buffered saline PBS.

4.2.7

Plasma UV-Vis absorbance measurements and instrument settings

Human plasma samples were diluted to 20% with isotonic PBS solution (1:4 v/v%
plasma: PBS). UV-Vis absorbance (Thermo Spectronic, Genesys 10-S) was measured
from diluted plasma in plastic cuvettes (Fisher Scientific, 3mL, polystyrene, absorbed
light in the wavelengths < 270 nm) filled to 1 mL. Absorbance was recorded over a
wavelength range from 190 nm to 1100 nm but focused to between 290 nm and 700 nm.
Absorbance features tracked were three different wavelengths and two wavelength
ranges: 1) the primary peak at 295 or 298 nm (since the primary peak had interference
from the polystyrene cuvette, it was excluded from further analysis), 2) the secondary
peak at 412 nm, 3) the tertiary peak at 571 nm, 4) the shoulder from the primary peak
from 322-373 nm (specifically the absorbance height at 373 nm), and 5) the shoulder
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from the secondary peak from 442-562 nm (specifically the absorbance height at 472
nm).

4.2.8

Tea/tisane standards

Standards for Hibiscus sabdariffa L. tisane, Oolong tea, and peach tisane identically
followed the brewing instructions provided to participants. Tea standards were measured
via UV-Vis in their pure form and then also spiked into donated plasma from donors as a
control. It is acknowledged that this control accounts for any intact tea/tisane component
absorbance, but not the metabolites from the tea/tisane that may impact plasma
absorbance.

4.2.9
4.2.7.1

Procedure and Experimental Details
Plasma UV-Vis absorbance measurements and instrument settings

To measure absorbance of human plasma samples as well as the tea standards, UV-Vis
spectroscopy measurements were conducted over a range of 190 nm to 1100 nm, cropped
to 290-700 nm to remove the absorbance contribution by the plastic cuvette. To ascertain
the effect of tea/tisane consumption in human lipid profiles, plasma samples from
different days (0, 3, 6, and 9 weeks) from the same donor were analyzed. For trend
analysis, five unique donors for each tea group (hibiscus, oolong, and peach) provided
fasting and post-meal blood samples at each visit. All samples were prepared 1:4 v/v%
plasma: PBS, measured over 270 nm to 700 nm, with four spectral areas of interest.
Secondary analysis included tabulating the primary shoulder median height, secondary
peak height, secondary shoulder median height, and tertiary peak height. Averages and
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standard deviations were computed for the following independent variables: fasting and
post-meal samples with comparisons for the five different plasma samples of the same
donor as well as comparisons across 3 participant groups over 9 weeks.
Ratiometric data analysis was conducted to ascertain relative features within a single
sample measurement. Ratios that differed greatly between the fasting and post-meal
plasma spectra provide the greatest potential to discern healthy from lipemic states. Ratio
percentages were calculated between different features including primary
shoulder/secondary peak (412 nm), primary shoulder/secondary shoulder, and primary
shoulder/tertiary peak (571 nm).

4.2.7.2

Box and whisker plotting and Probability value (P-value) calculation

To understand how our tea study data was distributed and in order to compare the data
systemically, we plotted the absorbance values in box and whisker plots. This type of
data analysis helped us to understand and visualizes our participant’s lipid profile
interactions pre-, mid-, and post-ingestion of the three teas study.
Thus, we decided to calculate the t-test values also known as the probability value (pvalue) for the difference between week 0 and week 3 at the second peak or 412 nm, and
the difference between week 0 and week 6 at the second peak or 412 nm. P-values can be
used as indicators of the hypothesis sufficiency. P-value sufficiency depends on the ɑ
value range. For the p-value that feels within the ɑ <= 0.05 range, which is consider a
significant value. Meanwhile, the p-value that equal to ɑ = 0.1 value, which is classified
as a marginally significant value.
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Figure 4-2 below shows the box and whisker plot elements 125, mainly there are one box
and two whiskers (the upper and the lower whiskers). Minimum is the lowest data value
(the lower whisker), median is the middle line of the box and is known as the second
quartile (Q2) (the mid-point/line inside the box), and maximum is the highest data value
(the upper whisker). The lower quartile (Q1) is the lower half of the box, the upper
quartile (Q3) is the upper half of the box, and the inter-quartile range (IQR) is the whole
box.
Several box positions can be observed in the box and whisker plots that include Figure
4-17 to Figure 4-20. Since the second quartile is not always in the middle of the box.
There are three position of the median (the mid-point/line) inside the box: (1) a normal
distribution that only happened when both sides of the box were equal and symmetric, (2)
a positive skew occurred when the upper side of the box was much larger than the lower
side, indicating that most of the data was higher than the median, and (3) a negative skew
manifested when the lower side of the box was larger than the upper side meaning that
most of the data was lower than the median.
The interquartile range is the length of the box, and this length differed from one tea
grouping to another. The length of the interquartile range is a simple visual indicator of
the data variability and distribution. Lastly, there were three positions of the whiskers: (1)
symmetric whiskers occurred when the length of the whiskers was equal such that the
length from Q1 to the minimum and the length from Q3 to the maximum were equal, (2)
top-skewed whiskers occurred when the length from Q3 to the maximum was larger than
the length from Q1 to the minimum, and (3) bottom-skewed whiskers were observed
91

when the length from Q1 to the minimum was larger than the length from Q3 to the
maximum.

Interquartile Range
(IQR)
Outliers

Outliers

Minimum

Maximum
Q1

Median

Lower Quartile

Q3

Upper Quartile

Figure 4-2 The whisker and box plot elements (created using the original draw of
McLeod et al. 125) shown horizontally. Future plots utilize this same representation
rotated counterclockwise 90o.
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Figure 4-3 Tea Extraction Processes. The left-hand side is the tea chemical infusion processes, the Hibiscus tea and peach tea
were infused according to Sindi et. al.126, and the Oolong tea was infused according to Fraser et. al.127. The right-hand side is the
tea water infusion processes, all teas were infused using the manufacturer brewing instructions. (made by using Lucidchart)

Figure 4-4 Tea Extraction Processes- Water Extraction. The teas water infusion
processes, all teas were infused using the manufacturer brewing instructions. There are
two main methods used to analyze the water extraction: UV-Vis and Chip device
(Chapter 6). (made by using Lucidchart)

4.3

Results and discussions

As we mentioned previously, lipoproteins and phospholipids absorb the maximum
amount of light over a similar wavelength region of 205–212 nm 50. The lipoprotein
spectrum reflects the absorption of two main components: cholesterol and phospholipids
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50

. High-density lipoproteins (HDL) fractions were recorded to be absorbed at 328 nm

and 408.8 nm, 50 while the natural autoxidation of low-density lipoproteins (LDL) were
recorded to be absorbed at 234 nm 51 with the absorbance of LDL alone at 205 nm 50.
Triglycerides, which is mainly fatty acid compounds, best absorbs UV light at 232 nm 52.
Albumin is a serum protein that the liver produces at rate of 9-14 g/day with amino acids
as the main products 53. Albumin has a strong peak at 204 nm and a weak peak at 277 nm
53

.

Initial tests were conducted to ascertain optimal dilution of the plasma portion of donated
human blood. Figure 3-2 shows UV-Vis absorbance for a broad range of wavelengths to
illustrate all of the absorbance area peaks and shoulders noted above. A comparison is
made between representative fasting and post-meal plasma samples.

In the Figure 3-2 above, absorbance feature measurements were trimmed to exclude the
primary peak, due to instrument saturation, and tabulated from three different
wavelengths and two wavelength ranges: 1) the secondary peak at 412 nm, 2) the tertiary
peak at 571 nm, 3) the primary shoulder at 322-373 nm, and 4) the secondary shoulder at
442-562 nm. We conclude from Figure 3-2 that the optimum dilution was 20% human
plasma with 80% PBS solution. Dilutions above 20% exceeded the absorbance ceiling,
while dilution decreases below 20% affected the secondary and tertiary peak resolvability
and height. The area underneath each peak decreased with decreasing concentration of
the plasma sample solution.
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Figure 4-5 Comparisons between the fasting and post-meal plasma data of healthy donor
at the optimum dilution (20%). The primary peak was at the wavelength range of 295298 nm. The secondary peak was at the wavelength 412 nm, consisting of a bigger peak
area for the fasting than the post-meal plasma. The tertiary peak was at 571 nm with a
similar peak area reduction as the secondary peak between fasting and post-meal.

Figure 4-4 shows the results of fasting and post-meal samples, which are representative
absorbance spectra of all experiments. The primary peak (not shown) of fasting plasma
was narrower and higher with a distinct shape. The secondary peak was observed as
shorter and wider compared to the first peak. The secondary peak was much wider
compared to the primary peak and was very unequal and small in height. We conclude
from Figure 4-4, peaks of the post-meal sample were wider with unequal shoulders
because of the presence of excess lipoprotein globules and free cholesterol molecules.

96

To further analyze these trends, we systematically compared which features yielded the
largest differences between fasting and post-meal data by ascertaining a percent
difference, D.

𝐷=[

𝑉1−𝑉2
(

𝑉1+𝑉2
)
2

] ∗ 100

Eqn 4-1

here V1 is the fasting height absorbance and V2 is the post-meal height absorbance for a
respective spectral feature, with an absorbance unit (a. u.). Spectral features included, as
shown in Figure 4-4, primary peak shoulder, secondary peak, secondary peak shoulder,
and tertiary peak.
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Figure 4-6 Reproducibility (n=5) of both the Fasting (a) and Post-meal (b) absorbance
values from different days of plasma blood donations from the same healthy male donor
at the optimum dilution of 30%. Represented as a modified whisker plot where yellow
represents the region from average absorbance to maximum absorbance and grey
represents the range from average to minimum absorbance. Variations were greater postmeal than for fasting samples.
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To discern experiment reliability, one donor’s blood donations were run five times on
different dates. Figure 4-6 shows the reproducibility data for fasting and post-meal
conditions of five independent sample donation days for the same donor over a 5-month
period. Fasting sample peaks were highly reproducible with similar peak location, width,
shape and area. The five repeats are represented in Figure 4-6 as a modified continuous
whisker plot where yellow and grey represents the full range of absorbance readings
above and below the average black line. The greatest fasting difference between runs
was the height of the secondary peak with a max to min range of 0.260 a.u. while
absorbance variations elsewhere were much smaller; the primary shoulder and tertiary
peak ranges were only 0.044 a.u. and 0.033 a.u., respectfully. The post-meal spectra
exhibited peaks at the same wavelengths, but post-meal sample peaks had greater
variability, especially with heights of the primary and secondary shoulders, the secondary
peak, and ternary peak. These three features had the greatest range between runs with
0.321 a.u. at the secondary peak, 0.121 a.u. and 0.171 a.u. at the primary shoulder and
tertiary peak respectfully. We conclude from these UV-Vis measurements that fasting
spectra are highly reproducible and post-meal spectra are sufficiently reproducible as
well as distinguishable to discern a lipemic state.
There were three different ratio metric percentages that were calculated to determine the
intra-spectra ratiometric standard: 1) Primary peak height/primary shoulder height, 2)
Secondary peak height/primary shoulder height, and 3) Primary peak height/Secondary
peak height. After further analysis, the primary peak was eliminated as mentioned the
previous chapter because of UV-Vis detector saturation. Thus, the primary shoulder

98

height/secondary peak height was utilized as our dominant ratiometric indicator. Table
4-1 shows the ratiometric values of 17 participants’ fasting and post-meal plasma at the
baseline (T=0w).

Table 4-1 Ratiometric calculation for n=17 participants at the baseline (T=0weeks) prior
to any tea consumption.
UV-vis Spectra
Fasting
Post-meal
Ratiometric
P-value
Absorbance (Height)
Plasma
Plasma
difference (D,
%)
Primary peak
height/primary shoulder
7.29
3.57
68.43
height
Secondary peak
height/primary
1.72 ± 0.33 1.48 ± 0.41 15.00
0.01
shoulder height
Primary peak
height/Secondary peak
4.19
2.41
53.79
height

Table 4-1 values were calculated using the average absorbance of fasting and post-meal
plasma of a healthy males and females aged between 18-45 years old, at the optimum
dilution of 20% (n=17). As we mentioned previously, that we exclude the primary peak
from further consideration. For subsequent ratiometric analysis, only the secondary peak
at 412 nm divided by the primary shoulder height at 373 nm will be utilized. With a
consistent 16% difference, this should be sufficient to ascertain lipemic state within only
a single sample. P-values can be used as indicators of the hypothesis sufficiency. For the
p-value of the difference between the fasting and post-meal plasma lipid profile at week 0
(baseline), p-value was 0.01, which is a significant value since it was ɑ <= 0.05. From
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those p-values we have concluded that our hypothesis about the effect of the lipemia on
post-meal human lipid profile was significant. This means that the lipid profile was
altered with consumption of high fat high carb meal with roughly 99% confidence. This
approach extends a single test to be able to screen unknown samples and determine
lipemic state without requiring a prior baseline.
Figure 4-7 shows the reproducibility data of the average absorbance for fasting and postmeal conditions at the baseline of seventeen plasma sample collections for different
participants over a 6-month period. Fasting sample peaks were highly reproducible with
similar peak location, width, shape and area; post-meal spectra profiles varied
significantly. The average absorbance data are represented in Figure 4-7 as a modified
continuous whisker plot where yellow and grey represents the full range of absorbance
readings above and below the average black line.
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Figure 4-7 Reproducibility of the participant’s fasting (n=17) and post-meal (n=14)
absorbance values at the 0-week baseline of the tea study trial of blood plasma collections
from 17 healthy male and female participants at the optimum dilution of 20%.
Represented as a modified whisker plot where yellow and grey represents the full range
of spectra above and below the average black line, respectively.

The greatest fasting difference between runs was the height of the secondary peak with a
max to min range of 0.160 a.u. while absorbance variations elsewhere were much
smaller; the primary shoulder and tertiary peak ranges were only 0.053 a.u. and 0.018
a.u. respectfully. The post-meal spectra exhibited peaks at the same wavelengths, but
post-meal sample peaks had greater variability, especially with heights of the primary and
secondary shoulders, the secondary peak, and ternary peak. These three features had the
greatest range between runs with 0.635 a.u. at the secondary peak, and 0.381 a.u. and
0.145 a.u. at the primary shoulder and tertiary peak respectfully (Table 4-2). We have
excluded the outliers of the participants data. We conclude from these measurement
values within Figure 4-7 that post-meal spectra are sufficiently distinguishable as to
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discern a lipemic state but note that the baseline variability will make it challenging to
ascertain tea impacts.
Table 4-2 Reproducibility (n=17) of the participant’s fasting and post-meal absorbance
values at the 0-week baseline of the tea study trial of blood plasma collections from 17
healthy male and female participants at the optimum dilution of 20%

Fasting T=0w

1Post-meal T=0w

Wavelength
373
412
571
373
412
571

Ave
0.294 ± 0.053
0.512 ± 0.159
0.096 ± 0.018
0.705 ± 0.506
0.959 ± 0.791
0.236 ± 0.194

Thus, Figure 4-8 below shows an intra-individual comparison between the UV-Vis data
analysis of fasting and post-meal plasma of one of the Hibiscus tea study trial
participants. The data shows several different comparisons between fasting and post-meal
plasma at different times of the trial: baseline, 3-week, 6-week, and 9-week.
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Figure 4-8 UV-Vis Data Analysis of Hibiscus Tea Participant’s Plasma. Fasting and
post-meal comparisons at baseline, 3-week, 6-week, and 9-week. This intra-individual
comparison illustrates an example of considerable variability in the fasting plasma
samples and reproducibility in the post-meal samples.

Of the changes affected the fasting lipid profile during the trial, the predominant effect in
both the fasting and post-meal profiles was in the height of the secondary peak and
shifting up of the primary shoulder. Individual participant profiles have been compiled
into Appendix B for further analysis and comparisons.
Figure 4-9 shows an intra-individual comparison between the UV-Vis data analysis of
two of the Hibiscus tea participants fasting and post-meal plasma. The data shows several
different comparisons between fasting and post-meal plasma at different time of the trial:
baseline, 3-week, 6-week, and 9-week.
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Figure 4-9 UV-Vis Data Analysis of Hibiscus Tea Participant’s Plasma (Fasting and
Post-meal) (Intra-individual Comparison)

In general, we observe different lipid profile responses to the tea consumption from the
different participant’s lipid profiles. Most of the changes during the six weeks of the tea
consumption were able to be captured by tracking the height of the secondary peak and
the shift of the primary shoulder, using Equation 4-1 to calculate the difference
percentage between the week-0 and week-6 of the participants fasting and post-meal
plasma samples. Table 4-3 below, shows the ratiometric values of the UV-Vis secondary
peak average height (a. u.) / primary shoulder average height (a. u.) of the Hibiscus tea,
Oolong tea, and peach tea participants’ fasting and post-meal plasma at week-0, week-3,
week-6, and week-9.
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Table 4-3 Ratiometric calculation for the Hibiscus tea, Oolong tea, and peach tea
participants at week-0, week-3, week-6, and week-9
Tea Type
UV-vis Secondary
Fasting
Post-meal
Ratiometric
peak height/primary
Plasma
Plasma
difference
shoulder height
Absorbance
Absorbance (D, %)
All
Week-0
1.74
1.48
16.01
Participants
Hibiscus
Week-3
1.56
1.51
3.30
Tea
Week-6
1.78
1.60
10.82
Week-9
1.70
1.54
9.76
Oolong Tea Week-3
1.59
1.19
28.09
Week-6
1.67
1.21
31.92
Week-9
1.58
1.19
27.92
Peach Tea
Week-3
1.55
1.21
24.65
Week-6
1.57
1.10
35.38
Week-9
1.31
1.10
17.56

Table 4-3 values were calculated using the average absorbance of fasting and post-meal
plasma of a healthy males and females aged between 18-45 years old, at the optimum
dilution of 20% (Hibiscus tea n=8, Oolong tea n=5, and peach tea n=4). With a 5%
decrease from week-0 to week-6 of the Hibiscus tea group, this slight decrease should be
sufficient to ascertain the effect of the Hibiscus tea on human lipid profile compared to
the other tea. We used this approach to extend our analysis and calculate the
reproducibility of the tea study data.

4.3.7

Hibiscus tea reproducibility data analysis

Reproducibility (n=6-8) of the participant’s fasting absorbance values from a) baseline
(n=8) b) 3 weeks (n=8), c) 6 weeks (n=8), and d) 9 weeks (n=6) of the Hibiscus tea trial
of plasma blood collections from eight healthy male and female participants at the
optimum dilution of 20% are shown in Figure 4-10. To consolidate all of this data, it has
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been represented as a modified whisker plot where yellow and grey represents the full
range of spectra above and below the average black line, respectively.
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Figure 4-10 Reproducibility (n=6-8) of the participant’s fasting absorbance values from
a) baseline (n=8) b) 3 weeks (n=8), c) 6 weeks (n=8), and d) 9 weeks (n=6) of the
Hibiscus tea trial of plasma blood collections from eight healthy male and female
participants at the optimum dilution of 20%. Represented as a modified whisker plot
where yellow and grey represents the full range of spectra above and below the average
black line, respectively.

The greatest fasting difference between the different periods; baseline, 3-week, 6-week,
and 9-week of the Hibiscus tea trial runs was the height of the secondary peak with a max
to min range of 0.166 a.u., 0.137 a.u., 0.116 a.u., and 0.116 a.u., respectfully while
absorbance variations elsewhere were much smaller; the primary shoulder ranges were
only 0.037 a.u., 0.111 a.u, 0.039 a.u., and 0.115 a.u. respectfully, and tertiary peak ranges
were 0.015 a.u., 0.035 a.u., 0.021 a.u., and 0.029 a.u. respectfully. Table 4-3 shows the
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fasting and post-meal plasma reproducibility data. Table 4-4 shows the Hibiscus tea
fasting and post-meal plasma reproducibility data. Also, Table B-5 shows the Hibiscus
tea fasting and post-meal plasma average and standard deviation data.
We conclude from Figure 4-10 measurements that there was not any difference in the
secondary peak height after six weeks of consuming the Hibiscus tea. As we plot the data
of the fasting lipid profile the Hibiscus tea study trial in Figure 4-10, we also plotted the
post-meal lipid profile of the same participants at the same period time of the study.
Figure 4-11 shows the reproducibility (n=6-8) of the participants post-meal absorbance
values from a) baseline (n=8) b) 3 weeks (n=8), c) 6 weeks (n=8), and d) 9 weeks (n=6)
of the Hibiscus tea trial of plasma blood collections from eight healthy male and female
participants at the optimum dilution of 20%. Represented as a modified whisker plot
where yellow and grey represents the full range of spectra above and below the average
black line, respectively.
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Figure 4-11 Reproducibility (n=6-8) of the participants post-meal absorbance values
from a) baseline (n=8) b) 3 weeks (n=8), c) 6 weeks (n=8), and d) 9 weeks (n=6) of the
Hibiscus tea trial of plasma blood collections from eight healthy male and female
participants at the optimum dilution of 20%. Represented as a modified whisker plot
where yellow and grey represents the full range of spectra above and below the average
black line, respectively.

The greatest post-meal difference between the different periods; baseline, 3-week, 6week, and 9-week of the Hibiscus tea trial runs was the height of the secondary peak with
a max to min range of 0.190 a.u., 0.279 a.u., 0.255 a.u., and 0.235 a.u. respectfully while
absorbance variations elsewhere were much smaller; the primary shoulder ranges were
only 0.076 a.u., 0.127 a.u., 0.144 a.u., and 0.122 a.u., respectfully. Tertiary peak ranges
were 0.025 a.u., 0.044 a.u., 0.047 a.u., and 0.047 a.u., respectfully. Table 4-4 shows the
Hibiscus tea fasting and post-meal plasma reproducibility data. Also, Table B-5 shows
the Hibiscus tea fasting and post-meal plasma average and standard deviation data.
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Table 4-4 Hibiscus tea Reproducibility Data of the Participants (n=6-8) Fasting and Postmeal Plasma at: week-0 (n=8), week-3 (n=8), week-6 (n=8), and week-9 (n=6)
Tea
Sample
Spectra Area
Time Period
Type
Type
(a. u.)
Week-0 Week-3 Week-6
Week-9
Fasting
Primary shoulder 0.037
0.111
0.039
0.115
(373 nm)
Hibiscus
Secondary peak
0.166
0.137
0.116
0.104
Tea
(412 nm)
Tertiary peak
0.015
0.035
0.021
0.029
(571 nm)
Post-meal Primary shoulder 0.076
0.127
0.144
0.122
(373 nm)
Secondary peak
0.190
0.279
0.255
0.235
(412 nm)
Tertiary peak
0.025
0.044
0.047
0.047
(571 nm)

We conclude from these measurements included of Figure 4-11, that there was a
significant decrease percentage in the height of the primary shoulder, the secondary peak,
and the tertiary peak was 38%, 33%, and 40%, respectfully for week-0/week-6, after six
weeks of consuming the Hibiscus tea. The decrease percentage of primary shoulder
height, secondary peak height, and tertiary peak height was 41%, 38%, and 43%,
respectfully for week-0/week-9, three weeks post pausing the tea consumption.

4.3.8

Oolong tea reproducibility data analysis

Figure 4-12 reports reproducibility (n=5) of the participants fasting absorbance values
from a) baseline b) 3 weeks, c) 6 weeks, and d) 9 weeks of the Oolong tea trial of plasma
blood collections from five healthy male and female participants at the optimum dilution
of 20%. Represented as a modified whisker plot where yellow and grey represents the
full range of spectra above and below the average black line, respectively.
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Figure 4-12 Reproducibility (n=5) of the participants fasting absorbance values from a)
baseline (n=5) b) 3 weeks (n=5), c) 6 weeks (n=5), and d) 9 weeks (n=5) of the Oolong
tea trial of plasma blood collections from five healthy male and female participants at the
optimum dilution of 20%. Represented as a modified whisker plot where yellow and grey
represents the full range of spectra above and below the average black line, respectively.

The greatest fasting difference between the different periods; baseline, 3-week, 6-week,
and 9-week of the Oolong tea trial runs was the height of the secondary peak with a max
to min range of 0.117 a.u., 0.108 a.u., 0.079 a.u., and 0.065 a.u., respectfully while
absorbance variations elsewhere were much smaller; the primary shoulder ranges were
only 0.065 a.u., 0.075 a.u., 0.049 a.u., and 0.055 a.u., respectfully. Tertiary peak ranges
were 0.024 a.u., 0.030 a.u., 0.017 a.u., and 0.026 a.u., respectfully. Table 4-5 shows the
Oolong tea fasting and post-meal plasma reproducibility data. Table B-6 shows the
Oolong tea fasting and post-meal plasma average and standard deviation data.
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We conclude from these values of Figure 4-12 measurements that there was any
difference in the secondary peak height after six weeks of consuming the Oolong tea.
This data result indicates there was no effect from consuming the Oolong tea and benefits
to the lipid profile.
As we plot the data of the fasting lipid profile of the Oolong tea study trial in Figure
4-12, we also plotted the post-meal lipid profile of the same participants at the same
period time of the study in Figure 4-13. Figure 4-13 shows the reproducibility (n=5) of
the participants post-meal absorbance values from a) baseline b) 3 weeks, c) 6 weeks, and
d) 9 weeks of the Oolong tea trial of plasma blood collections from five healthy male and
female participants at the optimum dilution of 20%. Represented as a modified whisker
plot where yellow and grey represents the full range of spectra above and below the
average black line, respectively.
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Figure 4-13 Reproducibility (n=5) of the participants Post-meal absorbance values from
a) baseline (n=5) b) 3 weeks (n=5), c) 6 weeks (n=5), and d) 9 weeks (n=5) of the Oolong
tea trial of plasma blood collections from five healthy male and female participants at the
optimum dilution of 20%. Represented as a modified whisker plot where yellow and grey
represents the full range of spectra above and below the average black line, respectively.

The greatest post-meal difference between the different periods; baseline, 3-week, 6week, and 9-week of the Oolong tea trial runs was the height of the secondary peak with
a max to min range of 0.919 a.u., 0.548 a.u., 0.317 a.u., and 0.437 a.u., respectfully
while absorbance variations elsewhere were much smaller; the primary shoulder ranges
were only 0.522 a.u., 0.414 a.u., 0.342 a.u., and 0.451 a.u. respectfully. Tertiary peak
ranges were 0.210 a.u., 0.181 a.u., 0.157 a.u., and 0.181 a.u., respectfully. Table 4-5
shows the Oolong tea fasting and post-meal plasma reproducibility data. Table B-6 shows
the Oolong tea fasting and post-meal plasma average and standard deviation data.
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Table 4-5 Oolong tea Reproducibility Data of the Participants (n=5) Fasting and Postmeal Plasma at: week-0, week-3, week-6, and week-9
Tea
Sample
Spectra Area
Time Period
Type
Type
(a. u.)
Week-0 Week-3 Week-6
Week-9
Fasting
Primary shoulder 0.065
0.075
0.049
0.055
Secondary peak
0.117
0.108
0.079
0.065
Oolong
Tertiary peak
0.024
0.030
0.017
0.026
Tea
Post-meal Primary shoulder 0.076
0.414
0.342
0.451
Secondary peak
0.919
0.548
0.317
0.437
Tertiary peak
0.210
0.181
0.157
0.181

We conclude from these values of Figure 4-13 measurements that despite the
considerable variability between the participant’s lipid profile, that there was a slight
decrease in the height of the secondary peak after six weeks of consuming the Oolong
tea. The decrease percentage of secondary peak height was 11% and 27%, respectfully
for week-0/week-6, and week-0/week-9.
4.3.9

Peach tea reproducibility data analysis

Figure 4-14 reproducibility (n=3-4) of the participants fasting absorbance values from a)
baseline (n=4) b) 3 weeks (n=4), c) 6 weeks (n=4), and d) 9 weeks (n=3) of the peach tea
trial of plasma blood collections from four healthy male and female participants at the
optimum dilution of 20%. Represented as a modified whisker plot where yellow and grey
represents the full range of spectra above and below the average black line, respectively.
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Figure 4-14 Reproducibility (n=3-4) of the participants fasting absorbance values from a)
baseline (n=4) b) 3 weeks (n=4), c) 6 weeks (n=4), and d) 9 weeks (n=3) of the peach tea
trial of plasma blood collections from four healthy male and female participants at the
optimum dilution of 20%. Represented as a modified whisker plot where yellow and grey
represents the full range of spectra above and below the average black line, respectively.

The greatest fasting difference between the different periods; baseline, 3-week, 6-week,
and 9-week of the peach tea trial runs was the height of the secondary peak with a max to
min range of 0.072 a.u., 0.102 a.u., 0.081 a.u., and 0.070 a.u., respectfully while
absorbance variations elsewhere were much smaller; the primary shoulder ranges were
only 0.038 a.u., 0.063 a.u., 0.064 a.u., and 0.040 a.u., respectfully. Tertiary peak ranges
were 0.013 a.u., 0.018 a.u., 0.024 a.u., and 0.010 a.u., respectfully. Table 4-6 shows the
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peach tea fasting and post-meal plasma reproducibility data. Table B-7 shows the peach
tea fasting and post-meal plasma average and standard deviation data.
We conclude from these values of Figure 4-14 measurements that there was a slight
decrease in the height of the secondary peak after six weeks of consuming the peach tea.
The decrease percentage was 21% and 35% for week-0/week-6 and week-0/week-9,
respectfully. This data result indicates there was an effect of consuming the peach tea on
the human lipid profile. This effect might be because the existence of the Hibiscus as a
minor but supporting ingredient within the brand of peach tea utilized in the trial.
As we plot the data of the fasting lipid profile the peach tea study trial in Figure 4-14, we
also plotted the post-meal lipid profile of the same participants at the same period time of
the study in Figure 4-15. Figure 4-15 shows the reproducibility (n=3-4) of the
participants post-meal absorbance values from a) baseline (n=4) b) 3 weeks (n=4), c) 6
weeks (n=4), and d) 9 weeks (n=3) of the peach tea trial of plasma blood collections from
four healthy male and female participants at the optimum dilution of 20%. Represented as
a modified whisker plot where yellow and grey represents the full range of spectra above
and below the average black line, respectively.

115

1

Absorbance (a. u.)

Post-meal T=0w (n=4)

Post-meal T=3w (n=4)

0.8
Min range
Max rang e
Averag e

0.6

Min rang e
Max range
Averag e

0.4
0.2
10

Absorbance (a. u.)

Post-meal T=6w (n=4)
0.8
0.6

Post-meal T=9w (n=3)

Min rang e
Max rang e
Averag e

0.4

Min rang e
Max ra ng e
Averag e

0.2

29
8
34
0
38
2
42
4
46
6
50
8
55
0
59
2
63
4
67
6
29
8
34
0
38
2
42
4
46
6
50
8
55
0
59
2
63
4
67
6

0
Wavelength (nm)

Wavelength (nm)

Figure 4-15 Reproducibility (n=3-4) of the participants Post-meal absorbance values
from a) baseline (n=4) b) 3 weeks (n=4), c) 6 weeks (n=4), and d) 9 weeks (n=3) of the
Peach tea trial of plasma blood collections from four healthy male and female
participants at the optimum dilution of 20%. Represented as a modified whisker plot
where yellow and grey represents the full range of spectra above and below the average
black line, respectively.

The greatest post-meal difference between the different periods; baseline, 3-week, 6week, and 9-week of the peach tea trial runs was the height of the secondary peak with a
max to min range of 0.375 a.u., 0.226 a.u., 0.234 a.u., and 0.233 a.u., respectfully while
absorbance variations elsewhere were much smaller; the primary shoulder ranges were
only 0.458 a.u., 0.246 a.u., 0.274 a.u., and 0.257 a.u., respectfully. Tertiary peak ranges
were 0.155 a.u., 0.080 a.u., 0.089 a.u., and 0.079 a.u., respectfully. Table 4-6 shows the
peach tea fasting and post-meal plasma reproducibility data. Table B-7 shows the peach
tea fasting and post-meal plasma average and standard deviation data.
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Table 4-6 Peach tea Reproducibility Data of the Participants (n=3-4) Fasting and Postmeal Plasma at: week-0 (n=4), week-3 (n=4), week-6 (n=4), and week-9 (n=3)
Tea
Sample
Spectra Area
Time Period
Type
Type
(a. u.)
Week-0 Week-3 Week-6
Week-9
Fasting
Primary shoulder 0.038
0.063
0.064
0.040
Secondary peak
0.072
0.102
0.081
0.070
Peach
Tertiary peak
0.013
0.018
0.024
0.010
Tea
Post-meal Primary shoulder 0.375
0.246
0.274
0.257
Secondary peak
0.919
0.226
0.234
0.233
Tertiary peak
0.155
0.080
0.089
0.079

We conclude from these values of Figure 4-15 measurements that there was a significant
decrease in the height of the primary shoulder, the secondary peak, and the tertiary peak
was 24%, 43%, and 32%, respectfully for week-0/week-6, after six weeks of consuming
the peach tea. The decrease percentage of primary shoulder height, secondary peak
height, and tertiary peak height was 33%, 50%, and 39%, respectfully for week-0/week9, three weeks post pausing the tea consumption.
Figure 4-16 shows the data after consuming tea for 6 weeks, providing a visual
comparison of the average of all the 17 participants fasting and post-meal plasma, with
color coding into the different tea groups.
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Figure 4-16 Comparison of the average absorbance of all the 17 participants of the
different tea groups over the 6 weeks of tea consumption. Decreases in post-meal
secondary peaks and in some cases tertiary peaks are apparent.

As we see in the plots of the Figure 4-16, there was a slight difference between the
secondary peak height of the fasting plasma data of the different group of teas with a
decrease percentage between 3% and 15%. The 15% decrease percentage was the effect
of consuming Hibiscus tea for six weeks.
Also, there was a slight difference between the secondary peak height of the post-meal
plasma data of the different group of teas with a decrease percentage between 4% and
39%. While the 39% was the effect of the Oolong tea consumption for six weeks.
Hibiscus tea average of the post-meal plasma was the lowest compared to two other tea.
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To understand how our tea study data was distributed and in order to compare the data
systemically, we plotted the absorbance values in box and whisker plots. This type of
data analysis helped us to understand and visualizes our participant’s lipid profile
interactions pre-, mid-, and post-ingestion of the three teas study.
Figure 4-17 shows the whisker plot with a comparison between the participant’s fasting
and post-meal samples of four groups: all participants (n=17), Hibiscus tea (n=8), Oolong
tea (n=5), and peach tea (n=4) at the wavelength of the primary shoulder (373 nm), the
secondary peak (412 nm), and the tertiary peak (571 nm) for the week 0 baseline. There
was a huge difference between the data of the Oolong tea and other teas at the
wavelength of 412 nm. The post-meal data of the Oolong tea showed large variability
while the other two tea results did not demonstrate such variability. Also, the maximum
of the post-meal of Oolong tea was really high compared to the rest of the data.
Similar to the previous figure, Figure 4-18 shows the whisker plot of a comparison
between the participants fasting and post-meal samples of Hibiscus tea, Oolong tea, and
Peach tea at 373, 412, and 571 nm for both the baseline and week 6 of the tea study. As
we observed from Figure 4-18, the Oolong tea post-meal data at week 0 was inconsistent
from the rest. There was a clear visual difference between the Oolong tea post-meal data
and the Hibiscus tea post-meal data at week 6 at the wavelength of 412 nm, since the
median of the Oolong tea data fell above the box (IQR) of the Hibiscus tea data. In
addition, there is a significant decrease from week 0 to week 6 on the Oolong tea postmeal data at 412 nm. Similarly, there is a significant increase from week 0 to week 6 on
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the Hibiscus tea post-meal data at the wavelength of 412 nm. At the same wavelength,
there is a slight decrease from week 0 to week 6 in the Hibiscus tea fasting data.
Figure 4-19 shows the whisker plot of a comparison between the Hibiscus tea participants
fasting and post-meal samples at the wavelength of 373, 412, and 571 nm for all periods
of time: baseline, 3-week, 6-week, and 9-week. From this figure, the visual difference
between the fasting data at week 0, week 3, and week 6 is apparent. Thus, we decided to
calculate the t-test values also known as the probability value (p-value) for the difference
between week 0 and week 3 at the second peak or 412 nm, and the difference between
week 0 and week 6 at the second peak or 412 nm. P-values can be used as indicators of
the hypothesis sufficiency. For the p-value of the difference between the week 0 and
week 3, p-value was 0.04, which is a significant value since it was ɑ <= 0.05. Meanwhile,
the p-value of the difference between the week 0 and week 6, p-value was 0.1, which is
classified as a marginally significant value since it was ɑ = 0.1. From those p-values we
have concluded that our hypothesis about the effect of the Hibiscus tea on human lipid
profile was significant. This means that the lipid profile was altered with consumption of
Hibiscus tea with roughly 96% confidence in 3 weeks and 90% confidence in 6 weeks.
Combined with the standards work in Chapter 3 and further work in Chapter 5, the lipid
compositional change most likely responsible for the absorbance change at 412 nm is
LDL and TG.
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Figure 4-17 Comparison between the participants fasting and post-meal samples at the wavelength of 373, 412, and 571 nm for
the baseline at week 0. While absorbances above 1 indicate saturation of the instrument, the full range is shown to illustrate
the significant saturation that occurred with some of the samples despite the 20% dilution protocol.
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Figure 4-18 Comparison between the participants fasting and post-meal samples of Hibiscus tea, Oolong tea, and Peach tea at
the wavelength of 373, 412, and 571 nm for the period comparing week 0 and week 6 of the tea study.
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Figure 4-19 Comparison between the Hibiscus tea participants fasting and post-meal samples at the wavelength of 373, 412,
and 571 nm for the period of time: week 0, 3-week, 6-week, and 9-week. Pairwise comparisons at 412 nm illustrate
statistically significant differences from baseline to week 3 and baseline to week 6.
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Figure 4-20 Ratiometric comparison between the participants fasting and post-meal
plasma samples for the period of time: week 0 and week 6, to study the tea effect.
Ratiometric values enabled discernment of lipemic state from only a single sample. All
three teas illustrate less fasting to post-meal differences at week 6 than week 0. This will
be explored further.

Figure 4-20 above shows the whisker plot of the ratiometric comparison between the
participants fasting and post-meal samples from baseline to week 6, for the ratio of the
secondary peak (412 nm) divided by the primary peak (373 nm). This figure shows there
was a ratio increase in all tea post-meal data with smaller post-meal differences at week 6
than week 0. This indicates that either the ratiometric analysis needs to be revisited or it
will be necessary to recruit more participants to reduce the range of the data and improve
population statistics. However, a single sample could not be used, as this stage to
generalize study results.
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4.4

Conclusions

This study structure was designed to compare fasting and post-meal lipid profiles for
inter-individual and intra-individual comparison across 3 participant groups over 9
weeks: a control group who drank peach tea, a group who drank Hibiscus sabdariffa L.
(HS) and a group who drank Oolong tea. There were a few different comparisons
between the plasma of the participants at the fasting and post-meal state for the baseline
and 6-week data.
We conclude that our data results suggest changes occur over 3 weeks and 6 weeks of
drinking teas, especially in the secondary peak at 412 nm. However, additional data must
be obtained to fully test our hypotheses. We observed a slight difference between the
intra-individual lipid levels of the fasting and post-meal plasma on the same day from the
same donor. Also, there were slight differences between the inter-individual lipid levels
of the fasting and post-meal plasma of the same donors on different days, and/or different
donors of same tea group at same day, and/or last but not least different donors of
different tea group at same day. Our final observation of the current data will be finalized
when we conduct the chemical screening of our samples using the LC/MS instrument
(data was hypothesized to be presented in chapter 5 , but due to the COVID-19
lockdown, and the university shutdown, we could not complete our data extraction to be
analyzed by LC/MS). Also, we are seeking more data and more participants for our
study to conclude the effect of each tea and especially our target tea the Hibiscus tea on
both the arterial stiffness and blood lipid profile.
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5

Liquid-Chromatography and Mass Spectrometry
Analysis of Human Serum to Ascertain Lipid Profiles
with a Tea Intervention

This chapter was a collaboration project with Associate Professor. John Durocher and his
master student Basirat Tolulope Shittu from Biological Sciences Department. Dr.
Durocher and Basirat measured the arterial stiffness measurements and we collected
participants fasting and post-meal blood to conduct the lipid profile measurements, using
the UV-Vis, LC/MS, and our designed portable device.

Abstract
Preliminary chemical data is being sought to support an application to the National
Institutes of Health (R21 NCCIH) in October 2018. Based upon preliminary data in Dr.
Durocher’s lab showing decreases in metabolic syndrome indicators with human
consumption of Hibiscus sabdariffa L., and data from Dr. Minerick's lab quantifying
hyperlipemic status in human serum samples. We propose to run a mini study to examine
the chemical structure of Hibiscus sabdariffa L. extract, and to develop a protocol to
quantify a lipemic profile (fasting and post-meal). This requires standard patterns for
low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride, and
Habiscus sabdariffa L. HPLC-MS data will be compared with existing UV-Vis data
(Chapter 3 and Chapter 4), forthcoming microdevice UV-Vis absorbance data (Chapter
6), and the hypertension heart test utilized to detect metabolic syndrome indicators
(Basirat Shittu’s master thesis). Combined, this data will reveal any benefit and extent of
the interest of Hibiscus sabdariffa L. on cardiovascular health.
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5.1 Introduction
For medical dependency diagnostics, a sensitive and precise analytical method is required
to quantitatively analyze lipid samples. Well-developed analytical methods include gas
chromatography (GC), liquid chromatography (LC), and mass spectrometry (MS). Of
these, mass spectrometry (MS) is an extremely powerful method with high sensitivity and
specificity, high throughput and high accuracy 30. Lipid analyses using MS are fairly
mature and tailorable to new applications 30.
There are three main parts of the mass spectrometry: ion source, mass analyzer, and
detector. Mass spectrometry (MS) is a method that can recognize the molecule by their
chemical structure and masses, also analysis the molecule based on their element
composition. In MS, ions arrange and categorize based on their mass to charge ratio
(m/z)128, 129.
Chromatography is a technique that separate a components mixture by dissolving in the
mobile phase (gas or liquid) moving through a column of stationary phase (solid or
liquid) 129, 130. There are many types of chromatography such as: ion-exchange
chromatography, adsorption chromatography, and molecular chromatography 129. Liquid
chromatography (LC) is a powerful technique that separate a mixture of components
depend on their elute rate from the stationary phase to the mobile phase 131. Some
components elute faster to the mobile phase and those have an earlier retention time
(RT), while other components elute much slower and those usually saved by the
stationary phase and they have a delayed retention time 131. There are many types of
liquid chromatography such as: paper chromatography, thin-layer chromatography
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(TLC), and column liquid chromatography-based LC 131. High-performance liquid
chromatography (HPLC) is a chromatography technique that invented in 1970 by C.
Horvath132, by coupling a high pressure pumps (~500 psi) and the strengthened packed
columns, that known later by the high-pressure liquid chromatography 131. A decade of
developing resulted with an HPLC instrument that have an injector system (introduce the
elute to the chromatograph system), detectors (record the elute signal and the signal
delivered to a computer and the translated as chromatogram), columns (small chemical
particles), and a high-pressure pumps (that can promote a pressure of ~6000 psi) 131.
There are eight categories and 1.68 million catalogued lipid compounds, each having
highly complex structures, which makes lipid analysis challenging 30. There are two
classes of approaches to analysis lipid samples: targeted and non-targeted. Targeted lipid
analyses focus on known lipids whereby researchers develop a special method with high
sensitivity for quantitative analysis of the known lipid. In contrast, non-targeted lipid
analyses are designed to help to identify as many lipid species as is possible in the
sample30.
Blood is one of the most complex matrices for mass spec (MS) analysis because within
blood, lipids actively associate with proteins for stability and active transport into tissue.
Proteins are relatively larger molecules compared to lipids and can oviscape the lipid MS
signal. The protein albumin comprises the largest fraction of proteins in human blood and
thus became a focal protein in this research 58. In 1934, serum albumin was crystallized
and became one of the first human serum proteins to be extracted and isolated for clinical
and medical usage in 1940s 57.
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Lipid sampling and isolation from biofluids then becomes is another challenge.
Biofluids, such as blood, are extremely complex, requiring selective lipid extraction from
the biological matrix for analysis. Prior to MS, lipid extraction requires careful testing of
both the extraction efficiency as well as the extraction reproducibility. In general, to
maximize lipid integrity and operability, it is best to simplify the whole lipid extraction
process as much as possible 30. In 1950s, many blood lipid extraction methods were
developed such as Folch (1957) and Bligh & Dyer (1959) extraction methods54. There are
four different method types that we can use to extract human lipids from blood and
effectively separate the lipids from the proteins. Extraction types include liquid-liquid
extraction (LLE), solid-liquid extraction (SLE), one-phase extraction (OPE), and twophase extraction (TPE). Both Folch and Bligh & Dyer methods, which form the
foundations of present-day optimized methods, are TPE which use methanol and
chloroform as solvents 54.
There are many delicate and explicit methods that are well-developed to quantitatively
and analytical analyze lipid levels in human subjects, as we mentioned previously, such
as high-performance liquid chromatography mass spectrometry (HPLC-MS). The
demand for MS of lipids has grown as the complex roles of lipid chemistries in
cardiovascular health has been learned. Lipemia is a condition of high concentrations of
circulating lipid globules in blood. Cholesterol, and more broadly, lipids present in the
cardiovascular system, are indicators of CVD risk. Furthermore, transient lipemia is the
most frequent interference of blood laboratory tests ranging from CVD to pathogen and
sepsis detection 10. Lipemia is commonly qualitatively measured via the cloudiness of
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human blood serum/plasma; sample turbidity is predominantly influenced by high
concentrations of low density lipoprotein particles 10, 15, and is not comprehensively
indicative of the diverse lipid profiles influencing cardiovascular health.
In 2003, lipidomic serum studies were communicated as a more precise tool beyond total
cholesterol measures. Lipids are central to all human cells contributing to cell
functionality, metabolism, and disease mechanisms 30. Lipidomic status is a condition of
lipid profile states in human liquids, which includes information on the lipids, their
behaviors, characteristics, and complexations with other molecules 30. The full screening
of a human lipid profile is known as the lipidome.
There are some studies associating the childhood lipid serum level to adult’s coronary
heart diseases (CHD) 17. Also, other studies coupling the serum cholesterol level in young
adults with the proportion of coronary heart diseases in mid age adults 17. The power of
examining dynamic changes in the lipidome was apparent in a study done by Porkka,
Viikari et al., of >40 healthy Finnish 9-year-old boys between 1980-1989. The final
compiled data showed intra-individual diffrences between the short-term (2 and 7 days
apart) and long-term (3-year intervals) of serum lipid levels in children. The most
influenced affect indicator on their long-term tracking was their biological variation 17.
On other hands, there are some studies indicate the imperfection of the relationship
between the childhood and adulthood lipid level since there are short and long term
variations effect the lipid levels such as seasonal, biological, and methodological
variations17. Those studies gave us insight that we could prevent risk of cardiovascular
diseases in young college students that might affect them in their middle age.
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More recent work has elucidated lipid variations over the timespan of hours, which
appears to be closely tied to diet, body mass index (BMI), weight, smoking, exercise,
clinical conditions, various diseases, and medications affect 36, 94, 99. Preliminary studies
have suggested some evidence that tea consumption may impact cardiovascular function
and lipid profiles 59-64, which was reviewed more extensively in Chapter 4.
Thus, a study structure was designed to compare inter-individual and intra-individual
fasting and post-meal lipid profiles for a control group over 6 weeks compared to
participants who drank Hibiscus tea (HS) and compared to participants who drank
Oolong tea. The cardiovascular and UV-Vis quantified lipid profiles are reported
separately. This manuscript reports the MS results from a non-targeted analysis of
Hibiscus HS tea, and peach tea combined with targeted lipid analysis of fasting and postmeal serum of week 6 samples from select participants over a 6-week tea consumption
trial. The data that shows the hyperlipemic status of the post-meal samples are shown in
Chapter 3, there are several graphs that explicit the lipid profile differences between the
fasting plasma and the post-meal plasma samples of same or different participant and
date of blood collection, which called the lipidemic status level. Also, in Chapter 4 results
we have explicit in details the findings of the Hibiscus tea, Oolong tea, and peach tea in
human lipid profile and their effect in the hyperlipemic reduction.
Based upon preliminary data, conducted in our collaborator Dr. John Durocher’s lab, that
showed that HS tea reduced hypertension and blood pressure, this study hypothesized
that blood lipid profiles would demonstrate a more favorable balance between high
density and low-density lipoprotein levels with HS tea or Oolong tea consumption. A
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peach tea control was also tested because we were unable to identify any literature
reporting any lipid or cardiovascular changes with fruit teas. This portion of the study
utilized HPLC/MS analysis for more depth understand of the chemical active components
in each tea that effect and help to reduce the lipids and arterial stiffness profiles. To
develop and validate HPLC-MS measurements, lipid standards were first tested, and
comparisons were made between previously obtained UV-Vis measurements (chapter 3),
forthcoming microdevice UV-Vis absorbance data (chapter 6), to detect metabolic
syndrome indicators. Combined, this data will reveal any benefit and extent of benefit of
Hibiscus sabdariffa L. on cardiovascular health.
Next tea extract samples for HS and peach were individually analyzed to ascertain
relatively abundance of chemical compounds in each tea. Extraction protocols were
selected and optimized using pure standards followed by adding standards into a baseline
fasting serum sample.

This chapter is the third part of the tea study date collections was analyzing the chosen
teas and human serum at the baseline and after 6 weeks of the study using the HPLC/MS
for more depth understand of the chemical active components in each tea that effect and
help to reduce the lipids and arterial stiffness profile.

Development extraction processes to analysis and testing of tea samples and serum of the
tea study participants using two main methods: UV-Vis (in chapter 4, for the UV-Vis
part) and LC/MS are detailed in this Chapter (chapter 5) and are being developed into a
manuscript.
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Next, representative participant extracted lipid profiles were tested for those participants
who showed the greatest cardiovascular response to consumption of HS or Oolong on
total cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL), and
triglycerides (TG) over a 6-week period of time. The study was structured to enable
comparisons between donated serum of the participant at the fasting and post-meal state
data using HPLC/MS. The second comparison involved analyzing participant serum at
the baseline (week 0) and after 6 weeks of consuming one of three types of tea. Samples
were extracted to run triplicate HPLC-MS lipid profiles for select fasting serum at t=0w
and t=6w, post-meal serum at t=0w and t=6w to identify LDL, HDL, triglyceride profiles
for the Hibiscus sabdariffa L., and peach teas. This study will demonstrate method
development and enable preliminary data to discern lipemic profiles for human blood
samples while examining the impacts of a Hibiscus sabdariffa L. intervention. The
preliminary data is expected to be utilized to obtain funding for more extensive research
into dietary impacts on lipid profiles.

5.1.1

Objective

Based upon preliminary data showing decreases in metabolic syndrome indicators with
human consumption of Hibiscus sabdariffa L. (arterial stiffness and blood pressure)
and data quantifying hyperlipemic status in human serum samples (blood lipids)
(Chapter 3 and Chapter 4), this work examined the chemical structure of Hibiscus
sabdariffa L. extract and to develop a protocol to quantify a lipemic profile (fasting and
post-meal). This requires standard profiles for low density lipoprotein (LDL), high
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density lipoprotein (HDL), triglyceride, and Hibiscus sabdariffa L. HPLC-MS data was
compared with existing UV-Vis data, and microdevice UV-Vis absorbance data.
Combined, this data will reveal any benefit and extent of benefit of Hibiscus sabdariffa L.
on cardiovascular health. The entire matrix is demonstrated in Table 1.

5.2 Materials and methods
The structure of the 9-week trial was 4 times visit to sleep lab and portage health clinic,
participants drink tea for 6 weeks (2 cups/day) and then three weeks without our assigned
tea. There are two parts for this study: Cardiovascular measurements (arterial
stiffness/blood pressure) and blood lipids: Orientation session, participants were
abstained from food and coffee for at least 5 hours, from participant blood pressure,
weight and height measurements, we decided if the participant were eligible to join the
study. Baseline measurements: participant was fasting overnight for (12 hours), and then
at the sleep lab up in SDC, arterial stiffness/blood pressure measurements were recorded.
After that, the participant had her/his blood drown at the portage health clinic. 3-week of
the study: blood collections (fasting and post meal) were done at the portage health clinic.
6-week of the study: At the SDC sleep lab for arterial stiffness and portage health clinic
for the blood collections. Last but not least, 9-week of the study: Just blood collections
fasting, and post meal were done at the portage health clinic.
5.2.1

Participant Recruitment and Exclusion Criteria

Same as in section 4.2.2 above.
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5.2.2

Study Structure and Sample Collection
Same as mentioned in section 4.2.3 above. The flow chart (

Figure 5-2) below describes procedures followed to process the whole blood to serum and
serum for UV-Vis and HPLC/MS analyzing processes, respectfully. This chapter focuses
especially on lipid extraction from blood serum, as well as the lipid purification processes
using the Bligh and Dyer method 56.
5.2.3

Chemicals and standards preparation

Dichloromethane (DCM) (DX0835-8, CAS 75-09-2, 99.5%) EMD Millipore Sigma,
methanol (MeOH) Sigma-Aldrich 34860 for HPLC (99.9%), acetonitrile (ACN)
(≥99.9%, for LC-MS) Fluka Analytical 34967, and isopropanol (IPA) (99%) USP
Grade BDH2032 VWR Analytical were all utilized as extraction solvents for the lipids.
Ammonium formate salt, eluent additive for LC-MS, LiChropur™, (99%), SigmaAldrich 70221 Supelco. Ammonium acetate for mass spectrometry, LiChropur™, eluent
additive for LC-MS, Sigma-Aldrich 73594. Formic acid (98%-100%) for LC-MS
LiChropur™, Sigma-Aldrich 5.33002. Methyl tert-Butyl ether (MTBE) for HPLC
(99.8% pure) Sigma-Aldrich 34875. Acetic acid solution for HPLC Sigma Aldrich
45754. Heptane for HPLC (99% pure) Sigma Aldrich 34873.
Phosphate buffered saline (PBS), same as 4.2.1 above.
Mobile phase A (1L) was prepared by mixing as purchased water/ACN at 60:40 v/v in 10
mM ammonium formate (0.63 g) and 0.1% formic acid (1 mL). Mobile phase B (1L) was
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prepared by mixing as purchased IPA/ACN at 90:10 v/v spiked with 10 mM ammonium
formate (0.63 g) and 0.1% formic acid (1 mL) 25, 126, 127, 133-135.
The following lipid solutions were prepared to a final concentration consistent with the
NIH National Heart, Lung, and Blood Institute115, lists the acceptable lipid levels in
human blood plasma, adult’s borderline, high cholesterol and triglyceride measurements.
All values are in mg/dL (milligrams per deciliter) 116, see Table 3-1. Thus, lipid
concentrations were selected to fall within acceptable ranges and were spiked to HDL
200 mg/dL, LDL 100 mg/dL, TG 100 mg/dL, and for BSA 35 mg/dL.
High-density lipoprotein (HDL) solutions, Low-density lipoprotein (LDL) solutions,
Triglyceride (TG) solution, and Bovine serum albumin (BSA) solution were prepared
same as mentioned in section 3.2.2 above.
5.2.4

HPLC-MS conditions in analyzing tea study samples

This research study used HPLC-MS to run triplicate samples of standards: LDL, HDL,
and triglyceride. Also, triplicate samples of tisane: Hibiscus sabdariffa L., Oolong tea,
and peach. Also, run triplicate samples of the extracted lipids of fasting and post-meal
human serum samples: at baseline of week 0 and at week 6, to compare the serum
profiles before and after donor consumption of the Hibiscus sabdariffa L. tisane, Oolong
tea, and peach tisane for six weeks. This structure is designed in order to report side by
side UV-Vis and HPLC-MS results. See Figure 5-3 and Figure 5-4.
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5.2.4.1 Hibiscus sabdariffa L. tea Extraction procedures
A standard for Hibiscus sabdariffa L. extract was run as well as donated serum from
donors after 6-week of tea consumption. Hibiscus tea was extracted following Sindi et. al.
2013 by adding 100 mg of dried H. sabdariffa to 10 ml of: water, methanol, ethyl acetate
solvents, with and without the addition of 1% (v/v) formic acid solution. Temperatures
between 25 °C and solvent boiling point will be used for each of the triplicate samples.
The time of extraction will be 10 minutes. At the end of each extraction, the whole
mixture will be filtered through a paper filter 126. Similar extractions will be completed
for Oolong tea and peach tisanes.

HPLC-MS analysis procedures of Hibiscus sabdariffa L. and Herbal tea
High-performance liquid chromatography (HPLC) using a reversed phase (RP) column
was used to quantify the bioactive compound in the Hibiscus tisane. The column will be
incubated at 40 °C with the autosampler cooled to 4 °C and the elution system configure
d for binary with Mobile Phase A and B described previously. The method used was
described by126.
5.2.4.2 Oolong tea extraction procedure
A water infusion method will be used for the extraction of Oolong tea because the active
compounds in the Oolong tisane are different than the one in the hibiscus, that is the
reason for using another extraction method than the one we used for the Hibiscus tisane.
Oolong tea infusions will be prepared in triplicate by infusing 50 mg tea in 5 ml boiling
water at 100 °C for 10 minutes and once cool, saved in 15 ml tube 127. A 0.5 ml aliquot
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will be filtered through a paper filter to remove any solid particulates. The filtrate will be
diluted with 0.5 ml acetonitrile and analyzed by LC-MS 127.
5.2.4.1 Peach tea extraction procedure
An infusion method will be used for peach tisane extraction, following manufacturer
directions by adding 8 oz. of boiled water at 100 °C to the tisane bag and leaving it to
infuse for 10 minutes. The infusion will be prepared in triplicate and the final extract will
be obtained by filtering through paper filter. Freshly prepared extracts of peach tisane
will be analyzed immediately by HPLC-MS without treatment or storage 126.

5.2.5

LC/MS experimental Design

5.2.5.1 Lipid standard preparations
A. Low-density lipoprotein (LDL) triplicate standard samples
Based on Sommer’s method for extracting LDL from human blood samples,133 sequential
ultracentrifugation was utilized to isolate and extract LDL derived from a normal
individual. Also, lipids were extracted according to Bligh and Dyer 56. The extracted lowdensity lipoproteins, lipid standards as well as the isolated and extracted LDL lipids were
filtered through Silica 60 resin (200–400 mesh) and were washed out first with methyl tbutyl ether (MTBE), and then followed by a mixture solution of methanol (MeOH)
containing 10 mM ammonium acetate (0.63 g). Samples were subsequently dried under a
nitrogen stream.
B. High-density lipoprotein (HDL) triplicate standard samples
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Prior research 135 indicates that the same extraction method can be utilized to extract both
LDL and HDL. Using an centrifugation134, 135, low and high density lipoproteins were
extracted from healthy volunteer blood serum. The extracted low-density lipoproteins
were purified at 4 oC overnight using phosphate buffer (pH 7.4). Using filtration, the
extracted LDL was concentrated 135.
C. Triglyceride (TG) standard triplicate samples
Using a solvent mixture of dichloromethane (DCM): Methanol (MeOH) (2:1 v/v) with
concentration between 1–10 mg/mL, triglyceride stock solution was prepared and stored
at − 20°C. The triglyceride standard selected contains five different triglyceride analytes
with different molecular weights: Triacetin (218.21 g/mol), Tributyrin (C4:0) (302.37
g/mol), Tricaproin (386.52 g/mol), Tricaprylin (470.69 g/mol), and Tricaprin (554.85
g/mol) 25. Figure 5-1 below shows the chemical structures of the triglyceride molecules.
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Figure 5-1 Chemical Structures of Different Triglyceride Molecular Weight (Made using
ChemDraw Software)

The only difference that we used 10-time higher volume of the human serum samples to
be able to detect the five triglyceride analytes that are exist in our triglyceride standard
mixture, which they are listed above based on their elution order, too.

5.2.5.2 Lipid extraction from human serum preparations
This chapter focuses especially on lipid extraction from blood serum, as well as the lipid
purification processes using the Bligh and Dyer method 56. Two methods were tested for
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lipid extraction: Folch method and Bligh & Dyer method. The two methods both began
with extraction of blood serum, which required removal of both red and white blood cells
as well as all clotting factors, fibrinogen, and proteins. Samples were allowed to clot 1530 minutes at room temperature before centrifugation (10 min, 1004 RCF (relative
centrifugal force)). Serum samples were isolated and stored at –5°C until analysis 54. See

Figure 5-2 above.
Folch method: The optimized Folch 55 lipid extraction method was performed using 100
μL of human serum in 15 mL tubes (VWR Sigma Aldrich). The Bird 25 modification
utilized dichloromethane (DCM): methanol (MeOH) 2:1 v/v organic phases to extract
lipids from the serum to a total volume of 2000 μL. Samples were vortexed and incubated
at room temperature for an hour. Next, 400 μL of NaCl 0.9 v/v was added and the
samples revortexed. Phases were separated by centrifugation (5 min, 22.6 RCF) followed
by collecting and discarding the upper serum phase. An additional 400 μL of NaCl:
MeOH: DCM, (48:47:3, v/v/v) was added to the lower organic phase and vortexed for 30
seconds. After a second centrifugation, the upper phase was again collected and
discarded. A third 400 μL addition of 48:47:3 NaCl: MeOH: DCM was added to the
lower phase, vortexed, centrifuged, and the upper phase discarded. Finally, the purified
lower phase was evaporated under vacuum25 to yield pure lipids, which was then stored
at –5 °C until analysis. Lipids extracted were resuspended into 300 μL ACN/IPA/H2O
(65:30:5 v/v/v) just prior to HPLC/MS analysis.
Bligh & Dyer method: This optimized lipid purification method 56 was performed in 15
mL tubes (VWR Sigma Aldrich) with 30 μL of human serum 25. Lipids were extracted
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and purified by washing the serum twice using stage-wise addition of MeOH, DCM, and
water in the proportions 1:2:0.8 and 2:2:1.8 respectively 56. First 190 μL of MeOH was
added to the 30 μL of human serum, vortexed for 20 seconds, then 380 μL of DCM was
added, vortexed for 20 s, then120 μL of water was used added to induce phase separation.
Samples were vortexed for 10 sec, allowed to rest at room temperature for 10 min, then
centrifuged (10 min, 8000 RCF, 10oC). The upper phase was collected and discarded.
Solvents in previous steps were again added, this time using a solvent mixture 2:2:1.8
MeOH: DCM: H2O. The lower lipid-rich organic layer (370 μL) was then collected and
evaporated under vacuum to yield pure lipids and stored at –5 °C. Lipids extracted using
the Bligh & Dyer 56 method were resuspended into 300 μL ACN/IPA/H2O (65:30:5
v/v/v) just prior to HPLC/MS analysis.
We have decided to use one site of mobile phases for all of our LC-MS extractions, since
our samples are a site of samples that run all together. Mobile phase A (1L) was prepared
by mixing as purchased water/ACN at 60:40 v/v in 10 mM ammonium formate (0.63 g)
and 0.1% formic acid (1 mL). Mobile phase B (1L) was prepared by mixing as purchased
IPA/ACN at 90:10 v/v spiked with 10 mM ammonium formate (0.63 g) and 0.1% formic
acid (1 mL) 25, 126, 127, 133-135.

5.2.5.3 Data Analysis
To quantify the targeted chemical compounds and molecules (in our research lipid and
tisane components) using HPLC-MS instrument, we must use an isotope molecule of the
targeted molecule that called an internal standard (IS). In our research we have not used
any internal standard so far because we only trying to target the presence of the different
143

lipids in the human fasting and post-meal serum samples. Also, to compare and reconnect
our finding results in this chapter with our previous findings in chapter 3 and chapter 4.
In this chapter we have decided to use the retention time (RT) of the lipid standard
components as indicator to identify the lipid molecules presence in the extracted lipid of
the human serum samples.
Analyzing human serum lipids using the LC-MS instrument was a huge challenge, that
cannot be optimized without an excellent sample preparation and extraction. In this
chapter we have used Bligh and Dyer method which is a liquid-liquid extraction (LLE) to
achieve the maximum preconcentration of the low concentrated lipid prior the analysis of
the high-performance liquid chromatography mass spectrometry (HPLC-MS).
HPLC-MS analyses were run for lipid standards, tea extracts, and participant serum who
were engaged in a 9-week tea consumption study. Data was analyzed to ascertain
standards, controls, analysis reproducibility, variations over time, and comparisons
between tea/tisane consumption groups.

Figure 5-2 is a flow chart illustrating the sequential procedures followed to process the
whole blood to serum and serum for UV-Vis and LC/MS analyzing processes,
respectfully. The measurements of the lipid levels profile using the UV-Vis methodology
are detailed along with experiments and comparisons to ascertain any tea/tisane
consumption benefits on blood lipid levels and/or arterial stiffness profiles (Chapter 4).
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Figure 5-2 Lipid Extraction Flowchart. The left-hand side is the human serum lipid extraction processes using the liquidliquid extraction (LLE) methods of Bird et. al. 25 and Bligh et. al. 56 for the HPLC-MS data analysis process. The righthand side is the human plasma preparation for the UV-Vis data analysis process. (made by using Lucidchart)
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Figure 5-3 Tea Extraction Processes- Chemical Extraction. The tea chemical infusion processes, the Hibiscus tea and peach
tea were infused using Sindi et. al.126, and the Oolong tea was infused using Fraser et. al.127. This process mainly used to
analysis the samples by HPLC-MS instrument. (made by using Lucidchart)

5.3

Results and discussions

Analyzing human serum lipids using the HPLC-MS instrument was a huge challenge,
that cannot be optimized without an excellent sample preparation and extraction. We
have tested two different liquid-liquid extraction methods (Folch method and Bligh &
Dyer method) in our serum sample preparation to extract the triglyceride molecules, but
we found one of them more effective than the other one into our lipid preconcentration
steps that prior the HPLC-MS analysis.
Until now, in this chapter we have used Bligh and Dyer method which is a liquid-liquid
extraction (LLE) method to achieve the maximum preconcentration of the low
concentrated lipid prior the analysis of the high-performance liquid chromatography mass
spectrometry (HPLC-MS).
We have plane to use HPLC-MS analyze; lipid standards, tea extracts, and participant
serum samples (who were engaged in a 9-week tea consumption study). So far, we have
analyzed the triglyceride standard and post-meal serum samples only.

5.3.1

Lipid standard

To ascertain the lipid: low-density lipoproteins (LDL), high-density lipoproteins (HDL),
and triglycerides (TG) existence in human serum. As we mentioned in material and
method section above, we are aiming to use different extraction method for our three
different lipid standards, prior their HPLC-MS analysis.
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For the low-density and high-density lipoproteins, we are planning to use untargeted
HPLC full scan below to demonstrate the component of the standards (this part has not
finish yet duo to the lockdown of the university during the COIVD-19 pandemic). The
results of the HPLC for the LDL and HDL standards will be presented here when they are
finished.
For the triglyceride standard, data was analyzed to ascertain the existence of five different
molecular weight triglycerides in the extracted human serum samples (post-meal sample).
Using the same triglyceride (TG) standard sample, the Folch method was compared to the
Bligh & Dyer method. The Bligh & Dyer56 method was found to be the most accurate
and the best fit for our standard (a mixture of five different triglycerides with different
molecular weights). From human serum samples and applying the Bligh & Dyer56
method, we have extracted four different triglyceride molecules. Figure 5-4 below shows
the HPLC data analysis of the triglyceride (TG) standard at concentration of 10 mg/mL.
The HPLC untargeted full scan below shows the HPLC data of the triglyceride standard
demonstrating all five derivatives of the triglyceride. The Triacetin (218.21 g/mol) which
is the lowest MW elutes at 2.73 minutes, 2) Tributyrin (C4:0) (302.37 g/mol) elutes at
12.40 minutes, 3) Tricaproin (386.52 g/mol) elutes at 16.60 minutes, 4) Tricaprylin
(470.69 g/mol) elutes at 19.36 minutes, and 5) the highest MW, Tricaprin (554.85 g/mol)
elutes at 21.14 minutes. As we see from Figure 5-6, as the molecular weight goes up the
elution time of the molecule got delayed, that means the molecule elute from the column
based on their molecular weight.
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Figure 5-4 HPLC data analysis of Triglyceride standard at concentration of 10 mg/mL
showing a five different molecular weights of triglyceride compounds in the mixture.

As we have mentioned above in the introduction part about the mass spectrometry (MS)
function that focus mainly in fragmenting and verifying the compound molecular
chemical structure and masses by using a range of mass to charge (m/z). For the mass
spectrometry (MS) part in Figure 5-4 above, 1) Triacetin was targeted at the mass range
m/z 158-160, using 91.81% of mobile phase A, and 8.19% mobile phase B, 2) Tributyrin
(C4:0) was targeted at the mass range m/z 214-216, using 60.53% of mobile phase A and
39.47% mobile phase B, 3) Tricaproin was targeted at the mass range m/z 270-272, using
38.17% of mobile phase A and 61.83% mobile phase B, 4) Tricaprylin was targeted at the
mass range m/z 326-328, using 23.46% of mobile phase A and 76.54% mobile phase B,
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and 5) Tricaprin was targeted at the mass range m/z 382-384, using 5% of mobile phase
A and 95% mobile phase B.

5.3.2

Tea standard

In this part we will present the HPLC untargeted full scans of the three teas: Hibiscus tea,
Oolong tea, and peach tea. As we mentioned in the material and method section. Tea will
be extracted using different extraction method, while we will use one HPLC untargeted
full scan for all of them, to analysis the component of the tea and indicate their elution
time (ET)/ retention time (RT), (this part has not finish yet due to the lockdown of the
university during the COIVD-19 pandemic).

5.3.3

Human blood serum samples

In this part we will present the HPLC full targeted scan for the existence of the LDL,
HDL, and triglyceride components in the extracted human serum lipid samples. The LDL
and HDL extraction and HPLC analysis part have not been done yet due to the lockdown
of the university during the COIVD-19 pandemic. The targeted HPLC analysis of the
extracted human serum lipid will target the components that will be found in the
untargeted HPLC scan of the slandered that will be presented in section 5.3.1 above.
Figure 5-5 below shows the HPLC full targeted scan of the extracted human triglycerides
with 10x times higher concentration of serum (to begin with the lipid extraction), the
human serum was prepared using the procedures of Bligh & Dyer 56 to extract
triglycerides from human samples. We conclude from Figure 5-5, we could detect only
four of the triglycerides that were in our standards; the lowest molecular weight
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triglyceride, Triacetin (218.21 g/mol), could not be detected even though, we increased
the volume of the human serum 10x times higher than the required volume to start the
lipid extraction steps from human serum in the original Bligh and Dryer extraction
method.
As we see the retention time (elution time) of the triglyceride molecules in the extracted
samples in Figure 5-5 was a bit delayed (for about 1 min) compared to the triglyceride
standard sample (data showing the Figure 5-4 above), due to the modification that
HPLC-MS’s scientists have done on the instrument.
The Triacetin (218.21 g/mol) which is the lowest MW id not elute at all, 2) Tributyrin
(C4:0) (302.37 g/mol) elutes at 13.28 minutes, 3) Tricaproin (386.52 g/mol) elutes at
17.95 minutes, 4) Tricaprylin (470.69 g/mol) elutes at 21.61 minutes, and 5) the highest
MW, Tricaprin (554.85 g/mol) elutes at 22.65 minutes. Exactly, the molecules eluted in
same order they eluted during the standard HPLC run, based on their molecular weight.
As the molecular weight goes up the elution time of the molecule got delayed, that means
the molecule elute from the column based on their molecular weight from the lowest to
the highest MW.
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Figure 5-5 HPLC of Human Post-meal Serum at 10x higher concentration of Human
serum. Four of the five triglycerides were detected from the TG standard-spiked serum.

For the mass spectrometry (MS) part in Figure 5-5 above, 1) Tributyrin (C4:0) was
targeted at the mass range m/z 214-216, using 55.87% of mobile phase A and 44.13%
mobile phase B, 2) Tricaproin was targeted at the mass range m/z 270-272, using 30.98%
of mobile phase A and 69.02% mobile phase B, 3) Tricaprylin was targeted at the mass
range m/z 326-328, using 5% of mobile phase A and 95% mobile phase B, and 4)
Tricaprin was targeted at the mass range m/z 382-384, using 5% of mobile phase A and
95% mobile phase B.
In this part we will present the extracted human fasting and post-meal serum of the tea
study participants at different time of the study (0, 3, and 6 weeks) (this part has not
finish yet due to the lockdown of the university during the COIVD-19 pandemic). We
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will use the same type scan of the HPLC that we used to analysis our extracted human
serum lipid samples which are presented previously in this part of the results. The only
difference that we will target the components that were found in the tea standards during
their untargeted HPLC scan (data will be presented in section 5.3.2). We will compare
between the data of the fasting and post-meal extracted serum of the participants at
different time of the study. These comparisons will assist us to deeply understand the
effect of the Hibiscus tea in human lipid level and arterial stiffness.

5.4 Conclusions
We found the Bligh & Dyer method was the most reliable and accurate method to extract
the triglyceride standard (five different triglycerides with different molecular weights)
from human serum. We concluded from this chapter, that triglyceride is one of the lipids
that effected and altered the human post-meal serum lipid levels.

5.5 Future work
High performance liquid chromatography mass spectrometry (HPLC-MS) proposal
requests an additional run of the LDL, HDL, Hibiscus sabdariffa L., oolong, peach tea,
and the participants of the tea study fasting and post-meal serum at t=0w, t=3w, and
t=6w, for each group of tea. In total, we need to run an additional a total of 23 sample
runs once the lab are opened. This preliminary data will enable us to demonstrate method
development and capabilities to discern lipemic profiles for human blood samples while
examining the impacts of a Hibiscus sabdariffa L. intervention.
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6 Portable Lab on a Chip Device for Lipemia Detection
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Abstract
Because of the need for mobile blood donation clinics to identify lipemic states, transient
elevated lipid levels in blood that adversely affects donated blood quality and
cardiovascular health, a portable millifluidics device was designed and tested. An
Arduino UNO R3 microcontroller was utilized with a photodiode to detect light intensity
passing through a millifluidics device housing the blood sample. Five light emitting
diodes (LEDs) at five different wavelengths functioned as the light source. When human
plasma samples were introduced in the microchannel aligned in the LED to photodiode
pathway, light absorbance changed and illustrated a dependence with wavelength. A 3Dprinted two-piece box was designed to house the microcontroller and create a dark
atmosphere. Results from the millifluidics device were compared to prior laboratory UVVis spectroscopy screening results of similar fasting and lipemic blood samples.
Key words: Arduino, LED, photodiode, Lipids, Triglycerides, TG, Low-density
lipoproteins, LDL, High-density lipoproteins HDL, Albumin, BSA, UV-Vis
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6.1

Introduction

With careful controls, ultraviolet-visible spectroscopy (UV-Vis) can easily and accurately
measure the absorbance of chemical compounds and discern relative concentrations of
those compounds. Spectrophotometers are ubiquitous in most labs, but their portability,
expense, and volume requirement of >1 milliliter of solution inhibit mobile usage. In this
work, we designed an inexpensive, compact and portable unit utilizing UV-Vis for blood
sample screening of lipemic states. In place of a cuvette, we designed a simple
millifluidics device that could be positioned within the unit to quickly measure the
absorbance of a biological sample.
Blood sample references and standards can become cost prohibitive for mobile blood
donation clinics when the volumes required for traditional UV-Vis lipid profiling tests are
performed. Prices per blood test can vary between $15 to >$1000 for complete blood
counts, chemical analysis and pathogen screening. Because of the high volume that must
be used for UV-Vis, we decided to develop a method to recreate the test but in a smaller
volume with less cost. Also, since benchtop UV-Vis instruments weigh ~40 pounds, they
cannot be easily transported and used by individuals such as physician and patients at
home for routine or quick check-ups. Therefore, introducing an accurate, portable unit
that easily can measure the lipid levels in a short time (few minutes) would simplify
testing logistics and reduce lab test expenses. Further, introducing a medical or lab
microdevice that can be used in blood donation clinics or university labs that requires
only 50 microliter volume of sample will reduce blood and biological waste expenses.
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This work explored the development and testing of a portable instrument to test
lipoprotein levels accurately and efficiently with a nearly three order of magnitude
reduction in blood volume and reference standards; the ultimate goal is to make these
tests more accessible and easier to conduct so that they can be performed quickly in a
mobile donation clinic, physician’s office or even at home.
In Chapter 3, we used a benchtop UV-Vis to measure the lipid levels in human blood by
comparing fasting and post-meal plasma samples. This previous work measured the
effect of high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides
(TG), and serum albumin (BSA) on the UV-Vis lipid profile. We found that the
wavelength ranges from 373 to 600 nm had the biggest lipid profile difference between
fasting and post-meal samples as shown in Figure 6-1. Therefore, this was the range we
focused on in the unit design and subsequent experiments.
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Figure 6-1 Five different colored LEDs with different wavelengths correspond to specific
sections of the UV-Vis spectra.

Kittipanyangam et al. served as a model system for measuring absorbance without the use
of a UV-spectrophotometer 136. They designed a more portable light absorbance
measurement device. However, in their experiment they only used red, green, and blue
light emitting diodes (RGB LED). In our experiment, additional wavelengths must be
tested to ascertain key features from the lipid absorbance profile obtained via the UVspectrophotometer (Figure 6-1 above). Therefore, we adapted the concept to our custom
application; our LED’s may be switched out as is needed for additional tests. Their
microdevice required an interface to send data to a computer, while we decided to
implement an Arduino as this feature simplifies the unit, reducing cost and complexity.
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Sorouraddin et al. also reported a design of a portable spectrophotometer 137. Their design
was simple, using an LED, a light dependent resistor (LDR) sensor, and a fluidic cell for
the serum. This design was specked to be small similar to ours, because their solution is
iron serum while ours is phosphate-buffered saline (PBS) and blood plasma. Their LED
and LDR were 10 mm apart from each other in order to minimize current leakage. They
coated the inside of their box and windows with black masking tape so light would not be
absorbed by the surfaces, which we also mimicked in our design.
This chapter examines the design and use of a millifluidics device and portable
absorbance unit to measure human plasma lipid levels after fasting and after a high-fat,
high-carbohydrate meal for 20 donors. In this work, the results of the millifluidics device
were cross-correlated to previous results using a benchtop UV-Vis spectroscopy
screening of similar blood samples. Calibration standards for high density lipoproteins,
low density lipoproteins, triglycerides, and serum albumin were systematically measured
individually and combined to measure the contribution of blood plasma turbidity
(cloudiness) and lipemia (the high concentration of lipid particles).

6.2

Materials and Methods

6.2.1

Donor and sample information

Donor recruitment, sample acquisition, and data handling all followed IRB approved
procedures per Michigan Tech M0540 [318164-13]. Donors (all genders) were recruited
between the ages of 19-45, were healthy, smoking and non-smoking and omnivorous.
Donors fasted overnight for 12 hours.
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Upon informed consent, the fasting blood sample was collected by a trained phlebotomist
at the SDC Portage Health Clinic in the morning and a second sample was collected two
hours after the donor ate a high-fat, high-carbohydrate meal.
Blood samples were immediately transported to the research lab following all
transportation safety protocols. Whole blood was centrifuged (Fisher Scientific
LR56495, Waltham, MA) at 4000 rpm (relative centrifugal force (RCF) = 894 g) for 10
minutes. The plasma was isolated and stored frozen until use.
6.2.2

Chemical preparation

Phosphate-buffered saline (PBS) with a conductivity of 0.1 S/m was prepared using:
24.935 mL of E-pure water (Millipore, MA), 1.233 g Sigma-Aldrich D9434 Dextrose
powder (99% pure, St. Louis, MO), and 65.386 mL Sigma-Aldrich D9434 PBS salt stock
solution (99% pure). Both fasting and post-meal blood plasma samples were diluted to
20% plasma and 80% PBS to remain within the absorption detection limits of the UVVis.
High-density lipoprotein (HDL) standard was prepared using 0.154 mL Sigma-Aldrich
L8039 high density lipoprotein from human plasma (95% pure, St. Louis, MO)
combined with 0.846 mL PBS to achieve a total volume of 1 mL at 200 mg/dL HDL.
Low-density lipoprotein (LDL) standard was prepared, using 0.1667 mL Sigma-Aldrich
L7914 low density lipoprotein from human plasma (95% pure, St. Louis, MO)
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combined with 0.8333 mL of PBS to achieve a total volume of 1 mL with 100 mg/dL
LDL.
Triglyceride (TG) standard was prepared, using 1 µL Sigma-Aldrich 17810 triglyceride
mix (C2-C10, St. Louis, MO), combined with 200 µL of human plasma, and 0.799 mL of
PBS to achieve a total volume 1 mL with 100 mg/dL triglyceride. Plasma was utilized as
a solvent for TG standard solutions because TG was hydrophobic which did not dissolve
sufficiently in PBS.
Bovine serum albumin (BSA) standard was prepared using 0.05 g/mL of Sigma-Aldrich
A7906 Albumin from bovine serum (98% pure, St. Louis, MO), by dissolving BSA
powder into 1 mL of PBS solution, to achieve 50 mg/dL BSA.
6.2.3

Glass slide design and PDMS casting process

Polydimethylsiloxane (PDMS) is a silicon-based organic polymer used for its
hydrophobic properties. To create the PDMS solution, a Sylgard 184 Silicone Elastomer
Kit was used (DOW Corning Corporation, Midland, MI 48686) which includes a base
and a curing agent. The ratio of base to curing agent used is 10:1. To create a gel the
height of 4.992 g of base was combined with 0.523 g of curing agent. After mixing the
curing agent and base in a plastic petri dish, the solution was put in an air vacuum
(Nalgene and Thermo Fisher Scientific 6821, Waltham, MA) at 255 Torr for five minutes
in order to release the bubbles created during mixing. The solution was allowed to sit for
24 hours to become set and usable. Once solid, the PDMS was cut with a surgical scalpel.
This technique was utilized because the chamber depth needed was much greater than
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traditional micrometer scale fluidic features. As shown in Figure 6-2, the PDMS casting
was cut into two equivalent strips of 76.2 mm long and 12.5 mm wide and then
positioned on a glass slide (AmScope, 25.4 x 76.2 mm, 1mm - 1.2 mm thick) with an
open channel in the middle measured at 0.4 mm for the sample.

Top View
PDMS

Side View

Glass Slide

Figure 6-2 PDMS (10:1) Cast Glass Slide (25.4 mm x 76.2 mm, with 1-1.2 mm
thickness)
6.2.4

Plasma millifluidics-chip device absorbance measurements and device
settings

An Arduino UNO R3 (Version 4.0, SparkFun Electronics, Boulder, CO) was used to
incorporate open-source hardware and software. The goal was to build a microcontroller
that would use a photodiode to read the voltage given off by an LED. The LED’s
(CHANZON, China) 5mm LED’s with colors of UV purple (395-400nm), blue (450455nm), green (515-525nm), yellow green (570-575nm), and yellow (588-592nm) and
purchased through Amazon. A photodiode is a reverse biased diode, so when light falls
on the photodiode, current will flow; current is blocked without light 138. The photodiode
VTB1114H0ND (Excelitas Technologies, Waltham, MA), Sensor Photodiode 920nm
Radial (Digi-Key, Thief River Falls, MN). Therefore if there is light, the photodiode
162

converts light into a measurable electric current which can be converted to voltage with a
known resistor 139. In order to obtain absorbance results, the following formula, derived
from the Beer-Lambert Law, was used to convert voltage, V, into absorbance, A 136,
following Equation 6-1 below.
𝑉

−𝑉𝑧𝑒𝑟𝑜

𝐴 = −𝑙𝑜𝑔 𝑉𝑠𝑎𝑚𝑝𝑙𝑒 −𝑉
𝑠𝑜𝑙𝑣𝑒𝑛𝑡

𝑧𝑒𝑟𝑜

Eqn 6-1

Vzero was the voltage when the path of the LED and photoresistor is blocked (e.g. no
light). Vsample was the voltage when the LED light was transmitted through the sample, in
this case plasma and PBS. Vsolvent was the voltage when the LED light was transmitted
through the solvent, in this case PBS. Equation 6-2 shows that the absorbance of a sample
is a logarithmic ratio of the amount of radiation falling upon a material to the amount of
radiation transmitted through the material.
𝐼

𝐴 = −𝑙𝑜𝑔 𝐼 = 𝑒𝑐𝑙
0

Eqn 6-2

Where A is the absorbance, e is the molar extinction coefficient (M-1cm-1), c is the
concentration (M), and l is the pathlength (cm). These two equations were utilized to
determine absorbance and infer concentration of the lipids in samples.
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6.2.5

3-D Box Design:

Figure 6-3 A diagram of the 3-D box design with the circuit simply incorporated
A box was designed to keep the Arduino and millifluidics device in darkness while
testing. To create an area that could easily be manipulated, we iteratively designed a box
within which two of the sides could be removed. The LEDs were individually positioned
on the Arduino UNO side on the bottom of the box, while the photodiode was positioned
on a breadboard opposite the LED to detect the light emission on the top of the box. The
LED and photodiode were positioned directly across from each other with a gap of 76.2
millimeters in order to acquire more accurate and reproducible results and avoid leakage
of current 140. The box was 3D-printed using a Lulzbot Taz6 printer (LulzBot, Fargo,
North Dakota) with a 1.2mm Moarstruder toolhead and PolyLite PLA material. A
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diagram of this box design with the circuit simply incorporated can be seen in Figure 6-3
above.
6.2.6

Photodiode and LED Circuitry:

Circuit A

Arduino
Connection
Circuit B

Figure 6-4 In Circuit A, a photodiode converts the LED light into a current which is then
converted into a DC voltage. In Circuit B, the voltages are scaled into a range of 0 to 5
volts which makes more logical sense to the Arduino. These voltages are then read by the
Arduino and outputs the respective value.

In Figure 6-4 Circuit A, there is a resistor next to the photodiode to limit the current
going into it. The photodiode converts the light intensity into a current which is then put
through this circuit in order to receive a voltage reading. The photodiode is placed in the
pins of X1-1 and X1-2 with pin X1-2 being set to ground. Capacitors in parallel with the
resistors cause only the DC voltage to pass through that part of the circuit and leave the
AC voltage behind, which is necessary to output values in the range the Arduino can read
and proportional to the incident light on the surface of the diode. Circuit B involves an
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inverting feedback operational amp (op-amp) to decrease the differential voltage between
the inputs. These two op-amp circuits make the measured output voltages fall into the
range of 0 to 5 volts. These circuits are connected to the signal pin on the Arduino such
that the photodiode output voltage readings are received by the software and analyzed.

Circuit C

Figure 6-5 In Circuit C, the current going into the LED is reduced so that the LED is not
burnt out but still able to light up. A potentiometer was also used to change the brightness
of the LED if needed.

In Figure 6-5, the LED part of the circuit, a resistor is in series with a potentiometer to
limit the current into the LED. A potentiometer was used in order to change the
brightness of the LED if needed by changing the amount of current delivered into it. In
order to actually have effect on the LED, the pins of X1-1 and X1-2 are connected in
series to pins on the Arduino where the LED is placed.
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The LED’s were too bright even when the current into the LED’s was reduced as much as
possible, so the maximum voltage of 5 Volts was often produced. In order for the LED
outputs to fit within the voltage boundaries of the sensitive photodiode, filter sheets were
needed to reduce the light intensity transmitted through the sample. Five LEE Filters 298
(15 Neutral Density) (Knight Sound & Lighting, Cuyahoga Falls, OH) were stacked in
order to reduce the LED emission intensity without affecting the wavelength (color) of
the light. Different amounts of layers of filters needed to be used based on the color of the
LED which can be seen in Table 6-1.

Table 6-1 Each LED color with number of filters needed to create a correct voltage with
the corresponding voltage reading
LED Color
Orange Yellow
Green Blue Purple

Number of Filters Used

1

1

5

5

5

Voltage Reading with Corresponding
Filters

7V

9V

35 V

36 V

37 V

6.3

Results Obtained

In Chapter 3, we have conducted the optimal dilution (20%) of the plasma portion of the
collected human blood samples (fasting and post-meal blood samples). We will run an
initial test to ascertain the optimal dilution of the plasma portion of donated human blood
using our millifluidic device. Table 6-2 shows the LED color which are an indicator for
different wavelength ranges that feel throughout the UV-Vis spectra of the lipid profile.
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Table 6-2 The LED Color wavelength throughout the UV-Vis Spectra
LED Color
Wavelength (nm)
UV-Vis Spectra
UV Purple
395-400nm
primary shoulder
Blue

450-455nm

secondary shoulder/ Secondary Peak

Green

515-525nm

secondary shoulder

Yellow Green

570-575nm

Tertiary Peak

Yellow

588-592nm

Tertiary Peak

As we designed this experiment, we decided to triplicate each data run to discern
experiment reliability, also we will run at least five different blood collections to obtain
the average value of the data and the standard deviation value (STD).
To discern which lipoprotein standard most contributed to the post-meal absorbance
increases, purchased standards for HDL, LDL, TG, and BSA were added to fasting
plasma samples. We will analysis our data using several comparisons between the fasting
and post-meal plasma samples with the addition of the standards (LDL, HDL, TG, and
BSA) to fasting plasma at different combinations (single, duo, trio, and quad) using a
specific LED at a certain wavelength range to illustrate the absorbance area peaks and
shoulders. Concentrations of the standards were fixed: HDL at the concentration of 200
mg/dl, LDL at the concentration of 100 mg/dl, TG at the concentration of 100 mg/dl, and
BSA at the concentration of 35 mg/dl. These concentrations are consistent with Table 63 116.
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Table 6-3 Lipid Levels in Adult Blood
Total cholesterol
HDL (mg/dL)
LDL (mg/dL)
(mg/dL)
Good
<200
<100
40
Borderline 200-239
n/a
130-159
High
n/a
240
160
Low
n/a
<40
n/a

Triglycerides
(mg/dL)
<149
150-199
200
n/a

Table 6-3, compiled from the NIH National Heart, Lung, and Blood Institute 115, lists the
acceptable, adult’s borderline, high cholesterol and triglyceride measurements. All values
are in mg/dL (milligrams per deciliter) 116. Thus, lipid concentrations were selected to fall
within acceptable ranges and were spiked to HDL 200 mg/dL, LDL 100 mg/dL, TG 100
mg/dL, and for BSA 35 mg/dL.
The design for this experiment changed quite a bit each time a different test was done,
and issues were realized. Some of the factors that were tested to optimize the design were
different circuit configurations, box designs, and experiment setups. The first electrical
circuit designed was very simple and did not place the voltages in a range that had results
that made sense. A more complex circuit design was planned out with the help of Mark
Sloat from the Electrical Engineering Department to receive the voltage values that
reflected the light intensity. This design was also created in order easily manipulate the
individual components if needed, such as the LED to change the color.
With this original design, there were some concerning results. As an example of these
concerns, Table 6-4 shows the blue and green LED voltage and absorbance results of
20% Fasting Plasm and 20% Post-Meal Plasma. As can be seen, some of the absorbances
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that were calculated using the voltage readings were negative numbers which should not
be possible. By seeing these issues, we knew there were still some things not designed
correctly.
Table 6-4 Blue and green LED voltage and absorbance results after the first design was
completed
20% Fasting Plasma Voltage (V)
20% Post-Meal Plasma Voltage (V)
LED
Color Voltage Absorbance Normalized Voltage Absorbance Normalized
(V)
(Eq.)
Absorbance (V)
(Eq.)
Absorbance
(UV-Vis)
(UV-Vis)
Blue 2.4
-0.204
0.086
1.7
0.046
0.213
Green 1.5

-0.368

0.037

1.3

-0.222

0.134

The box design changed a lot throughout the testing of this experiment. The first design
planned out and created was a two-piece enclosed box that was able to test different
distances between the LED and photodiode. This method was difficult to use, but it did
give some insight about how the distance between the LED and photodiode did not affect
the output voltage. The reimagined box design was a box with only two sides in order for
the components to be more accessible. This design also had a set distance between the
LED and photodiode of 76.2 centimeters because of the knowledge found in the first
design.
Another issue in this experiment was that the LED’s were too bright so the voltage being
read was the maximum value possible. In order to prevent this issue from happening,
filters were implemented into the design. One or five filters, depending on the LED color,
were used in order to get the photodiode to produce voltage readings that actually made
logical sense in the 0 to 5 Volts range.
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Another setup that was changed from issues that were persisting was the plasma sample
reflecting the light away when placed as a drop. In order to prevent this issue from
occurring a PDMS path was used so the plasma sample could be in long line in order for
the absorbance to be correctly measured. This helped to also increase the path length of
the light which would mean the device would have to be considered a millifluidic device
instead of a microfluidic device. This final design setup was not tested due to the
COVID-19 pandemic and the university shutdown.

6.4

Conclusions

The device configuration has not yet been fully optimized. The sequence of tests talked
about above revealed issues, but ideas were implemented to remove some of these issues.
Upon altering the design to address these issues and retesting, we learned that some of
ideas we came up with did not fix everything. The design still was not perfect as there
were issues in accuracy of voltage readings since results using the same variables were
sometimes different between tests. Therefore, the overarching goal is to design a
millifluidic device and portable optical detection unit that is more convenient and robust
than what the market has now. We are trying to improve the convenience of an
economical medical screening tool to enhance the measurement quality of lipemia and
cholesterol. The device could be expanded to cover different sizes and types of
lipoproteins to better understand lipid metabolism by using different body liquids such as:
tears, urine, and saliva.
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6.5

Future Work

Using the Microfabrication Facility of Michigan Technological University, we want to
fabricate a microdevice that measures lipids using only one drop of whole blood. Similar
methods to this project will be used for this future one. Creating a channeled system for
this device would help be more stable and accurate in cholesterol measurements. A
channel would also increase the path length between the LED and photodiode which is
needed to produce more accurate absorbance results.
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7 Conclusions
The overarching premise for this body of research was: Given that low-density
lipoproteins of large and small lipid globules have been shown to directly affect plasma
turbidity, we hypothesize that optical and electrical measurements can be simplified into
a portable, point-of care unit to discern high-density, low-density lipoprotein, and
triglyceride levels in human blood samples for diagnosis of lipemia or for other CVD risk
determinations. Efforts in this dissertation focused on systematically detecting the
transient lipemic state. This work could serve as a foundation to discern both transient
and chronic cholesterol levels in a manner simpler than those employed for current
medical tests.

The main hypothesis in Chapter 2 was that a combination of optical and electrical
measurements (absorbance and electrical characterizations) could discern high-density
and low-density lipoprotein levels in human blood samples for diagnosis of lipemia or
other CVD risk indicators. The main goal was to utilize readily available laboratory
equipment to measure and compare fasting plasma and blood samples to post-meal
samples. In the process, protocols were optimized, and data analyzed to select the
simplest and most sensitive detection method. Four tools were examined to detect lipemia
in red blood cells and plasma: dielectrophoresis, cell lysis, electrical characterizations,
and UV-Vis. Two of the experimental tools, dielectrophoresis and cell lysis, tested RBCs
while electrical characterizations and UV-Vis tested plasma. Dielectrophoresis, cell
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lysis, and electrical characterizations were not sufficiently sensitive enough to discern a
lipemic state from a healthy state in the blood samples tested. However, the UV-Vis
optical absorbance tool was able to successfully discerned lipemia in diluted blood
plasma. Differences were likely apparent between fasting and post-meal plasma samples
because the lipids, lipoproteins, and proteins predominantly exist in the plasma of the
human blood.
In Chapter 3, the main purpose was an in-depth examination of the use of a rapid ultraviolet – visible (UV-Vis) spectroscopy screening of human blood plasma after 12 hours
of fasting as well as screening following a high-carbohydrate and high-fat meal, which
was termed post-meal. The overarching goal was to identify lipemia states using a drop
or two of blood of an unknown sample. Thus, absorbances at the primary peak, primary
shoulder, secondary peak and tertiary peak were examined. To internally normalize
within a single sample, a ratiometric analysis was conducted and determined that the ratio
of the secondary peak to the primary shoulder was sufficiently different between a
lipemic and non-lipemic state to discern an unknown sample with a confidence of 99%.
Chapter 3 also examined the UV-Vis of lipoprotein standards. Individual lipoproteins
were added at recommended healthy levels to fasting plasma. The resulting absorbance
profile was compared to the post-meal profile of the same individual. The presence of
both low-density lipoproteins (LDL) and triglycerides (TG) simultaneously added to
fasting plasma were best able to reproduce the post-meal plasma lipid profile. One very
interesting finding was that the combination of low-density lipoproteins (LDL) and highdensity lipoproteins (HDL) on fasting plasma reduced the lipid profile values due to
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HDLs beneficial stabilization of LDL discernable via a reduction in turbidity. This
suggests that LDL globules are likely more diffuse in the plasma when associated with
HDL.

Chapter 4 built upon prior exploratory studies which had examined tea consumption and
positive impacts on various dimensions of cardiovascular functionality. The hypothesis
for this study was that blood pressure and blood lipid levels will be reduced with
consumption of either Hibiscus tea or Oolong tea. Data was collected for 17 participants
over an intended 9-week period; however, data collection was halted for 50 participants
due to COVID-19 disruptions. A control tea was also examined. Due to the limited
number of participants completing in each tea condition, results were inconclusive.
A difference was observed between the intra-individual lipid levels of the fasting and
post-meal plasma on the same day, of the same donor. Slight differences were also
observed between the inter-individual lipid levels of the fasting and post-meal plasma of
the same donors on different days over the 9-week trial. Average lipid profiles were also
compiled for different donors of the same tea group on the same day, and for different
donors of different tea groups on the same day.
An ANOVA analysis of the data is in progress. Completed analysis revealed that the
UV-Vis lipid profile was altered with consumption of Hibiscus tea. The difference from
the baseline at week 0 to week 3 had a p-value of 0.04 and from week 0 to week 6 had a
p-value of 0.10. When the lipid profiles are more closely examined with the standard
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analyses completed in Chapter 3, the lipid compositional changes most likely responsible
for the absorbance changes at week 3 and week 6 are LDL and TG. Further chemical
analysis work in Chapter 5 will provide further insights into this prediction.
Chapter 5 focused on chemical screenings of Chapter 4 study samples using Liquid
Chromatography and Mass Spectroscopy to ascertain chemical composition and
abundance of the lipoproteins. The main goal was to explore whether ingestion of
Hibiscus tea impacts lipid chemical composition and/or abundance. HPLC-MS analysis
required sample extraction and purification first. Preliminary data from lipid extraction
trials revealed that the Bligh & Dyer extraction method was the most accurate and the
best fit method for recovering a triglyceride standard as well as the extraction of human
lipids from human serum. We concluded that triglycerides are one of the lipids that
effected and altered within human post-meal serum lipid levels as compared to fasting
serum lipid levels. Additional observations of the current data will be finalized once the
chemical screening of samples is completed using the HPLC/MS instrument. Preliminary
results and experimental structure and plans were presented in chapter 5, but due to the
COVID-19 lockdown, and the university shutdown, all sample extraction and HPLC/MS
analyses could not be completed.

Chapter 6 examined the design and use of a millifluidics device and portable absorbance
unit to measure human plasma lipid levels after fasting and after a high-fat, highcarbohydrate meal. The overarching goal was to design a millifluidic device and portable
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optical detection unit with greater convenience and robustness than current products on
the market now. The device configuration underwent one round of optimizations but
requires further design upgrades and improvements. The second-generation design still
revealed issues in reproducibility and accuracy of light absorbance voltage readings since
results using the same samples were sometimes different between tests. The device has
the potential to be expanded to measure lipoproteins in additional body liquids such as
tears, urine, and saliva to better understand lipid metabolism.
The new knowledge gained from this dissertation includes a simple dilution-based,
reagent-free method to discern lipemic status in donated blood samples. A ratiometric
analysis was conducted such that lipemic status could be discerned with a 99%
confidence from a single unknown sample. These results are partially corroborated with
UV-Vis lipoprotein standards as well as a gold-standard medical tool, HPLC-MS.
Additional knowledge was gained regarding the time-dependent reduction in lipid
profiles of participants consuming Hibiscus and Oolong teas as compared to the peach tea
control. While the participant study was interrupted due to COVID-19 lab closures, the
data obtained provides preliminary suggestive evidence that these teas do influence lipid
profiles over time. A new device was also engineered to demonstrate portable lipid
testing. Future work will involve measuring cholesterol levels in different human body
liquids such as tears, urine, skin, and saliva since research has been initiated into the
ability to use fluids other than blood (plasma or serum) for diagnostic testing. Using other
bio-fluids may make the test less invasive for the patient.
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A. Supplemental Materials of Chapter 3:
Analysis of Lipemic Levels of Human Blood Samples Compared to Low-Density, HighDensity, and Triglyceride Standards Using UV-Vis Spectroscopy:

Definitions:
Resistance (R): a degree of opposition to electric current flow, causing energy
dissipation, and is measured in ohms (Ω).
R = V/I
Whereas (V) is the crossing voltage and (I) is the current passing through.
Conductance (G): is the degree to which an object conducts electricity and is measured
in Siemens (S) or mhos (Ω).
G= I/V = 1/R
Whereas (V) is the crossing voltage and (I) is the current passing through it (Wikipedia).
Parallel Capacitance (C): is the ability to carry and hold charge.
Inductance (L): Property that opposes the change of current flowing through, and is
measured in henry (H).

Apolipoproteins classes and subclasses:
Apolipoproteins have two main types which can be derived from different types of
lipoproteins. These two major types of apolipoproteins are: apolipoproteins B which is
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derived of LDL lipoprotein particles and most of the rest of apolipoproteins are derived
of HDL lipoprotein particles. Apolipoprotein E is derivative of IDL lipoproteins.
Apolipoproteins have six main classes and several sub-classes:

1.
2.
3.
4.
5.
6.

Apolipoproteins A (apo A-I, apo A-II, apo A-IV, and apo A-V)
Apolipoproteins B (apo B48 and apo B100)
Apolipoproteins C (apo C-I, apo C-II, apo C-III, and apo C-IV)
Apolipoproteins D
Apolipoproteins E
Apolipoproteins H (Wikipedia)

UV-Vis dilutions figures:
3.5
3

Primary Peak
298nm

Absorbance (a. u.)

2.5
2

1.5
1

Secondary
Peak 412nm

Tertiary Peak
571nm

0.5
0

Wavelength (nm)
Fasting Plasma

Post-meal Plasma

Figure A-1 Comparisons between the fasting and post-meal plasma data of a healthy
donor at the optimum dilution (30%), data from (D1, F&PR3) blood donation. The
primary peak was at the wavelength range of 295-298 nm. The secondary peak was at the
wavelength 412 nm, consisting of a bigger under peak area for the fasting than the postmeal plasma. The tertiary peak was at 571 nm with same under peak area conclusion as
the secondary peak between fasting and post-meal.
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Under-curve area calculation:

Figure A-2 Graphical Presentation of the Trapezoidal Method 141
Based in the integration of Trapezoidal Rule 141:
𝑥2

∫ 𝑓(𝑥)𝑑𝑥 = [

𝑓(𝑥1 ) + 𝑓(𝑥2 )
] (𝑥2 − 𝑥1 )
2

𝑥1

When: x1 and x2 are wavelengths, 𝑓(𝑥1) and 𝑓(𝑥2) are neutralized absorbance.
𝑥2
𝑎 𝑥1 + 𝑎 𝑥2
] (𝑤𝑥2 − 𝑤𝑥1 )
∫ 𝑓(𝑥)𝑑𝑥 = [
2
𝑥1
𝑤2

𝑦1 + 𝑦2
](𝑥2 − 𝑥1 )
2

∫ 𝑓(𝑤)𝑑𝑤 = [
𝑤1

The total under-curve area calculation:
𝑥𝑛

𝑥𝑛

𝑥1

𝑥2

𝑥𝑛

∫ 𝑓(𝑥)𝑑𝑥 = ∑ (∫ 𝑓(𝑥)𝑑𝑥 + ∫ 𝑓(𝑥)𝑑𝑥 + ⋯ + ∫ 𝑓(𝑥)𝑑𝑥)
0

0

0

𝑥1

𝑥𝑛−1

A. Outliers’ calculation:
𝑖 − 0.5
𝑄(𝑝) = 𝑄 (
) = 𝑥𝑖
𝑛
As the table below shows, first we find the (𝑥𝑖 − 𝑥̀ )2 where xi is the total area of each
single run and x’ is the average of the total area. Second, we find the 𝑝 =
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𝑖−0.5
𝑛

whereas

(p) is the quantile, (i) is the total number of run and (n) is the total number of runs. From
this step, we find the variance of the∑𝑛1(𝑥𝑖 − 𝑥̀ )2 , which the variance equal to

2
∑𝑛
1 (𝑥𝑖 −𝑥̀ )

𝑛

.

Third, we find the standard deviation of the population, which equal to either standard
deviation of all xi or standard deviation of the variance. We rearrange the runs into new
order from the lowest to the highest value of the total area. Fourth, we find the lower
quartile Q(0.25) which equal to (Quartile. INC) of this [(Q(p) =xi),1], the upper quartile
Q(0.75) which equal to (Quartile. INC) of this [(Q(p) =xi),3], and interquartile range
(IQR) which equal to [Q(0.75)-Q(0.25)]. Finally, we find the lower fence which equals
[Q(0.25)-(1.5 IQR)], and find the upper fence which equals [Q(0.75)+(1.5 IQR)]. Any
total area that comes out of the range is outlier 142.

181

Table A-1 The Outliers Calculation of Fasting Plasma Samples Runs
Plasma Sample Fasting
Total
Xi - X' (Xi 𝒊
2
Type
Plasma
Area
X')
Sample
(Xi)
D1, R2
226.9
-43.26 1871.43 1

Average (x')

𝟓

Q(p)
= Xi

0.1

210.2

D1, R3

211.6

-58.56

3429.3

2

0.3

211.6

D1, R4

461

190.84

36419.9

3

0.5

226.9

D1, R5

241.1

-29.06

844.484

4

0.7

241.1

D1, R6

210.2

-59.96

3595.2

5

0.9

461

270.16

Sum (Xi - X')2

46160.3

Variance

9232.1

Standard
Deviation of
Population
Lower Quartile
Q (0.25)
Upper Quartile
Q (0.75)
Interquartile
Range IQR
Lower Fence

𝑷=
𝒊 −𝟎.𝟓

96.084

96.084

211.6
241.1
29.5
167.35

Upper Fence

285.35
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Table A-2 The Outliers Calculation of Post-meal Plasma Samples Runs
𝑷
Plasma Sample Post-meal
Total
Xi - X' (Xi - X')2 i
𝒊 − 𝟎. 𝟓
=
𝟓
Type
Plasma
area
Sample
(Xi)
D1, R1
599
41.88
1753.93
1
0.1

Average (x')

458.5

D1, R2

638.4

81.28

6606.44

2

0.3

518.4

D1, R3

458.5

-98.62

9725.90

3

0.5

571.3

D1, R4

518.4

-38.72

1499.24

4

0.7

599

D1, R5

571.3

14.18

201.07

5

0.9

638.4

557.12

Sum (Xi - X')2

19786.59

Variance

3957.32

Standard
deviation of
population
Lower quartile
Q (0.25)
Upper quartile
Q (0.75)
Interquartile
range IQR
Lower fence

Q(p)
= Xi

62.91

62.91
518.4
599
80.6
397.5

Upper fence

719.9
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Reproducibility data:
Primary Peak
298nm
Secondary Peak
412nm

Primary Peak
298nm
Secondary Peak
412nm

Post-meal Absorbance (a. u.)

Fasting Absorbance (a. u.)

Tertiary Peak
571nm
D1, R6

D1, R5
D1, R4

Outlier
D1, R3

Tertiary Peak
571nm
D1, R5
D1, R4
D1, R3
D1, R2

D1, R1

D1, R2

Wavelength (nm)

Wavelength (nm)

Figure A-3 Reproducibility of the area peaks of both the Fasting and Post-meal Plasma
data from different days of blood donations. (Fasting: Sept 8th –Nov 28th, 2016, Postmeal: June 30th – Nov 21st, 2016). Reproducibility of both conditions were results of a
healthy male donor at the optimum dilution of 30%.
Figure 9 shows the reproducibility data for fasting and post-meal conditions of five
different runs. All peaks of fasting samples were reproduced at the same wavelengths
with same strength of shape and under area size except run 4, which was statistically an
outlier. All peaks of post-meal samples were reproducing at the same wavelengths with
same strength of shape and under area size, however, the secondary shoulder of R2 was
shifted higher than the other runs and the secondary peak of R3 and R1 have the smallest
under peak area. The tertiary peak of R1 was almost non-existent. We conclude from the
Figure 9, the UV-VIS measurement results of the post-meal plasma using five different
plasma donations within the timespan between June 30th and November 21st of 2016 were
successfully reproduced. Samples excluded were due to loss of sample such that UV-Vis
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could not be run or other errors in sample handling/mislabeling. Outliers for successful
measurements are noted in the Figure.
Under-curve area calculation:
The under-curve area was calculated using the Trapezoidal Rule integration from x1 to x2,
with approximation of 𝑓(𝑥) assumed to vary linearly from x1 to x2. For more calculation
details, see appendix A.
Table 2 shows the resulted calculation of the under-curve area of the fasting plasma runs
reproducibility Figure. As we concluded from the reproducibility Figure 9 of the fasting
plasma runs, the run 4 was the outlier. We reasoned that this run led to dissimilar data
including place of blood donation, human error when transferring from the donation
tubes to the centrifuge tubes, and human error in the separation of plasma and RBCs and
transfer to their respective sample containers.
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Wavelength (nm)

Absorbance (a.u.)

Absorbance (a. u.)

Absorbance (a. u.)

Absorbance (a. u.)

Absorbance (a. u.)

Absorbance (a. u.)

Table A-3 Under-curve area calculation Comparison of Fasting (Average and Standard Deviation without the outlier run) and Postmeal Plasma at Same Wavelengths of the Five Different Areas of the First Donor (D1)
Total Area
Primary Peak primary
Secondary Peak secondary
Tertiary
Shoulder
Shoulder
Peak
Plasma Sample
Data

Wavelength (nm)

Wavelength (nm)

Wavelength (nm)

Wavelength (nm)

Wavelength (nm)
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FR2
FR3
FR4 (Outlier)
FR5

226.9
211.6
461.0
241.1

66.80
66.05
92.06
68.41

26.82
25.67
70.31
29.53

53.18
39.59
89.78
51.19

28.59
27.93
75.95
30.93

3.900
3.420
12.28
4.480

FR6
Average
PR1
PR2
PR3
PR4
PR5
Average

210.2
222.5 ± 14.55
599.0
638.4
458.5
518.4
571.3
581.8 ± 70.33

65.29
66.64 ± 1.330
93.90
84.70
95.11
101.3
104.4
96.08 ± 7.607

24.89
26.73 ± 2.030
82.42
81.44
74.91
285.0
121.1
92.49 ± 89.10

47.77
47.93 ± 5.990
97.64
106.9
80.27
99.69
116.7
105.2 ± 13.43

26.11
28.39 ± 1.990
117.3
123.2
77.41
85.87
96.27
105.7 ± 19.76

3.400
3.800 ± 0.510
20.73
24.12
11.68
13.78
17.81
19.11 ± 5.049

Outliers calculation:
Using descriptive statistics, we calculated the quartiles.
𝑖 − 0.5
𝑄(𝑝) = 𝑄 (
) = 𝑥𝑖
𝑛
Where (p) is the quantile of the data, (i) is the run number, (n) is the total number of the
runs, and (xi) is the total under-curve area of the run. Additional calculation details are
shown in Appendix A 142.
Table A-4 Outliers results of the Fasting and Post-meal Plasma Samples
Fasting Plasma
Total Area Post-meal Plasma
Total Area
Sample Data
Sample Data
Lower Fence
167.4
Lower Fence
397.5
R6
210.2
R3
458.5
R3
211.6
R4
518.4
R2
226.9
R5
571.3
R5
241.1
R1
599
Upper Fence
285.4
R2
638.4
R4
461
Upper Fence
719.9

Table 3 shows the lower fence of fasting samples at 167.4, which usually comes lower
than the smallest total area value, and upper fence at 285.4, which any total area value
that comes after it will be an outlier. Since run 4 of our fasting samples was higher than
the upper fence, it was an outlier. We inferred from Table 3 that there was likely a human
mix up while handling this sample.
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Convert the rpms to g-force:
Calculation formula: g = RCF (relative centrifugal force) = 0.00001118 × r × RPM,
where g = Relative centrifuge force, r = rotational radius (cm), and RPM = revolutions
per minute. http://www.centrifuge.jp/cgi-bin/calc-e.cgi
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B. Supplemental Materials of Chapter 4:
The Effect of Hibiscus sabdariffa, and Camellia sinensis (Oolong) Tea on Blood Lipids
Levels in Humans. LC-MC Lipid Profiling: Lipid Extraction from Human Serum to
Analysis Lipidemic Levels of Triglyceride, LDL, and HDL.

Table BB-1 Table of high-density lipoprotein (HDL) standard samples
Sample#
HDL level VHDL Stock VPBS vol.
HDL Molar
(mg/dL)
sol.
(mL)
Concentration
(mL)
1*
200
0.1538
0.8462
1
2
100
0.5
0.5
1
3
80
0.80
0.20
1
4
50
0.63
0.37
1
5
35
0.70
0.30
1
6
15
0.43
0.57
1
*To conduct the serial dilution with minimal HDL for each run, the VLDL Stock solution
relies upon the previous sample’s final solution (Total Vol. column).

Sample#

1
2
3
4
5
6

Table BB-2 Triglyceride standard samples
Triglyceride Iterative*
Plasma vol. VPBS sol.
level
VTrigl. Stock (L)
(L)
(mg/dL)
sol.
(L)
100
1
300
699
90
900
100
80
888.89
111.11
70
875
125
60
857.143
142.86
50
833.33
166.67

Triglyceride
Molar
Concentration
1000
1000
1000
1000
1000
1000

*VTrigl. Stock solution relies upon the previous sample’s final solution (Total Vol.
column).
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Table B-3 Plasma samples
Start
Plasma PBS
Final
concentration volume volume concentration
(%)
(%)
(L)
(L)
100
500
500
50
50
900
100
45
45
888.88
111.12
40
40
875
125
35
35
857.14
142.86
30
30*
833.32
166.68
25
25
800
200
20
20
750
250
15
15
666.66
333.34
10
10
500
500
5

Final
volume
(L)
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000

Furthermore, the studies in lipidomic have generated overwhelming amounts of data,
which need bioinformatics technology to aid in data processing for acquiring meaningful
biology information.
Determination of cholesterol level in blood is important in clinical applications 105.
According to the NIH National Heart, Lung, and Blood Institute, these values in Table 4
are the acceptable, borderline, and high cholesterol and triglyceride measurements for
adults. All values are in mg/dL (milligrams per deciliter) 116.

Table B-4 Cholesterol Level in Adults Blood
Total
HDL
LDL
Triglycerides
cholesterol cholesterol cholesterol (mg/dL)
(mg/dL)
(mg/dL)
(mg/dL)
Good
<200
<100
<149
40
Borderline 200-239
n/a
130-159
150-199
High
n/a
240
160
200
Low
n/a
<40
n/a
n/a
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The Cholesterol Reference Method Laboratory Network (CRMLN) was generated by
Centers for Disease Control and Prevention (CDCP), improving cholesterol
measurements by facilitating the in vitro diagnostic products manufacturing with the
effectiveness of their assays traceability to the National Reference System for Cholesterol
(NRS/CHOL). The CRMLN helps medical products manufactories to validate and
calibration their diagnostic products which can measure blood cholesterol level more
reliably in clinical laboratories tests 14.
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UV-Vis Data measurement of the plastic and glass cuvette:
Plastic Cuvette (empty)

Glass Cuvette (empty)

Plastic Cuvette - PBS Solution

0.03
0.02

0.8

0.01
0
190

390

590

790

-0.01

990

Absorbance

Absorbance

Quartz Cuvette - PBS Solution

1

0.6
0.4
0.2

-0.02

0

-0.03

190

Wavelength (nm)

390

590

790

990

Wavelength (nm)

Figure B-1 Comparison between Plastic and Glass Cuvette (Empty or PBS solution)

Tea study reproducibility UV-Vis Data measurement:
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Table B-5 Reproducibility (n=6-8) of the participant’s fasting and post-meal absorbance
values from a) baseline (n=8) b) 3 weeks (n=8), c) 6 weeks (n=8), and d) 9 weeks (n=6)
of the Hibiscus tea trial of plasma blood collections from eight healthy male and female
participants at the optimum dilution of 20%
Wavelength SD
Ave
Fasting T=3w
373
0.111
0.294
412
0.137
0.457
571
0.035
0.088
Post-meal T=3w 373
0.127
0.480
412
0.279
0.723
571
0.044
0.154
Fasting T=6w
373
0.039
0.281
412
0.116
0.501
571
0.021
0.092
Post-meal T=6w 373
0.144
0.447
412
0.255
0.716
571
0.047
0.146
Fasting T=9w
373
0.093
0.301
412
0.104
0.512
571
0.029
0.097
Post-meal T=9w 373
0.122
0.425
412
0.235
0.656
571
0.047
0.138
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Table B-6 Reproducibility (n=5) of the participants fasting and post-meal absorbance
values from a) baseline (n=5) b) 3 weeks (n=5), c) 6 weeks (n=5), and d) 9 weeks (n=5)
of the Oolong tea trial of plasma blood collections from five healthy male and female
participants at the optimum dilution of 20%
Wavelength SD
Ave
0.075
0.322
Fasting T=3w
373
0.108
0.510
412
0.030
0.106
571
0.414
0.697
Post-meal T=3w 373
0.548
0.832
412
0.181
0.244
571
0.049
0.308
Fasting T=6w
373
0.079
0.514
412
0.017
0.102
571
0.342
0.785
Post-meal T=6w 373
0.317
0.951
412
0.157
0.283
571
0.045
0.288
Fasting T=9w
373
0.065
0.455
412
0.026
0.096
571
0.451
0.652
Post-meal T=9w 373
0.437
0.779
412
0.181
0.231
571
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Table B-7 Reproducibility (n=3-4) of the participants fasting and post-meal absorbance
values from a) baseline (n=4) b) 3 weeks (n=4), c) 6 weeks (n=4), and d) 9 weeks (n=3)
of the peach tea trial of plasma blood collections from four healthy male and female
participants at the optimum dilution of 20%
Wavelength SD
Ave
0.063
0.264
Fasting T=3w
373
0.102
0.409
412
0.018
0.082
571
0.246
0.551
Post-meal T=3w 373
0.226
0.667
412
0.080
0.176
571
0.064
0.259
Fasting T=6w
373
0.081
0.407
412
0.024
0.086
571
0.274
0.550
Post-meal T=6w 373
0.234
0.604
412
0.089
0.165
571
0.040
0.256
Fasting T=9w
373
0.070
0.335
412
0.010
0.081
571
0.257
0.486
Post-meal T=9w 373
0.233
0.534
412
0.079
0.148
571
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Hibiscus Tea (G#1):
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Figure B-2 Hibiscus Tea Trial, Participant #1
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Figure B-3 Hibiscus Tea Trial, Participant #2
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Figure B-4 Hibiscus Tea Trial, Participant #3
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Figure B-5 Hibiscus Tea Trial, Participant #4
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Figure B-6 Hibiscus Tea Trial, Participant #5
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Figure B-7 Hibiscus Tea Trial, Participant #6
198

8
69

Wavelength (nm)

8
59

8
49

8
39

8
629

8
59

8
49

8
39

8
29

Wavelength (nm)

1

Absorbance (a. u.)

G#1, D#7, T=3w

G#1, D#7, T=0w

0.8
0.6

Fasting

0.4

Fasting

Post- meal

Post- meal

0.2
01

G#1, D#7, T=6w

Absorbance (a. u.)

0.8

G#1, D#7, T=9w

0.6
0.4
0.2

Fasting

Fasting

Post- meal

Post- meal

0
8
69

8
59

8
49

8
39

88
6299

8
59

8
49

8
39

8
29

Wavelength (nm)

Wavelength (nm)

Figure B-8 Hibiscus Tea Trial, Participant #7
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Figure B-9 Hibiscus Tea Trial, Participant #8
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Figure B-10 Oolong Tea Trial, Participant #1
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Figure B-11 Oolong Tea Trial, Participant #2
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Figure B-12 Oolong Tea Trial, Participant #3
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Figure B-13 Oolong Tea Trial, Participant #4
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Figure B-14 Oolong Tea Trial, Participant #5
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Figure B-15 Peach Tea Trial, Participant #1
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Figure B-16 Peach Tea Trial, Participant #2
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Figure B-17 Peach Tea Trial, Participant #3
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Figure B-18 Peach Tea Trial, Participant #4
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